
<html lang="en"     class="pb-page"  data-request-id="812911b0-2d9a-4b88-873d-b806a868b75f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm3009103;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist" /></meta><meta name="dc.Creator" content="Martin H.  Bolli" /></meta><meta name="dc.Creator" content="Christoph  Boss" /></meta><meta name="dc.Creator" content="Christoph  Binkert" /></meta><meta name="dc.Creator" content="Stephan  Buchmann" /></meta><meta name="dc.Creator" content="Daniel  Bur" /></meta><meta name="dc.Creator" content="Patrick  Hess" /></meta><meta name="dc.Creator" content="Marc  Iglarz" /></meta><meta name="dc.Creator" content="Solange  Meyer" /></meta><meta name="dc.Creator" content="Josiane  Rein" /></meta><meta name="dc.Creator" content="Markus  Rey" /></meta><meta name="dc.Creator" content="Alexander  Treiber" /></meta><meta name="dc.Creator" content="Martine  Clozel" /></meta><meta name="dc.Creator" content="Walter  Fischli" /></meta><meta name="dc.Creator" content="Thomas  Weller" /></meta><meta name="dc.Description" content="Starting from the structure of bosentan (1), we embarked on a medicinal chemistry program aiming at the identification of novel potent dual endothelin receptor antagonists with high oral efficacy. ..." /></meta><meta name="Description" content="Starting from the structure of bosentan (1), we embarked on a medicinal chemistry program aiming at the identification of novel potent dual endothelin receptor antagonists with high oral efficacy. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 16, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3009103" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3009103" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3009103" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3009103" /></link>
        
    
    

<title>The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3009103" /></meta><meta property="og:title" content="The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0017.jpeg" /></meta><meta property="og:description" content="Starting from the structure of bosentan (1), we embarked on a medicinal chemistry program aiming at the identification of novel potent dual endothelin receptor antagonists with high oral efficacy. This led to the discovery of a novel series of alkyl sulfamide substituted pyrimidines. Among these, compound 17 (macitentan, ACT-064992) emerged as particularly interesting as it is a potent inhibitor of ETA with significant affinity for the ETB receptor and shows excellent pharmacokinetic properties and high in vivo efficacy in hypertensive Dahl salt-sensitive rats. Compound 17 successfully completed a long-term phase III clinical trial for pulmonary arterial hypertension." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3009103"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3009103">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3009103&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3009103&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3009103&amp;href=/doi/10.1021/jm3009103" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7849-7861</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3008954" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300951u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+H.++Bolli">Martin H. Bolli</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph++Boss">Christoph Boss</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christoph++Binkert">Christoph Binkert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephan++Buchmann">Stephan Buchmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bur">Daniel Bur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Hess">Patrick Hess</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Iglarz">Marc Iglarz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Solange++Meyer">Solange Meyer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josiane++Rein">Josiane Rein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Rey">Markus Rey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Treiber">Alexander Treiber</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martine++Clozel">Martine Clozel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Fischli">Walter Fischli</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Weller">Thomas Weller</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 565 65 65. Fax: + 41 61 565 65 00. E-mail: <a href="/cdn-cgi/l/email-protection#8fe2eefdfbe6e1a1ede0e3e3e6cfeeecfbeae3e6e0e1a1ece0e2"><span class="__cf_email__" data-cfemail="3c515d4e485552125e535050557c5d5f485950555352125f5351">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3009103&amp;href=/doi/10.1021%2Fjm3009103" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7849–7861</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 3, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 June 2012</li><li><span class="item_label"><b>Published</b> online</span>16 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3009103" title="DOI URL">https://doi.org/10.1021/jm3009103</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3009103"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">15092</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">95</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3009103" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;H. Bolli&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;Boss&quot;},{&quot;first_name&quot;:&quot;Christoph&quot;,&quot;last_name&quot;:&quot;Binkert&quot;},{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;Buchmann&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bur&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Hess&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Iglarz&quot;},{&quot;first_name&quot;:&quot;Solange&quot;,&quot;last_name&quot;:&quot;Meyer&quot;},{&quot;first_name&quot;:&quot;Josiane&quot;,&quot;last_name&quot;:&quot;Rein&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Rey&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Treiber&quot;},{&quot;first_name&quot;:&quot;Martine&quot;,&quot;last_name&quot;:&quot;Clozel&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Fischli&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Weller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7849-7861&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3009103&quot;},&quot;abstract&quot;:&quot;Starting from the structure of bosentan (1), we embarked on a medicinal chemistry program aiming at the identification of novel potent dual endothelin receptor antagonists with high oral efficacy. This led to the discovery of a novel series of alkyl sulfamide substituted pyrimidines. Among these, compound 17 (macitentan, ACT-064992) emerged as particularly interesting as it is a potent inhibitor of ETA with significant affinity for the ETB receptor and shows excellent pharmacokinetic properties and high in vivo efficacy in hypertensive Dahl salt-sensitive rats. Compound 17 successfully completed a long-term phase III clinical trial for pulmonary arterial hypertension.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009103&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009103" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009103&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009103" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009103&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009103" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3009103&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009103&amp;href=/doi/10.1021/jm3009103" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3009103" /></input><a href="/doi/pdf/10.1021/jm3009103" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (678 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3009103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3009103%26sid%3Dliteratum%253Aachs%26pmid%3D22862294%26genre%3Darticle%26aulast%3DBolli%26date%3D2012%26atitle%3DThe%2BDiscovery%2Bof%2BN-%255B5-%25284-Bromophenyl%2529-6-%255B2-%255B%25285-bromo-2-pyrimidinyl%2529oxy%255Dethoxy%255D-4-pyrimidinyl%255D-N%25E2%2580%25B2-propylsulfamide%2B%2528Macitentan%2529%252C%2Ban%2BOrally%2BActive%252C%2BPotent%2BDual%2BEndothelin%2BReceptor%2BAntagonist%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D17%26spage%3D7849%26epage%3D7861%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jmcmar.2012.55.issue-17/production/jmcmar.2012.55.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from the structure of bosentan (<b>1</b>), we embarked on a medicinal chemistry program aiming at the identification of novel potent dual endothelin receptor antagonists with high oral efficacy. This led to the discovery of a novel series of alkyl sulfamide substituted pyrimidines. Among these, compound <b>17</b> (macitentan, ACT-064992) emerged as particularly interesting as it is a potent inhibitor of ET<sub>A</sub> with significant affinity for the ET<sub>B</sub> receptor and shows excellent pharmacokinetic properties and high in vivo efficacy in hypertensive Dahl salt-sensitive rats. Compound <b>17</b> successfully completed a long-term phase III clinical trial for pulmonary arterial hypertension.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The corresponding data sets have been deposited at the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, United Kingdom, <a href="http://www.ccdc.cam.ac.uk/" class="extLink">http://www.ccdc.cam.ac.uk/</a>, under the following deposition numbers: <a href="https://888522" class="ext-link">888522</a> (crystals from methanol), <a href="https://888506" class="ext-link">888506</a> (crystals from EtOAc/hexane).</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past decade, our understanding of the function of endothelin (ET) has evolved from describing it as a purely vascular factor regulating blood pressure<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> to recognizing it as a hormone influencing many cellular processes such as proliferation, apoptosis, and migration leading to tissue hypertrophy, remodeling, fibrosis, and inflammation.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> The three structurally closely related peptides, named endothelin-1 (ET-1), endothelin-2 (ET-2), and endothelin-3 (ET-3), are among the most potent vasoconstrictors known in humans. They convey their action through binding to two G-protein coupled receptors called ET<sub>A</sub> and ET<sub>B</sub>. Among the three isopeptides, ET-1 appears to be the key player in the cardiovascular system. ET-2 and ET-3 are specifically expressed in the gastrointestinal tract and the brain, respectively.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> On the vascular side, ET<sub>A</sub> receptors are mainly expressed on smooth muscle cells, mediating vasoconstriction, while ET<sub>B</sub> receptors expressed on endothelial cells and smooth muscle cells cause vasodilation and vasoconstriction, respectively. In addition, a wealth of tissue cells such as cardiomyocytes, renal cortex, and medulla cells, fibroblasts, macrophages, and neurons produce ET-1 and/or express the two ET receptors, illustrating that the ET system is not confined to the vasculature only.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Cross talk and receptor heterodimer formation has been proposed for the two ET receptors.<a onclick="showRef(event, 'ref6 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref6 ref12 ref13 ref14 ref15">(6, 12-15)</a> Both ET<sub>A</sub> and ET<sub>B</sub> receptors are involved in mediating ET-1 deleterious effects in diseases such as chronic heart failure, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, or kidney disease.<a onclick="showRef(event, 'ref6 ref7 ref10 ref16'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref10 ref16">(6, 7, 10, 16)</a> Furthermore, in many pathological situations, the ET system is up-regulated and a change in the ET<sub>A</sub>/ET<sub>B</sub> expression ratio in favor of ET<sub>B</sub> is observed in diseased tissue.<a onclick="showRef(event, 'ref11 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref11 ref17 ref18 ref19">(11, 17-19)</a> Several studies corroborate that increased activity of the ET system in tissue correlates with disease severity.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><div class="NLM_p">A large number of synthetic endothelin receptor antagonists have been investigated preclinically, and several small molecule inhibitors have been studied in clinical trials for chronic heart failure, hypertension, cancer, and fibrosis.<a onclick="showRef(event, 'ref5 ref22 ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref5 ref22 ref23 ref24 ref25 ref26 ref27">(5, 22-27)</a> Today, the dual ET<sub>A</sub>/ET<sub>B</sub> receptor antagonist bosentan (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> and the ET<sub>A</sub> selective antagonist (<i>S</i>)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid (ambrisentan)<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> are approved treatments for pulmonary arterial hypertension.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and in vitro activity of compound <b>1</b>. IC<sub>50</sub> values as measured with a <sup>125</sup>I-ET-1 binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When we initiated our medicinal chemistry program to identify a follow-up compound to sulfonamide <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), we decided that compound <b>1</b> should not only serve as the structural starting point for our quest for novel endothelin antagonists but should also represent the benchmark against which we gauge our novel compounds. A candidate suitable for clinical development needs to meet the following requirements: (1) The compound has to show a significantly increased potency on the ET<sub>A</sub> receptor when compared to compound <b>1</b>. (2) The compound should block the ET<sub>B</sub> receptor in vivo. (3) The compound needs to demonstrate oral efficacy superior to the one of compound <b>1</b> as assessed by measuring arterial blood pressure in conscious hypertensive Dahl salt-sensitive rats.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34-36)</a> (4) Pharmacokinetic properties assessed in animals must support once daily dosing in humans. (5) The compound should easily distribute into tissue in order to also reach ET receptors expressed in the tissue. (6) Because compound <b>1</b> inhibits the canalicular bile salt export pump,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> a candidate compound must be devoid of bile salt transport inhibition.</div><div class="NLM_p last">In the paragraphs below, we describe our efforts aimed at identifying a compound that meets all of the above criteria.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">The following description of the synthesis of a prototypical sulfonamide (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) and sulfamide (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) endothelin receptor antagonist shall illustrate the general approach chosen to prepare the compounds discussed in this manuscript.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Sulfonamide Endothelin Receptor Antagonists Exemplified with <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <b>6</b>, NH<sub>3</sub> in MeOH, rt, 16 h, (ii) MeOH, KOtBu, rt 3 h, 83–89% over 2 steps; (b) <b>3</b>, DMSO, rt, then <b>4</b>, rt, 16 h, 89%; (c) ethylene glycol, Na, 2 h, then <b>5</b>, 70–90 °C, 18 h, 73–91%; (d) <b>7</b>, THF, NaH, 1 h, then 2-chloro-5-bromopyrimidine, 75 °C, 2 h, 43%.</p></p></figure><div class="NLM_p">The preparation of the sulfonamide derivatives was carried out as previously described<a onclick="showRef(event, 'ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41 ref42">(38-42)</a> and usually started by reacting a dichloro-pyrimidine building block<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> (e.g., <b>3</b>) with a sulfonamide potassium salt (e.g., <b>4</b>) in DMSO at room temperature to give the monochloro-pyrimidine intermediate (e.g., <b>5</b>). The sulfonamide potassium salts were readily accessible by treating the respective sulfonyl chloride (e.g., <b>6</b>) with ammonia, followed by potassium <i>tert</i>-butylate in methanol, while the necessary dichloro-pyrimidines were obtained as described in the literature.<a onclick="showRef(event, 'ref40 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref40 ref42 ref43 ref44 ref45 ref46">(40, 42-46)</a> The monochlorides such as <b>5</b> were treated with a freshly prepared solution of sodium in ethylene glycol at elevated temperatures to give the corresponding alcohols (e.g., <b>7</b>). The alcohols were dissolved in THF and deprotonated with 2.5 equiv of sodium hydride and reacted with the respective 2-chloro- or 2-(methylsulfonyl) pyrimidines at elevated temperature. As reported earlier,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> these pyrimidines are either commercially available or prepared according to literature procedures.<a onclick="showRef(event, 'ref48 ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50 ref51 ref52">(48-52)</a> Final products such as <b>8</b> were obtained in good yields as white to beige powders after crystallization from methanol.</div><div class="NLM_p">The preparation of the various sulfamide building blocks needed for the synthesis of our sulfamide based endothelin receptor antagonists is exemplified with the propyl-sulfamide potassium salt <b>13</b> shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The procedure starts by reacting chlorosulfonyl isocyanate (<b>9</b>) dissolved in dichloromethane at 0 °C with 1 equiv of <i>tert</i>-butanol to give the BOC-protected amino-sulfonyl-chloride (<b>10</b>), which was subsequently added slowly to a solution of 1 equiv of the respective amine (e.g., <i>n</i>-propylamine) in the presence of 3 equiv of triethylamine in dichloromethane at 0 °C. The mixture was stirred overnight to drive the reaction to completion and was then concentrated. The residue was dissolved in a large volume of ethyl acetate. To avoid extraction of the BOC-protected sulfamides such as <b>11</b> into water, reagents and salts were removed by washing the ethyl acetate solution very carefully with a small volume of water and brine only. The organic extract was dried, and the sulfamide <b>11</b> was isolated by evaporating the solvent. This material was dissolved in approximately 5 M HCl in dioxane to affect BOC-deprotection. After stirring the mixture at room temperature for 4–8 h, the solvent was evaporated to give sulfamide <b>12</b>. The potassium salt <b>13</b> was obtained by dissolving <b>12</b> in methanol followed by the addition of potassium <i>tert</i>-butylate and subsequent evaporation of the solvent. Purification of the potassium salt <b>13</b> was achieved by trituration in diethylether and drying under high vacuum. Overall yields of the above process were good to excellent.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfamide Potassium Salt Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-BuOH, DCM, 0 °C to rt, 1 h; (b) add mixture prepared in (a) to propylamine, NEt<sub>3</sub>, DCM, 0 °C then 16 h rt; (c) 5 M HCl in dioxane, rt, 4–8 h; (d) MeOH, KOtBu, rt, 3 h, 46–98% over 4 steps.</p></p></figure><div class="NLM_p">Synthesis of the sulfamide based endothelin receptor antagonists followed the preparation of the corresponding sulfonamide analogues. As an example, the preparation of sulfamide <b>17</b> is outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Hence, reacting a dichloro-pyrimidine building block (e.g., <b>14</b><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>) with a sulfamide potassium salt such as <b>13</b> in DMSO at room temperature for 24–48 h gave the monochloro-pyrimidine intermediates (e.g., <b>15</b>). The ethylene-glycol side chain was introduced by applying similar conditions as described for the synthesis of the sulfonamides. Alternatively, the monochloride (e.g., <b>15</b>) was added to a mixture of 3 equiv of potassium <i>tert</i>-butylate and about 40 equiv of ethylene glycol in dimethoxyethane. These mixtures were usually heated to 90–100 °C for 24–70 h to furnish the corresponding alcohols (e.g., <b>16</b>) in yields of 70–90%. The final step, the attachment of the substituted pyrimidine, was performed as described for the sulfonamide derivatives in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. For the preparation of compound <b>17</b>, 2-chloro-5-bromo-pyrimidine was used. In general, the target compounds could be purified easily by recrystallization from methanol.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis of Sulfamide Endothelin Receptor Antagonists Exemplified with <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>14</b>, DMSO, rt, <b>13</b>, rt, 24–72 h, 83–93% (b) ethylene glycol, DME, KOtBu, 10 min, then <b>15</b>, 100 °C, 18–24h, 86–89%; (c) <b>16</b>, THF, NaH, 0.5–1 h, then 2-chloro-5-bromopyrimidine, 60–75 °C, 2 h, 88%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro SAR Discussion</h3><div class="NLM_p">Inspired by the structure of Tanabe’s clinical development compound <i>N</i>-(6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)-5-(<i>p</i>-tolyl)pyrimidin-4-yl)-4-(1-hydroxy-2-methylpropan-2-yl)benzenesulfonamide (T-0201, <b>2</b>)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we were curious to learn how the introduction of a pyrimidine to the ethylene glycol moiety of compound <b>1</b> would influence its affinity for the two endothelin receptors. In a first study illustrated by the compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, we observed that such an additional pyrimidine ring improves the affinity for ET<sub>A</sub> and ET<sub>B</sub> significantly. Compound <b>1</b> derivative <b>18</b>, for instance, is about 10 times more potent on ET<sub>A</sub> and about three times more active on ET<sub>B</sub> than compound <b>1</b> itself. A similar trend was observed with the pair of phenylethane sulfonamides <b>19</b> and <b>20</b>. Interestingly, also the weakly active methane sulfonamide derivative <b>21</b> profits from the introduction of a pyrimidine ring, and the resulting compound <b>22</b> is almost 10 times more potent on both ET<sub>A</sub> and ET<sub>B</sub> than compound <b>21</b>. We therefore had a closer look at the structure–activity relationship (SAR) of this additional pyrimidine moiety. While various substituents were tolerated in the 5-position of the pyrimidine, substituents in positions 4 and/or 6 clearly hampered the compound’s affinity for the ET receptors. This is illustrated with some examples of the phenylethane sulfonamide series compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. A comparable SAR, however, was observed with other scaffolds. Compared to the unsubstituted pyrimidine derivative <b>20</b>, the 5-methyl analogue <b>23</b> is less potent on both receptors. On the other hand, a 5-chloro (<b>24</b>), 5-bromo (<b>8</b>), 5-methoxy (<b>25</b>), 5-methylthio (<b>26</b>), and a 5-trifluoromethyl (<b>27</b>) substituent all led to a similarly improved affinity for ET<sub>A</sub>. While the bromo-, methoxy-, and trifluoromethyl substituent improved the potency on ET<sub>B</sub> only slightly, a 5-methylthio group increased the compound’s affinity for this receptor significantly. The 5-cyclopropyl substitutent in <b>28</b> reproduced the profile of its unsubstituted analogue <b>20</b>. As illustrated with compound <b>29</b>, a 4,6-disubstitution pattern yielded only poorly active compounds.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and in vitro activity of compound <b>2</b>. IC<sub>50</sub> values as measured with a <sup>125</sup>I-ET-1 binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Additional Pyrimidine at Ethylene Glycol<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>A</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>B</sub> [nM]</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>A</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>B</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4-<i>tert</i>-butyl phenyl</td><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">45.0</td><td class="colsep0 rowsep0" align="char" char=".">202</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phenethyl</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">25.7</td><td class="colsep0 rowsep0" align="char" char=".">1131</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">465</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">4534</td><td class="colsep0 rowsep0" align="char" char=".">9506</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">739</td><td class="colsep0 rowsep0" align="char" char=".">1765</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of Pyrimidine<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>A</sub> [nM]</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>B</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">465</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">5-methyl</td><td class="colsep0 rowsep0" align="char" char=".">17.8</td><td class="colsep0 rowsep0" align="char" char=".">1501</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">5-chloro</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">461</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">5-bromo</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">216</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">5-methoxy</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">202</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">5-methylthio</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">5-trifluoromethyl</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">145</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">5-cyclopropyl</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">424</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4,6-dimethoxy</td><td class="colsep0 rowsep0" align="char" char=".">4775</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements.</p></div></div></div><div class="NLM_p">On the one hand attaching a 5-bromo or a 5-methylthio-pyrimidine to the ethylene glycol moiety brought us closer to our goal of identifying endothelin antagonists more potent than compound <b>1</b>. On the other hand, these new compounds contain five aromatic rings and have a molecular weight well above 600 g/mol and therefore certainly do not qualify as lean molecules. In view of this, we carefully scrutinized the three substituents attached to positions 2, 4, and 5 of the core pyrimidine for possibilities to reduce the molecule’s size. For these studies, we kept the 5-bromo-pyrimidine residue at the ethylene glycol constant. The compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> document the SAR of the sulfonamide part in position 4. Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> illustrate the influence of the substituents in position 2 and 5, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. From Sulfonamides to Sulfamides<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0009.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ET<sub>A</sub> [nM]</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ET<sub>B</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">4-<i>tert</i>-butyl phenyl</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">19.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="center">10.4</td><td class="colsep0 rowsep0" align="center">341</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="center">73</td><td class="colsep0 rowsep0" align="center">3479</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">phenethyl</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="center">216</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3-phenyl-propyl</td><td class="colsep0 rowsep0" align="center">6.7</td><td class="colsep0 rowsep0" align="center">377</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="center">113</td><td class="colsep0 rowsep0" align="center">1146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="center">9.4</td><td class="colsep0 rowsep0" align="center">566</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl</td><td class="colsep0 rowsep0" align="center">4.3</td><td class="colsep0 rowsep0" align="center">552</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">benzyl-NH–</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="center">147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">methyl-NH–</td><td class="colsep0 rowsep0" align="center">7.9</td><td class="colsep0 rowsep0" align="center">194</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">ethyl-NH–</td><td class="colsep0 rowsep0" align="center">9.9</td><td class="colsep0 rowsep0" align="center">655</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl-NH–</td><td class="colsep0 rowsep0" align="center">3.8</td><td class="colsep0 rowsep0" align="center">322</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl-NH–</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">167</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-benzyl-methyl-N-</td><td class="colsep0 rowsep0" align="center">7.0</td><td class="colsep0 rowsep0" align="center">457</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">morpholino</td><td class="colsep0 rowsep0" align="center">187</td><td class="colsep0 rowsep0" align="center">1474</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements. Note that compounds <b>8</b> and <b>30</b>–<b>37</b> represent sulfonamides, while compounds <b>38</b>–<b>44</b> represent sulfamides.</p></div></div></div><div class="NLM_p">In a first step, we removed the <i>tert</i>-butyl group attached to the benzene sulfonamide moiety. This resulted in a 10-fold loss of affinity for both ET receptors. When a CH<sub>2</sub> group was introduced as linker between the phenyl ring and the sulfur to give compound <b>32</b>, a further loss of affinity was observed. Interestingly, moving the phenyl two CH<sub>2</sub> units away from the sulfonamide moiety (compound <b>8</b>) restored the compound’s affinity completely for the ET<sub>A</sub> receptor and partially for the ET<sub>B</sub> receptor. The affinity profile of phenyl-propane sulfonamide <b>33</b> is very similar to the one of the ethane analogue <b>32</b>. These observations combined with our aim to reduce molecular weight prompted us to study compounds lacking a phenyl ring in the sulfonamide part. Not unexpectedly though, the methane sulfonamide derivative <b>34</b> showed only moderate potency on the ET<sub>A</sub> receptor. Much to our delight, however, the ethane sulfonamide <b>35</b> was almost as potent as the much bulkier phenylethane sulfonamide <b>8</b>. As shown with compounds <b>36</b> and <b>37</b>, the affinity for ET<sub>A</sub> improves steadily with increasing length of the alkyl chain. No such trend was observed with the ET<sub>B</sub> receptor. In a next step, we prepared a number of compounds wherein the sulfonamide moiety was replaced by a sulfamide group. As illustrated with compounds <b>38</b>–<b>43</b>, these novel sulfamide derivatives represent potent ET receptor antagonists. Only the morpholine derivative <b>44</b> shows some loss of affinity toward the two receptors. Compared to the corresponding sulfonamides, the sulfamides have almost identical affinity for the ET<sub>A</sub> receptor (e.g., compare <b>8</b> with <b>38</b>, <b>35</b> with <b>39</b>, <b>36</b> with <b>40</b>, <b>37</b> with <b>41</b>). In contrast to the sulfonamide series, however, the IC<sub>50</sub> value for the ET<sub>B</sub> receptor improves with increasing length of the sulfamide alkyl chain. More importantly, the sulfamides show a trend toward improved potency on ET<sub>B</sub>. This observation clearly moved the sulfamides into the focus of our interest. For the following studies, we selected sulfamide <b>38</b> as a reference compound. Hence, while keeping the benzyl sulfamide moiety constant, we prepared a series of analogues with different substituents in position 2 of the core pyrimidine. Several examples are compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The pyrazine (<b>45</b>) and morpholine (<b>47</b>) derivatives showed an affinity profile almost identical to the one of the pyrimidine analogue <b>38</b>. The pyridine derivative <b>46</b>, on the other hand, lost potency, in particular on the ET<sub>B</sub> receptor. As illustrated with compounds <b>48</b> and <b>49</b>, the loss in affinity is clearly more pronounced for the 2-cyclopropyl (<b>48</b>) and the 2-methoxy (<b>49</b>) substituted pyrimidine scaffolds. The 2-methoxy–ethoxy substituent in compound <b>50</b> led to a small loss in affinity for both receptors when compared to <b>38</b>. Interestingly, complete removal of the substituent in position 2 of the core pyrimidine (<b>51</b>) reproduced the affinity profile of compound <b>50</b>, suggesting that the contribution of the 2-substituent to the binding affinity is small. This encouraged us to further evaluate the sulfamide series with scaffolds lacking a substituent in position 2 of the core pyrimidine. We therefore prepared a number of 2-unsubstituted pyrimidine derivatives incorporating a selection of 5-substituents that were known to lead to potent ET receptor antagonists.<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57 ref58">(53-58)</a> Some examples are compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. As shown with compounds <b>52</b> and <b>53</b>, a 3-methoxyphenoxy rather than a 2-methoxyphenoxy substituent led to an increase in potency on ET<sub>A</sub> but left the affinity for ET<sub>B</sub> unchanged. An unsubstituted phenyl ring directly bound to the core pyrimidine as in <b>54</b> had no impact on ET<sub>A</sub> affinity but caused a significant loss in the activity on ET<sub>B</sub>. Introducing a methyl group (<b>55</b>), or a chlorine (<b>56</b>) or bromine (<b>57</b>) atom to the para position of the phenyl ring improved the compounds’ affinity for both receptors significantly. Introducing even larger alkyl groups, as shown with compounds <b>58</b> and <b>59</b>, did not improve the compound’s affinity any further. In fact, both compounds showed a clearly reduced potential to block the ET<sub>B</sub> receptor.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of Scaffold: 2-Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0010.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>A</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> [nM]</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>B</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">2-pyrimidinyl</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">2-pyrazinyl</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">4-pyridyl</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">561</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">4-morpholinyl</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">192</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">1082</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">methoxy</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">2490</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">2-methoxy-ethoxy</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">554</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">hydrogen</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">525</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimization of Scaffold: 5-Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0011.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ET<sub>A</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> [nM]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ET<sub>B</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> [nM]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">max ΔMAP<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> [mmHg]</th><th class="colsep0 rowsep0" align="center">ABC<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> [mm Hg·h] (<i>n</i>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="center">202</td><td class="colsep0 rowsep0" align="center">–7 ± 4</td><td class="colsep0 rowsep0" align="center">–88 (8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">3-methoxyphenoxy</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">457</td><td class="colsep0 rowsep0" align="center">–10 ± 4</td><td class="colsep0 rowsep0" align="center">–245 (5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">2-chloro-5-methoxyphenoxy</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">712</td><td class="colsep0 rowsep0" align="center">–24 ± 5</td><td class="colsep0 rowsep0" align="center">–639 (5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="center">6.8</td><td class="colsep0 rowsep0" align="center">5067</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="center">0.7</td><td class="colsep0 rowsep0" align="center">441</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">506</td><td class="colsep0 rowsep0" align="center">–18 ± 6</td><td class="colsep0 rowsep0" align="center">–593 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">461</td><td class="colsep0 rowsep0" align="center">–14 ± 3</td><td class="colsep0 rowsep0" align="center">–445 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">4-ethylphenyl</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="center">1264</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">4-isopropyl-phenyl</td><td class="colsep0 rowsep0" align="center">3.6</td><td class="colsep0 rowsep0" align="center">2474</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Maximal mean arterial blood pressure reduction as extracted from the moving average over 6 h.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Area between curve (ABC) as calculated from the blood pressure recordings 24 h before and after administration of 3 mg/kg of the compound to conscious hypertensive Dahl salt-sensitive rats, max. ΔMAP = maximal reduction in mean arterial blood pressure; <i>n</i> = number of animals in the experiment, nd = not determined.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">For the structure of compound <b>1</b>, see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</p></div></div></div><div class="NLM_p last">In brief, the SAR studies discussed so far have shown that: (1) Introduction of a 5-bromo- or 5-methylthiopyrimidine to the ethylene glycol improves the compound’s affinity for both ET receptors significantly (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). (2) The bulky 4-<i>tert</i>-butyl benzene sulfonamide in compound <b>1</b> can be replaced by a benzyl or alkyl sulfamide moiety (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). (3) Sulfamide derivatives are more potent on ET<sub>B</sub> when compared to the corresponding sulfonamide analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). (4) A 2-substituent at the core pyrimidine is not mandatory to obtain potent ET antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). (5) A 3-methoxyphenoxy, 4-methylphenyl, 4-chlorophenyl, or 4-bromophenyl residue attached to position 5 of the core pyrimidine leads to potent ET receptor antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Efficacy Assessment</h3><div class="NLM_p">In a next step, we assessed in vivo the oral efficacy of some of the most potent examples listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. For this purpose, we measured the blood pressure lowering effect following oral administration by gavage of 3 mg/kg of each compound in conscious hypertensive Dahl salt-sensitive rats equipped with telemetry.<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59-61)</a> In this model, efficient blockade of the ET receptors results in a significant reduction of mean arterial blood pressure.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The pharmacological response was quantified by calculating the area between the curves (ABC) of the blood pressure recordings 24 h before and after treatment. As this experiment allowed for rapid and reliable assessment of the in vivo efficacy, we did not measure pharmacokinetic properties prior to pharmacological testing. In all experiments, the heart rate remained unaffected (data not shown). At an oral dose of 3 mg/kg, compound <b>1</b> maximally reduced mean arterial blood pressure by −7 ± 4 mmHg. The duration of action was about 15 h, which translated into an ABC of −88 mmHg·h (<i>n</i> = 8) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). A maximal reduction of mean arterial blood pressure by −30 ± 3 mmHg was achieved with a dose of 100 mg/kg. At this dose, compound <b>1</b> was active for about 72 h and displayed an ABC of −896 mmHg·h (<i>n</i> = 5).</div><div class="NLM_p">As apparent from the in vivo data given in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, compounds incorporating a 3-methoxyphenoxy (<b>52</b>), 2-chloro-5-methoxyphenoxy (<b>53</b>), a 4-chlorophenyl (<b>56</b>), or a 4-bromophenyl (<b>57</b>) substituent at position 5 of the core pyrimidine clearly exceeded the in vivo activity of compound <b>1</b>. At this point, we decided to evaluate sulfamides with a 4-bromophenyl substituted pyrimidine scaffold in more detail. Several examples prepared for this study are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. For the ET<sub>A</sub> receptor, the 4-bromophenyl derivatives reproduce the relative SAR observed with the corresponding 2-methoxyphenoxy analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) on a higher potency level (e.g., <b>39</b> vs <b>60</b>, <b>40</b> vs <b>61</b>, <b>44</b> vs <b>65</b>), and several compounds reach affinities below 1 nM. With respect to ET<sub>B</sub>, the relative SAR between the 4-bromophenyl derivatives and the 2-methoxyphenoxy-analogues is again similar. However, this time the bromo-phenyl derivatives in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> are often less potent when compared to their analogues in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (e.g., <b>38</b> vs <b>57</b>, <b>43</b> vs <b>64</b>). Notable exceptions are compounds <b>17</b> and <b>62</b>, which both retain their ET<sub>B</sub> affinity.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Optimization of the Sulfamide Moiety<a class="ref internalNav" href="#t6fn4" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0012.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> ET<sub>A</sub><a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> [nM]</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> ET<sub>B</sub><a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> [nM]</th><th class="colsep0 rowsep0" align="center">max ΔMAP<a class="ref internalNav" href="#t6fn2" aria-label="c">c</a> [mmHg]</th><th class="colsep0 rowsep0" align="center">ABC<a class="ref internalNav" href="#t6fn3" aria-label="d">d</a> [mm Hg·h] (<i>n</i>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">benzyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="center">461</td><td class="colsep0 rowsep0" align="center">–14 ± 3</td><td class="colsep0 rowsep0" align="center">–445 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">methyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="center">812</td><td class="colsep0 rowsep0" align="center">–21 ± 6</td><td class="colsep0 rowsep0" align="center">–1045 (5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">ethyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="center">830</td><td class="colsep0 rowsep0" align="center">–20 ± 10</td><td class="colsep0 rowsep0" align="center">–598 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="center">391</td><td class="colsep0 rowsep0" align="center">–25 ± 6</td><td class="colsep0 rowsep0" align="center">–922 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="center">158</td><td class="colsep0 rowsep0" align="center">–16 ± 4</td><td class="colsep0 rowsep0" align="center">–443 (5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl-NH–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="center">1474</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-benzyl-methyl-N–</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="center">5208</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">morpholino</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="center">2829</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl-NH–</td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="center">784</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl-NH–</td><td class="colsep0 rowsep0" align="left">3-methoxyphenoxy</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="center">468</td><td class="colsep0 rowsep0" align="center">–15 ± 3</td><td class="colsep0 rowsep0" align="center">–391 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl-NH–</td><td class="colsep0 rowsep0" align="left">6-chloro-3-methoxyphenoxy</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="center">208</td><td class="colsep0 rowsep0" align="center">–21 ± 5</td><td class="colsep0 rowsep0" align="center">–500 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="center">3058</td><td class="colsep0 rowsep0" align="center">–25 ± 4</td><td class="colsep0 rowsep0" align="center">–1116 (6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl</td><td class="colsep0 rowsep0" align="left">4-bromophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="center">2424</td><td class="colsep0 rowsep0" align="center">–22 ± 3</td><td class="colsep0 rowsep0" align="center">–734 (5)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn4"><div class="footnote" id="t6fn4"><sup>a</sup><p class="last">Note that compounds <b>17</b>, <b>57</b>, and <b>60</b>–<b>68</b> represent sulfamides, while compounds <b>69</b> and <b>70</b> are sulfonamides.</p></div><div class="footnote" id="t6fn1"><sup>b</sup><p class="last">IC<sub>50</sub> values as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing either the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptor, respectively. Data are given as geometric means of at least three independent measurements.</p></div><div class="footnote" id="t6fn2"><sup>c</sup><p class="last">Maximal mean arterial blood pressure reduction as extracted from the moving average over 6 h.</p></div><div class="footnote" id="t6fn3"><sup>d</sup><p class="last">Area between curve (ABC) as calculated from the blood pressure recordings 24 h before and after administration of 3 mg/kg of the compound to conscious hypertensive Dahl salt-sensitive rats; max ΔMAP = maximal reduction in mean arterial blood pressure; <i>n</i> = number of animals in the experiment; nd = not determined.</p></div></div></div><div class="NLM_p">When we tested the sulfamides of Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> in our rat model of hypertension, compounds incorporating a rather small alkyl sulfamide showed excellent in vivo activity (e.g., <b>60</b>, <b>61</b>, <b>17</b>). The propyl-sulfamide <b>17</b> emerged as a particularly interesting compound as it combined high in vivo efficacy with high potency on ET<sub>B</sub>. We therefore extended our study to the three propyl sulfamides incorporating a 4-chlorophenyl (<b>66</b>), a 3-methoxyphenoxy (<b>67</b>), or a 6-chloro-3-methoxyphenoxy (<b>68</b>) substituent in position 5 of the core pyrimidine (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The in vitro activity of compound <b>66</b> was inferior to the one of compound <b>17</b> as it was clearly less potent on ET<sub>B</sub>. While the 3-methoxyphenoxy derivative <b>67</b> was only slightly less potent than <b>17</b>, the chloro substituted analogue <b>68</b> was more potent on ET<sub>B</sub>. However, both compounds <b>67</b> and <b>68</b> showed a clearly lower activity in vivo. A comparison of sulfamide <b>17</b> with sulfonamides <b>69</b> and <b>70</b> confirmed our earlier finding that the sulfamides present a significantly higher affinity for the ET<sub>B</sub> receptor. In our context, the sulfonamides <b>69</b> and <b>70</b> are therefore clearly less attractive despite their high in vivo activity in the Dahl salt-sensitive rat model of hypertension (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_p">In brief, the <i>n</i>-propylsulfamide derivative <b>17</b>, later named macitentan,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> fulfilled the requirements we set forth at the beginning of our discovery program. Sulfamide <b>17</b> is highly potent on the ET<sub>A</sub> receptor with significant affinity for the ET<sub>B</sub> receptor and maximally reduces mean arterial blood pressure for at least 60 h at an oral dose of 3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Following a dose–response experiment, maximal reduction of mean arterial blood pressure by −25 ± 6 mmHg was reached with a dose of 3 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). No change in heart rate was observed over the range of 1–100 mg/kg in conscious Dahl salt-sensitive rats (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, data not shown). In a multiple dose experiment, Dahl salt-sensitive rats were treated for five consecutive days with 1 mg/kg/day of <b>17</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Mean arterial blood pressure was stably reduced by −20 mmHg over the whole treatment period and returned to baseline about 48 h after the last dose was given. No signs of tachyphylaxis were observed, and no rebound effect manifested at the end of the study as blood pressure values returned to baseline.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mean arterial blood pressure (MAP, left) and heart rate (HR, right) recordings in conscious hypertensive Dahl salt-sensitive rats before (control) and after oral administration of 3 mg/kg of compound <b>17</b>. Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curve of mean arterial blood pressure (MAP) reduction and area between curves (ABC) in hypertensive Dahl salt-sensitive rats after oral administration of compound <b>17</b> in 5% arabic gum. Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean arterial blood pressure (MAP) recordings of a repeated dose experiment administering 1 mg/kg/day of compound <b>17</b> over five consecutive days to hypertensive Dahl salt-sensitive rats equipped with telemetry (ABC = 1842 mmHg·h). Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In view of the excellent pharmacodynamic behavior of compound <b>17</b>, it came as no surprise that <b>17</b> also showed favorable pharmacokinetic properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In an iv experiment with male Wistar rats, the compound showed a low plasma clearance of 6.7 mL/min·kg translating into a half-life of 5.1 h. The volume of distribution reached 1.8 L/kg, indicating that the compound is distributing well into tissues. At an oral dose of 10 mg/kg, compound <b>17</b> reached a peak plasma concentration of 1670 ng/mL at 6 h after administration. Oral bioavailability was 69%. A similar pharmacokinetic behavior was found in the dog, emphasizing the compound’s attractiveness for further development. In the dog, compound <b>17</b> was rapidly (<i>T</i><sub>max</sub> = 2 h) and almost completely (<i>F</i> = 87%) absorbed and reached plasma concentrations close to 5000 ng/mL after oral administration of 10 mg/kg. Clearance and half-life are comparable in rat and dog.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PK Parameters of <b>17</b> in Male Wistar Rats and Male Beagle Dogs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">iv dose<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> [mg/kg]</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–inf</sub> [ng h/mL]</th><th class="colsep0 rowsep0" align="center" char="±">CL [mL/min·kg]</th><th class="colsep0 rowsep0" align="center" char="±">Vss [L/kg]</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> [h]</th><th class="colsep0 rowsep0" align="center" char=".">oral dose<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> [mg/kg]</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–inf</sub> [ng h/mL]</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> [ng/mL]</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> [h]</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> [%]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Wistar rat (<i>n</i> = 5)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">2680 ± 730</td><td class="colsep0 rowsep0" align="char" char="±">6.7 ± 2.1</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 1.9</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">18500 ± 8100</td><td class="colsep0 rowsep0" align="char" char="±">1670 ± 371</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beagle dog (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">3170 ± 520</td><td class="colsep0 rowsep0" align="char" char="±">5.4 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">27500 ± 6500</td><td class="colsep0 rowsep0" align="char" char="±">4590 ± 2540</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">87</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Wistar rat: solution in 50 mM aqueous tris(hydroxymethyl)methylamine (Tris) pH 8.3 buffer containing 45% PEG400; beagle dog: solution in 25% <i>N</i>-methylpyrrolidone (NMP), 25% PEG400, 50% 50 mM aqueous Tris pH 8.3 buffer.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Wistar rat: suspension in 7.5% aqueous modified gelatin; beagle dog: solution in PEG400.</p></div></div></div><div class="NLM_p">In the course of our PK studies we discovered that compound <b>17</b> is metabolized to the depropylated sulfamide <b>71</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). This compound represents a major metabolite reaching plasma exposure levels 4–5 times higher than that of <b>17</b>. Sulfamide <b>71</b> binds to the ET<sub>A</sub> and ET<sub>B</sub> receptors with IC<sub>50</sub> values of 3.4 and 987 nM, respectively and therefore clearly adds to the pharmacological activity of the parent compound <b>17</b>.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> As we learned later, metabolite <b>71</b> is also formed in humans.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Interestingly, oral administration of 10 mg/kg of the butyl analogue <b>62</b> to Wistar rats also led to significant plasma concentrations (<i>C</i><sub>max</sub> = 4100 ng/mL at 6 h after administration) of sulfamide <b>71</b>.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stucture of sulfamide <b>71</b>, a major metabolite of compound <b>17</b> in Wistar rats and Beagle dogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In 10.9% of the patients treated with compound <b>1</b>, a transient, dose dependent increase in serum liver aminotransferase levels of >3 times the upper limit of normal is observed.<a onclick="showRef(event, 'ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref66">(64-66)</a> Mechanistically, this observation has been attributed to the ability of compound <b>1</b> to inhibit bile salt transport in hepatocytes, eventually leading to intrahepatic cholestasis.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Minimizing the interaction of a potential follow-up compound with hepatic bile acid transport has therefore been a further goal of our optimization efforts. Several compounds have been assessed for their potential to interact with bile salt transport in a rat model,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and compound <b>17</b> showed no sign of bile salt transport inhibition in this model (data not shown).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, starting from the structure of compound <b>1</b>, we have discovered a novel series of highly potent ET receptor antagonists. While these novel compounds are still based on a pyrimidine core, the <i>tert</i>-butyl benzene sulfonamide part of compound <b>1</b> has been replaced by a series of simple alkyl sulfamide moieties. When compared to the corresponding sulfonamides, these novel sulfamides are characterized by an enhanced affinity for the ET<sub>B</sub> receptor, rendering them a particularly interesting class of novel ET receptor antagonists. In addition, many of these sulfamides show high oral efficacy in reducing arterial blood pressure in conscious hypertensive Dahl salt-sensitive rats. In vivo dealkylation of the alkyl sulfamide moiety in compounds <b>17</b> and <b>62</b>, for instance, to the pharmacologically active sulfamide <b>71</b> is another interesting feature of the sulfamide class as it leads to sustained pharmacological activity.</div><div class="NLM_p last">Sulfamide <b>17</b> emerged as a highly attractive candidate for further studies and can be characterized as a potent ET<sub>A</sub> receptor antagonist with significant affinity for the ET<sub>B</sub> receptor. In rat and dog models, the compound is well absorbed, distributes well into tissue, and is slowly cleared, suggesting that it is suitable for once daily dosing in humans. Recently published data on a phase I clinical trial with compound <b>17</b> confirm these expectations.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> In hypertensive Dahl salt-sensitive rats, <b>17</b> efficiently and dose dependently reduced the arterial blood pressure. More detailed studies with sulfamide <b>17</b> on its tissue penetration and ability to block the ET<sub>A</sub> and ET<sub>B</sub> receptor in vivo have been described in a separate publication.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In a rat model, compound <b>17</b> did not increase plasma bile salt concentrations. Compound <b>17</b> successfully completed a phase III clinical trial for pulmonary arterial hypertension recently.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> A phase IIIb clinical trial for digital ulcers<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> and a phase I/Ib trial for recurrent glioblastoma<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> are currently ongoing.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">All reagents and solvents were used as purchased from commercial sources (Sigma-Aldrich Switzerland, Lancaster Synthesis GmbH, Germany, Acros Organics USA). Moisture sensitive reactions were carried out under an argon atmosphere. Progress of the reactions was followed either by thin-layer chromatography (TLC) analysis (Merck, 0.2 mm silica gel 60 F<sub>254</sub> on glass plates) or by LC-MS. LC-MS: UltiMate 3000 RS pump, UltiMate 3000 column compartment (40 °C), UltiMate 3000 RS DAD, MSQplus (all Dionex, Switzerland), Sedex 85 ELSD (Sedere, VWR Germany). Column: Zorbax SB-AQ, 5 μm, 120 Å, 4.6 mm × 50 mm (Agilent). Gradient: 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid, within 1 min. Flow: 4.5 mL/min. Or LC-MS*: Waters Micromass; ZMD-platform with ESI-probe with Alliance 2790 HT. Colum: Gromsil ODS4, 3 μm, 120 Å; 2 mm × 30 mm. Gradient: 0–100% acetonitrile in water containing 0.05% formic acid, within 6 min. Flow: 0.45 mL/min; <i>t</i><sub>R</sub> is given in min. Purity of the target compounds was confirmed on two additional columns: on a Waters Atlantis T3, 5 μm, 4.6 mm × 30 mm, eluting with a gradient of 5–95% of acetonitrile in water containing 0.04% of trifluoroacetic acid; and on a Waters XBridge C18, OBD, 5 μm, 4.6 mm × 50 mm (Waters, Switzerland), eluting with a gradient of 5–95% of acetonitrile in water containing 13 mM of NH<sub>3</sub>. According to these three LC-MS analyses, all compounds showed a purity >95% (UV at 230 nm), and about 80% of the compounds showed a purity >98%. Purity and identity was further confirmed by NMR spectroscopy. HR-LC-MS: analytical pump, Waters Acquity Binary, Solvent Manager. MS: SYNAPT G2MS, source temperature 150 °C, desolvatation temperature 400 °C, desolvatation gas flow 400 L/h. Cone gas flow: 10 L/h. Extraction cone: 4 RF. lens: 0.1 V. Sampling cone: 30. Capillary: 1.5 kV. High resolution mode. Gain: 1.0. MS function: 0.2 s per scan, 120–1000 amu in full scan, centroid mode. Lock spray: leucine enkephalin 2 ng/mL (556.2771 Da) scan time 0.2 s with interval of 10 s and average of five scans. DAD: Acquity UPLC PDA detector. Column: Acquity UPLC BEH C18 1.7 μm 2.1 mm × 50 mm from Waters, thermostatted in the Acquity UPLC column manager at 60 °C. Eluents: water + 0.05% formic acid; B, acetonitrile + 0.05% formic acid. Gradient: 2–98% B over 3.0 min. Flow: 0.6 mL/min. Detection: UV 214 nm and MS, <i>t</i><sub>R</sub> is given in min. Prep HPLC: Waters XBridge Prep C18, 5 μm, OBD, 19 mm × 50 mm, gradient of acetonitrile in water containing 0.4% of formic acid, flow 75 mL/min. Melting points were determined by differential scanning calorimetry (DSC) using a DSC822e/400 instrument and the HSS7 sensor from Mettler Toledo, Switzerland. The sample is weighed in a 40 μL aluminum crucible which is open under a flow of 15 mL/min of nitrogen during the experiment. The scan goes from 20 to 320 °C at a rate of 5 K/min. The peak temperature of the melting endotherm was determined with the STARe software and was assigned to the melting point (mp). NMR spectroscopy: NMR spectra were recorded on a Varian Mercury 300VX spectrometer (<sup>1</sup>H 300 MHz, <sup>13</sup>C 75 MHz) or Bruker Avance II, 400 MHz UltraShield, <sup>1</sup>H (400 MHz), <sup>13</sup>C (100 MHz); chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS), and multiplicities are given as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), h (hextet), hept (heptuplet) or m (multiplet). X-ray diffraction: Crystals of <b>17</b> were mounted on a Bruker Nonius diffractometer equipped with a CCD detector and reflections were measured using monochromatic Mo Kα radiation. The structure was solved by direct methods using SIR92, refinement was performed with CRYSTALS. Full matrix least-squares refinement was performed with anisotropic temperature factors for all atoms except hydrogen which were included at calculated positions with isotropic temperature factors. Coordinates, anisotropic temperature factors, bond lengths, and angles will be deposited with the Cambridge Crystrallographic Data Centre.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Endothelin Receptor Inhibition</h3><div class="NLM_p">Binding assays were performed in 96-well plates with CHO membranes containing the recombinant ET<sub>A</sub> or ET<sub>B</sub> receptors in 200 μL of 50 mM Tris-HCl, 25 mM MnCl<sub>2</sub>, 1 mM EDTA pH 7.4, 0.5% BSA, 2.5% DMSO. The wells containing 0.5 μg/well of ET<sub>A</sub> membranes or 0.2 μg/well of ET<sub>B</sub> membranes were incubated for 2 h at RT with 15 pM [<sup>125</sup>I]ET-1 (10000 cpm) in the presence or absence of test substances. Minimum and maximum binding was derived from samples with and without 1 μM of unlabeled ET-1, respectively. After the 2 h incubation period, the membranes were filtered through GF/C filterplates (MultiScreen MAHFC 1H60 from Millipore), which had been pre-equilibrated with binding buffer, using cold 50 mM Tris HCl, 0.1% BSA pH 7.5. After drying of the filterplates, 25 μL of scintillation cocktail (MicroScint 20, Perkin-Elmer) were added to each well and the filterplates were counted in a microplate counter (TopCount, Canberra Packard S.A. Zürich, Switzerland). IC<sub>50</sub> values were calculated as the concentration of antagonist inhibiting 50% of the specific binding of ET-1. Two reference compounds were tested: BQ-123, a specific ET<sub>A</sub> antagonist, and sarafotoxin 6c (Bachem, Switzerland), a specific ET<sub>B</sub> antagonist. For these reference inhibitors, the following IC<sub>50</sub> values were found (geometric mean values): ET<sub>A</sub> mb, 20.5 nM (<i>n</i> = 13) for BQ-123 and >100 nM (<i>n</i> = 10) for Sarafotoxin; ET<sub>B</sub> mb, 0.208 nM (<i>n</i> = 12) for Sarafotoxin and >1000 nM (<i>n</i> = 12) for BQ-123.</div><div id="sec4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Telemetric in Vivo Studies<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59-61)</a></h4><div class="NLM_p last"> In vivo efficacy of the compounds was assessed by oral administration of 3 mg/kg of the compound suspended in 5% arabic gum to female hypertensive Dahl salt-sensitive rats equipped with a telemetric system recording the arterial blood pressure and heart rate. For both of these parameters, each rat served as its own control by using the data of the last 24 h before treatment. An area between curve (ABC) was calculated between the control and the treatment period to assess the compound’s efficacy. Maximal mean arterial blood pressure reduction was extracted from the moving average over 6 h of the blood pressure recordings. </div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Pharmacokinetics in the Rat</h4><div class="NLM_p last">The pharmacokinetic profile was determined in the male Wistar rat (<i>n</i> = 5). For this purpose, compound <b>17</b> was formulated as a solution in 50 mM aqueous tris(hydroxymethyl)methylamine (Tris) pH 8.3 buffer containing 45% PEG400 for intravenous administration at a dose of 1.0 mg/kg, and as a microsuspension in 7.5% aqueous modified gelatin for oral dosing at 10 mg/kg. Blood samples were taken at regular time intervals over a period of 24 h from a preimplanted catheter, and plasma was generated by centrifugation at 4000 rpm at 4 °C. Plasma concentrations were determined using a specific and sensitive LC-MS/MS method with a limit of quantification of 1.5 ng/mL.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Pharmacokinetics in the Dog</h4><div class="NLM_p last">The pharmacokinetic profile of compound <b>17</b> was determined in male beagle dogs (<i>n</i> = 3). The compound was administered orally at a dose of 10 mg/kg as a solution in PEG400 and intravenously at a dose of 1 mg/kg as a solution in 25% <i>N</i>-methylpyrrolidone (NMP), 25% PEG400, 50% 50 mM aqueous Tris pH 8.3 buffer.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Potassium (Phenethylsulfonyl)amide (<b>4</b>).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></h3><div class="NLM_p last">To a vigorously stirred solution of <i>N</i>-chlorosuccinimide (38.6 g, 289 mmol) in dichloromethane (300 mL) and water (150 mL), 2-phenyl-ethylmercaptane (10.0 g, 72.3 mmol) was added. The mixture became slightly warm (30 °C). The resulting suspension was stirred at rt for 3 h. The solvent was decanted, and the remaining slurry was extracted twice with dichloromethane (2 × 200 mL). The organic extracts were washed twice with satd aq NaHCO<sub>3</sub> solution and water, combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was suspended in heptane:ethyl acetate 10:1, filtered, and washed with additional ethyl acetate/hexane. The filtrate was concentrated, and the crude product was purified by colum chromatography on silica gel eluting with heptane:ethyl acetate 10:1 to give 2-phenyl-ethane sulfonylchloride (8.25 g, 56%) as a pale-beige oil; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 10:1) 0.32. This material (8.25 g, 40.3 mmol) was dissolved in THF (50 mL), and a solution of satd aq NH<sub>3</sub> (10 mL) was slowly added at −20 °C. The mixture was stirred at rt for 16 h before it was neutralized with 25% aq HCl. The organic solvent was evaporated, and the remaining residue was diluted with water (100 mL) and extracted four times with ethyl acetate (4 × 50 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to give 2-phenyl-ethane sulfonamide (6.21 g, 83%) as a pale-yellow solid. LC-MS: <i>t</i><sub>R</sub> = 0.58 min, [M + H]<sup>+</sup> = not detectable. To a solution of this material (6.21 g, 33.5 mmol) in methanol (60 mL), potassium <i>tert</i>-butylate (3.76 g, 33.5 mmol) was added. The mixture was stirred until a clear solution formed. The mixture was concentrated and the remaining residue was triturated with diethyl ether, filtered, and dried to give <b>4</b> (6.67 g, 89%) as a white powder. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.18–7.32 (m, 5 H), 3.05–3.11 (m, 2 H), 2.93–2.99 (m, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 140.1, 129.0, 128.8, 126.7, 56.8, 30.9.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine (<b>3</b>)</h3><div class="NLM_p last">Prepared as described in the literature.<a onclick="showRef(event, 'ref39 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref41">(39, 41)</a> LC-MS: <i>t</i><sub>R</sub> = 0.79 min, [M + H]<sup>+</sup> = 349.04. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.05 (d, <i>J</i> = 4.9 Hz, 2 H), 7.47 (t, <i>J</i> = 4.9 Hz, 1 H), 7.13 (td, <i>J</i><sub>t</sub> = 8.0 Hz, <i>J</i><sub>d</sub> = 1.5 Hz, 1 H), 7.00 (dd, <i>J</i><sub>1</sub> = 8.3 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1 H), 6.90 (td, <i>J</i><sub>t</sub> = 8.0 Hz, <i>J</i><sub>d</sub> = 1.4 Hz, 1 H), 6.79 (dd, <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1 H), 3.85 (s, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 160.2, 158.2, 156.6, 155.5, 149.3, 145.0, 144.6, 125.0, 121.8, 121.0, 116.9, 113.0, 56.2.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(6-Chloro-5-(2-methoxyphenoxy)-[2,2′-bipyrimidin]-4-yl)-2-phenylethane-sulfonamide (<b>5</b>)</h3><div class="NLM_p last">A solution of <b>3</b> (2.20 g, 6.30 mmol) and <b>4</b> (3.10 g, 13.86 mmol) in DMF (50 mL) was stirred at rt for 16 h. About half of the solvent was removed under reduced pressure before the mixture was diluted with diethyl ether (50 mL). A 10% aqueous solution of citric acid (50 mL) was added. The beige suspension that formed was filtered, the collected solid was washed with water (30 mL) and diethyl ether (30 mL), and dried under high vacuum at 50 °C to give <b>5</b> (2.79 g, 89%) as a beige powder. LC-MS: <i>t</i><sub>R</sub> = 0.89 min, [M + H]<sup>+</sup> = 497.81. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.99 (d, <i>J</i> = 4.9 Hz, 2 H), 7.64 (t, <i>J</i> = 4.9 Hz, 1 H), 7.20–7.26 (m, 4 H), 7.14–7.20 (m, 1 H), 7.10 (d, <i>J</i> = 8.0 Hz, 1 H), 7.02 (t, <i>J</i> = 7.3 Hz, 1 H), 6.83 (t, <i>J</i> = 7.5 Hz, 1 H), 6.61 (s br, 1 H), 3.83 (s, 3 H), 2.82–2.97 (m, 2 H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2′-bipyrimidin]-4-yl)-2-phenyl-ethanesulfonamide (<b>7</b>)</h3><div class="NLM_p last">At rt, potassium <i>tert</i>-butoxide (6.88 g, 6.03 mmol) was added portionwise to a solution of <b>5</b> (304 mg, 0.60 mmol) in ethylene glycol (10 mL) and DME (2 mL). The reaction mixture was heated to reflux for 17 h and then cooled to rt before being poured into 10% aq citric acid solution (25 mL). The mixture was extracted twice with ethyl acetate (2 × 50 mL). The combined organic extracts were washed with water (2 × 50 mL) and brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo to give sufficiently pure <b>7</b> as an off-white solid to be used without further purification. LC-MS: <i>t</i><sub>R</sub> = 0.89 min, [M + H]<sup>+</sup> = 524.05. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ: 3.21–3.28 (m, 2 H), 3.91–3.95 (m, 2 H), 3.98 (s, 3 H), 4.29–4.38 (m, 2 H), 4.66–4.70 (m, 2 H), 6.95 (t, <i>J</i> = 7.8 Hz, 1 H), 7.03 (d, <i>J</i> = 7.3 Hz, 1 H), 7.13–7.30 (m, 7 H), 7.42 (t, <i>J</i> = 4.8 Hz, 1 H), 8.48 (s br, 1 H), 8.93–8.99 (m, 2 H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(6-(2-((5-Bromopyrimidin-2-yl)oxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2′-bipyrimidin]-4-yl)-2-phenylethanesulfonamide (<b>8</b>)</h3><div class="NLM_p last">To a suspension of NaH (29 mg, 0.72 mmol, 60% in mineral oil) in THF (2 mL) and DMF (2 mL), alcohol <b>7</b> (150 mg, 0.29 mmol) was added. The mixture was stirred at rt for 5 min before 2-chloro-5-bromopyrimidine (138 mg, 0.72 mmol) was added. The mixture was stirred at 70 °C for 4 h before another portion of 2-chloro-5-bromopyrimidine (138 mg, 0.72 mmol) and NaH (29 mg, 0.72 mmol) was added. Stirring was continued at 70 °C for 22 h before another portion of 2-chloro-5-bromopyrimidine (138 mg, 0.72 mmol) and NaH (29 mg, 0.72 mmol) was added. Stirring was continued for further 3 h before the mixture was cooled to rt and poured into 10% aq citric acid solution (75 mL). The mixture was extracted twice with ethyl acetate (2 × 50 mL). The combined extracts were washed with 10% aq citric acid solution (50 mL) and concentrated. The crude product was purified on prep TLC plates (silica gel, 0.5 mm) using ethyl acetate:methanol:7 N NH<sub>3</sub> in methanol 8:2:1 to give <b>8</b> (84 mg, 43%) as a pale yellow solid; <i>R</i><sub>f</sub> (silica gel, ethyl acetate:methanol:7 N NH<sub>3</sub> in methanol 8:2:1) 0.68. LC-MS: <i>t</i><sub>R</sub> = 0.93 min, [M + H]<sup>+</sup> = 680.01. <sup>1</sup>H NMR (CDCl<sub>3</sub>) (2 conformers 1:2): δ 8.88–8.96 (m, 2 H), 8.49 (s, 1.33 H), 8.43 (s, 0.67 H), 7.50 (t, <i>J</i> = 5.0 Hz, 0.33 H), 7.35–7.42 (m, 0.67 H), 7.16–7.27 (m, 3.33 H), 7.01–7.15 (m, 2 H), 6.88–6.98 (m, 1.34 H), 6.79–6.87 (m, 1.67 H), 6.72–6.78 (m, 0.33 H), 5.02–5.07 (m, 0.67 H), 4.96–5.02 (m, 1.33 H), 4.72–4.77 (m, 0.67 H), 4.66–4.71 (m, 1.33 H), 4.18–4.34 (m, 1.33 H), 3.96 (s, 2 H), 3.90 (s, 1 H), 3.11–3.25 (m, 1.33 H), 2.91–3.00 (m, 0.67 H), 2.66–2.73 (m, 0.67 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) (2 conformers): δ 163.48, 163.47, 161.9, 161.8, 159.5, 159.4, 157.7, 157.6, 157.5, 155.9, 150.5, 149.7, 149.4, 146.7, 145.8, 138.6, 137.7, 128.58, 128.55, 128.4, 128.2, 127.3, 126.7, 126.2, 125.2, 122.9, 122.5, 121.5, 121.2, 120.8, 115.3, 113.0, 112.4, 112.1, 112.0, 66.1, 66.0, 65.1, 64.9, 56.5, 56.0, 55.8, 55.5, 29.7, 29.6.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Potassium (<i>N</i>-Propylsulfamoyl)amide (<b>13</b>)</h3><div class="NLM_p last">Chlorosulfonyl isocyanate (<b>9</b>, 28.3 g, 0.2 mol) was dissolved in DCM (100 mL) and cooled to 0 °C before a solution of <i>tert</i>-BuOH (18.8 mL; 0.2 mol) in DCM (100 mL) was added over 30 min. Stirring was continued without cooling for additional 30 min. The mixture was then carefully added over 1 h to a solution of <i>n</i>-propylamine (16.5 mL, 0.2 mol) and triethylamine (42 mL, 0.3 mol) in DCM (400 mL) at 0 °C. Stirring was continued without cooling for additional 16 h. The reaction mixture was concentrated in vacuo, and the residue was dissolved in EtOAc (1 L) and washed with water (100 mL) and brine (40 mL). The organic layer was dried over MgSO<sub>4</sub> and concentrated under reduced pressure to give <b>11</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.97 (t, <i>J</i> = 7 Hz, 3 H), 1.51 (s, 9 H), 1.62 (m, 2 H), 3.04 (q, <i>J</i> = 6 Hz, 2 H), 5.12 (t br, <i>J</i> = 5 Hz, 1 H), 7.17 (s br, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 11.6, 22.8, 28.4, 46.0, 84.1, 150.3. The residue was dissolved in dioxane (100 mL) followed by the addition of HCl in dioxane (4M; 250 mL). Stirring was continued for 4 h at rt. The solvent was evaporated under reduced pressure, and the residue was dried under HV to give sulfamide <b>12</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>; 300 MHz; Varian): δ 0.87 (t, 3H), 1.43 (m, 2H), 2.81 (q, 2H), 3.09 (m, 1H; NH), 6.42 (s, 2H; NH<sub>2</sub>). <sup>13</sup>C NMR(CDCl<sub>3</sub>): δ 11.6, 23.1, 45.7. The residue was dissolved in MeOH (200 mL), and KOtBu (22.4 g; 0.2 mol) was added. The solvent was removed under reduced pressure. The residue was taken up in diethylether (500 mL), and the precipitate was filtered off, washed with cold ether, and dried at HV to give potassium (<i>N</i>-propylsulamoyl)amide (<b>13</b>) (32.4 g, 92%) as an off-white powder.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-(4-Bromophenyl)-4,6-dichloropyrimidine (<b>14</b>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></h3><div class="NLM_p">To a solution of 4-bromophenylacetic acid (73.9 g, 0.34 mol) in methanol (400 mL), thionyl chloride (49.05 g, 30 mL, 0.41 mol) was added dropwise while the temperature of the reaction mixture was kept at 0–5 °C. Upon complete addition, the cooling was removed and the mixture was allowed to warm to rt. Stirring was continued for 3 h before the solvent was removed in vacuo. The yellow oil was dissolved in benzene and evaporated. The residue was dissolved in ethyl acetate and washed with brine, 2 N aq Na<sub>2</sub>CO<sub>3</sub>, and again brine. The organic extract was dried over MgSO<sub>4</sub> and evaporated and dried under high vacuum at 85 °C for 30 min to give 4-bromophenylacetic acid methyl ester (74.9 g, 95%) as a yellow oil. LC-MS: <i>t</i><sub>R</sub> = 0.93 min, [M + H]<sup>+</sup> = not detectable. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 3.60 (s, 3H), 3.67 (s, 2H), 7.22 (d, <i>J</i> = 8.5, 2H), 7.50 (d, <i>J</i> = 8.5, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 40.9, 52.5, 121.4, 131.2, 131.9, 133.1, 171.6.</div><div class="NLM_p">NaH (24.0 g, 0.82 mol, 60% in mineral oil) was suspended twice in THF (75 mL), and the solvent was decanted. The remaining slurry was diluted with THF (500 mL) and heated to 35–40 °C. A solution of 4-bromophenylacetic acid methyl ester (74.9 g, 0.33 mol) in THF (200 mL) was carefully added dropwise. Gas evolution started after about half of the phenylacetic acid ester had been added and the mixture became slightly warm. The addition was continued at 45 °C. Upon completion of the addition, stirring was continued at 40 °C for 5 min before the mixture was allowed to cool to rt. The evolution of gas had stopped before dimethylcarbonate (117.9 g, 1.31 mol) was added dropwise. Evolution of gas started, and the mixture became warm (32 °C). Upon completion of the addition, stirring of the mixture was continued for 24 h before it was cooled to 0 °C and acidified by adding 25% aq HCl (100 mL) and diluted with water (150 mL). The organic solvent was removed under reduced pressure, and the remaining aqueous mixture was extracted three times with ethyl acetate (3 × 200 mL). The organic extracts were washed with 1 N aq HCl and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was crystallized from diethyl ether/hexane. The solid material was collected, washed with cold diethyl ether/hexane, and dried under high vacuum to give 2-(4-bromophenyl)-malonic acid dimethyl ester (74.1 g, 79%) as beige crystals; mp 76–77 °C; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) 0.7, shows decomposition. LC-MS: this compound is not stable under HPLC conditions. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 3.76 (s, 6 H), 4.61 (s, 1 H), 7.25–7.30 (m, 2 H), 7.46–7.51 (m, 2 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 53.4, 57.3, 122.9, 131.2, 131.7, 132.0, 168.2.</div><div class="NLM_p">A solution of 2-(4-bromophenyl)-malonic acid dimethyl ester (11.73 g, 40.9 mmol) in methanol (100 mL) was added at 0 °C to a solution of sodium (2.83 g, 0.118 mmol) in methanol (100 mL). The mixture was stirred for 18 h at rt before formamidine hydrochloride (4.10 g, 50.9 mmol) was added. The suspension was stirred at rt for 4 h. The solvent was removed, and the residue was suspended in 10% aq citric acid (100 mL) and stirred for 10 min. The white precipitate was collected, washed with 10% aq citric acid, water, evaporated three times from cyclohexane, and dried under high vacuum at 40 °C to give 5-(4-bromophenyl)-pyrimidine-4,6-diol (9.90 g, 91%) as a pale-beige powder; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) at start. LC-MS: <i>t</i><sub>R</sub> = 0.52 min, [M + H]<sup>+</sup> = 267.08. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.43–7.48 (m, 2 H), 7.50–7.55 (m, 2 H), 8.13 (s, 1 H), 12.1 (s br, 2 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 101.4, 119.3, 130.6, 132.9, 133.2, 148.7, 163.2.</div><div class="NLM_p last">To a suspension of 5-(4-bromophenyl)-pyrimidine-4,6-diol (43.0 g, 0.16 mmol) in POCl<sub>3</sub> (500 mL) was carefully added <i>N</i>,<i>N</i>-dimethylaniline (50 mL). The mixture was heated to 130 °C for 2 h. The dark-brown solution was evaporated, and the residue was dissolved in dichloromethane (200 mL). Water (500 mL) was slowly added, and the mixture was stirred at rt for 30 min before the organic phase was separated. The aqueous phase was extracted two more times with dichloromethane. The organic extracts were washed with water and 1 N aq HCl, treated with charcoal, dried over MgSO<sub>4</sub>, filtered, and evaporated. The product was purified by crystallization from 2-propanol. The crystals were collected, washed with cold 2-propanol and dried under high vacuum to give <b>14</b> (39.8 g, 81%) as beige crystals; mp 100–101 °C; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) 0.79. LC-MS: <i>t</i><sub>R</sub> = 0.92 min, [M + H + CH<sub>3</sub>CN]<sup>+</sup> = 344.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.81 (s, 1 H), 7.68 (dt, <i>J</i><sub>d</sub> = 8.9 Hz, <i>J</i><sub>t</sub> = 2.4 Hz, 2 H), 7.22 (dt, <i>J</i><sub>d</sub> = 9.0 Hz, <i>J</i><sub>t</sub> = 2.4 Hz, 2 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 124.1, 131.0, 131.7, 132.3, 157.1, 161.4.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl-<i>N</i>′-propylsulfamide (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>14</b> (760 mg; 2.50 mmol) in DMSO (5 mL), the sulfamide potassium salt <b>13</b> (529 mg; 3.00 mmol) was added. The mixture was stirred at rt for 48 h, diluted with brine (25 mL), and extracted three times with ethyl acetate (3 × 25 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was crystallized form methanol to give <b>15</b> (706 mg, 69%) as a white solid; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) 0.49. LC-MS: <i>t</i><sub>R</sub> = 0.89 min, [M + H]<sup>+</sup> = 404.98. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.96 (t, <i>J</i> = 7.6 Hz, 3 H), 1.50–1.66 (m, 2 H), 2.94–3.03 (m, 2 H), 5.52 (s br, 1 H), 6.90 (s br, 1 H), 7.16–7.21 (m, 2 H), 7.68–7.74 (m, 2 H), 8.65 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 11.6, 22.7, 46.1, 118.6, 125.0, 128.9, 131.2, 133.6, 156.6, 157.0, 159.9.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-5-(4-Bromophenyl)-6-(2-hydroxyethoxy)-4-pyrimidinyl-<i>N</i>′-propylsulfamide (<b>16</b>)</h3><div class="NLM_p last">Ethylene glycol (58.7 g, 53 mL; 946 mmol) was dissolved in dimethoxyethane (80 mL), and KOtBu (8.80 g; 78 mmol) was added. The temperature rose to 40 °C. After stirring for 10 min, monochloride <b>15</b> (10.55 g; 26 mmol) was added and stirring was continued at 100 °C for 70 h. The reaction mixture was carefully added to a 1:1 mixture of water:10% aq citric acid solution. The product was extracted with ethyl acetate (2 × 120 mL), the combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduce pressure. The crude product was purified by flash column chromatography (silicagel, heptanes:ethyl acetate 1:1) to give alcohol <b>16</b> (9.65 g, 86%) as a white solid; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) 0.20. LC-MS: <i>t</i><sub>R</sub> = 0.88 min, [M + H]<sup>+</sup> = 430.98. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.95 (t; <i>J</i> = 7.6 Hz, 3 H), 1.60 (h, <i>J</i> = 7.6 Hz, 2 H), 2.98 (t, <i>J</i> = 7.0 Hz, 2 H), 3.82–3.86 (m, 2 H), 4.47–4.51 (m, 2 H), 5.70 (s br, 1 H), 7.13–7.22 (m, 2 H), 7.61–7.67 (m, 2 H), 8.48 (s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 11.6, 22.7, 46.1, 61.9, 69.8, 104.8, 123.8, 128.1, 131.6, 133.2, 155.9, 156.4, 166.6.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (<b>17</b>)</h3><div class="NLM_p last">Sodium hydride (1.67 g, 69.6 mmol, 55% in mineral oil) was suspended twice in hexane (10 mL), and the hexane was discarded. The remaining slurry was suspended in THF (200 mL), and <b>16</b> (10.0 g, 23.2 mmol) was added in portions. The mixture was stirred for 15 min and diluted with DMF (40 mL) before 5-bromo-2-chloropyrimidine (5.38 g; 27.8 mmol) was added. The reaction mixture was heated to 60 °C, and stirring was continued for 2 h. The mixture was poured into 10% aq citric acid solution (250 mL), and the product was extracted twice with ethyl acetate (2 × 300 mL). The combined organic extracts were washed twice with water (2 × 200 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by crystallization from methanol (100 mL) to give <b>17</b> (11.99 g, 88%) as a white powder; mp 135–136 °C; <i>R</i><sub>f</sub> (silica gel, heptane:ethyl acetate 1:1) 0.44. LC-MS: <i>t</i><sub>R</sub> = 0.79 min, [M + H]<sup>+</sup> = 588.86 (major isotope). HR-LC-MS: <i>t</i><sub>R</sub> = 1.96 min; (<i>m</i> + H)/<i>z</i> = 586.9711, found = 586.9714. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.51 (s, 2 H), 8.49 (s, 1 H), 7.58–7.63 (m, 2 H), 7.16–7.21 (m, 2 H), 6.88 (s, 1 H), 5.61 (t, <i>J</i> = 6.2 Hz, 1 H), 4.72–4.76 (m, 2 H), 4.62–4.66 (m, 2 H), 2.99 (q, <i>J</i> = 6.8 Hz, 2 H), 1.61 (h, <i>J</i> = 7.3 Hz, 2 H), 0.97 (t, <i>J</i> = 7.4 Hz, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 11.6, 22.7, 46.1, 65.3, 65.9, 104.8, 112.4, 123.7, 128.0, 131.7, 133.0, 155.7, 156.4, 159.7, 163.5, 166.3.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm3009103">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on synthesis and characterization of the sulfamide and 4,6-dichloropyrimidine building blocks and the target compounds <b>8</b> and <b>17</b>–<b>71</b>. Two X-ray single crystal structures of compound <b>17</b> crystallized from different solvents.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3009103/suppl_file/jm3009103_si_001.pdf">jm3009103_si_001.pdf (528.48 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3009103" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin H. Bolli</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#533e3221273a3d7d313c3f3f3a13323027363f3a3c3d7d303c3e"><span class="__cf_email__" data-cfemail="aac7cbd8dec3c484c8c5c6c6c3eacbc9decfc6c3c5c484c9c5c7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph Boss</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christoph Binkert</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan Buchmann</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bur</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Hess</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Iglarz</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Solange Meyer</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josiane Rein</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Rey</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Treiber</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martine Clozel</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Fischli</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Weller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion Pharmaceuticals
Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2385e3736-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge our co-workers Nassilia Attaba, Heiner Bammerlin, Bruno Capeleto, Stephane Delahaye, Udo Diessenbacher, Fabienne Drouet, Céline Mangold, David Monnard, Pascal Rebmann, Pauline Schrepfer, Walter Schmutz, Laure Thenoz, René Vogelsanger, Daniel Wanner, and Aude Weigel for the excellent work delivered, Prof. Dr. Henri Ramuz for scientific advice, and Dr. Markus Neuburger (University of Basel) for technical advice.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> Abbreviations Used</h2><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">area between curves</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CSD</td><td class="NLM_def"><p class="first last">Cambridge Structural Database</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detector</p></td></tr><tr><td class="NLM_term">ET</td><td class="NLM_def"><p class="first last">endothelin</p></td></tr><tr><td class="NLM_term">ET<sub>A</sub></td><td class="NLM_def"><p class="first last">endothelin A receptor</p></td></tr><tr><td class="NLM_term">ET<sub>B</sub></td><td class="NLM_def"><p class="first last">endothelin B receptor</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">KOtBu</td><td class="NLM_def"><p class="first last">potassium <i>tert</i>-butoxide</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mean arterial pressure</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span> </span><span class="NLM_article-title">A novel potent vasoconstrictor peptide produced by vascular endothelial cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1988&pages=411-415&author=M.+Yanagisawaauthor=H.+Kuriharaauthor=S.+Kimuraauthor=Y.+Tomobeauthor=M.+Kobayashiauthor=Y.+Mitsuiauthor=K.+Gotoauthor=T.+Masaki&title=A+novel+potent+vasoconstrictor+peptide+produced+by+vascular+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DTomobe%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMitsui%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DMasaki%26aufirst%3DT.%26atitle%3DA%2520novel%2520potent%2520vasoconstrictor%2520peptide%2520produced%2520by%2520vascular%2520endothelial%2520cells%26jtitle%3DNature%26date%3D1988%26volume%3D332%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Battistini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R.</span><span> </span><span class="NLM_article-title">Endothelins: A Quantum Leap Forward</span> <span class="citation_source-journal">Drug News Persp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1995&pages=365-391&author=B.+Battistiniauthor=R.+Botting&title=Endothelins%3A+A+Quantum+Leap+Forward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBattistini%26aufirst%3DB.%26aulast%3DBotting%26aufirst%3DR.%26atitle%3DEndothelins%253A%2520A%2520Quantum%2520Leap%2520Forward%26jtitle%3DDrug%2520News%2520Persp.%26date%3D1995%26volume%3D8%26spage%3D365%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kohan, D. E.</span><span> </span><span class="NLM_article-title">Endothelin-1 and Hypertension: From Bench to Bedside</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1007%2Fs11906-008-0013-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18367029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFGrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=65-69&author=D.+E.+Kohan&title=Endothelin-1+and+Hypertension%3A+From+Bench+to+Bedside"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-1 and hypertension: from bench to bedside</span></div><div class="casAuthors">Kohan, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Endothelin-1 (ET-1) exerts a wide range of biol. effects that can influence systemic blood pressure.  Recent studies indicate that increased activity of the ET system in the vasculature, with resultant activation of primarily ET A receptors, can contribute to hypertension.  In contrast, decreased prodn. of ET-1 in the renal medulla, and reduced activation of collecting duct ET B receptors, can also elevate systemic blood pressure.  Both ET A and combined A/B receptor blockers reduce blood pressure in hypertensive patients.  Several important questions remain with respect to the ET system in hypertension, including how ET receptor antagonists will interact with other antihypertensive agents, which receptor subtypes should be targeted, and what the effect of ET blockade will be on hypertension-related end-organ damage as opposed to blood pressure alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7jPMJMj6Uc7Vg90H21EOLACvtfcHk0lhYCylMrgo4UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFGrsLs%253D&md5=b7b81f0f9b472126c6893649de387320</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11906-008-0013-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-008-0013-2%26sid%3Dliteratum%253Aachs%26aulast%3DKohan%26aufirst%3DD.%2BE.%26atitle%3DEndothelin-1%2520and%2520Hypertension%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2008%26volume%3D10%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Thorin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">The Cardiovascular Physiology and Pharmacology to Endothelin-1</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2010&pages=1-26&author=E.+Thorinauthor=M.+Clozel&title=The+Cardiovascular+Physiology+and+Pharmacology+to+Endothelin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThorin%26aufirst%3DE.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DThe%2520Cardiovascular%2520Physiology%2520and%2520Pharmacology%2520to%2520Endothelin-1%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2010%26volume%3D60%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benigni, A.</span><span> </span><span class="NLM_article-title">New Therapeutics that Antagonize Endothelin: Promises and Frustrations</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=986-1001&author=G.+Remuzziauthor=N.+Pericoauthor=A.+Benigni&title=New+Therapeutics+that+Antagonize+Endothelin%3A+Promises+and+Frustrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DBenigni%26aufirst%3DA.%26atitle%3DNew%2520Therapeutics%2520that%2520Antagonize%2520Endothelin%253A%2520Promises%2520and%2520Frustrations%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D986%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span> </span><span class="NLM_article-title">Endothelin Receptors as Drug Targets in Chronic Cardiovascular Diseases: The Rationale for Dual Antagonism</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=825-834&author=M.+Clozelauthor=S.+Flores&title=Endothelin+Receptors+as+Drug+Targets+in+Chronic+Cardiovascular+Diseases%3A+The+Rationale+for+Dual+Antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DFlores%26aufirst%3DS.%26atitle%3DEndothelin%2520Receptors%2520as%2520Drug%2520Targets%2520in%2520Chronic%2520Cardiovascular%2520Diseases%253A%2520The%2520Rationale%2520for%2520Dual%2520Antagonism%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2006%26volume%3D67%26spage%3D825%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fonseca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renzoni, E. A.</span><span> </span><span class="NLM_article-title">Endothelin in Pulmonary Fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1165%2Frcmb.2009-0388TR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20448055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Grtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1-10&author=C.+Fonsecaauthor=D.+Abrahamauthor=E.+A.+Renzoni&title=Endothelin+in+Pulmonary+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin in pulmonary fibrosis</span></div><div class="casAuthors">Fonseca, Carmen; Abraham, David; Renzoni, Elisabetta A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  The endothelin receptor-ligand system includes a family of polypeptides and G-protein-coupled receptors, which, in addn. to their classic activity in the regulation of vascular tone (both directly and through the control of nitric oxide), were implicated in a wide variety of other key biol. processes.  In this regard, the endothelins are potent mitogens and motogens for mesenchymal cells, and can induce cell differentiation, increasing both the synthesis and deposition of extracellular matrix components and contractile ability.  The endothelins are produced as inactive pre-pro-polypeptides, with gene transcription (as well as the proteolytic processing to mature active forms) under the influence of many factors, including cytokines, hypoxia, biomech. and shear stress, pathogen products, and many growth factors.  These complex regulatory events underlie the assocn. and potential role of endothelins in a no. of human diseases affecting many different target organs, including the vasculature (atherosclerosis and hypertension), kidney (renal crisis and chronic kidney disease), heart (coronary heart disease), and lungs (pulmonary fibrosis and pulmonary hypertension).  This review focuses on the biochem. of endothelin and the pathobiol. of endothelin in lung fibrosis, with particular emphasis on idiopathic pulmonary fibrosis, and examines the antifibrotic potential of endothelin receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLmNdPDGlzLVg90H21EOLACvtfcHk0lggiP8MD0R2jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Grtbg%253D&md5=00482558d543a7f59d6e1bea6ddf73ac</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2009-0388TR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2009-0388TR%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DD.%26aulast%3DRenzoni%26aufirst%3DE.%2BA.%26atitle%3DEndothelin%2520in%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2011%26volume%3D44%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span> </span><span class="NLM_article-title">The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=2863-2867&author=A.+Inoueauthor=M.+Yanagisawaauthor=S.+Kimuraauthor=Y.+Kasuyaauthor=T.+Miyauchiauthor=K.+Gotoauthor=T.+Masaki&title=The+human+endothelin+family%3A+three+structurally+and+pharmacologically+distinct+isopeptides+predicted+by+three+separate+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMiyauchi%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DMasaki%26aufirst%3DT.%26atitle%3DThe%2520human%2520endothelin%2520family%253A%2520three%2520structurally%2520and%2520pharmacologically%2520distinct%2520isopeptides%2520predicted%2520by%2520three%2520separate%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D2863%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Webb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Inhibitors of Endothelin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C17%3A%3AAID-MED2%3E3.0.CO%3B2-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=8979248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=17-67&author=M.+L.+Webbauthor=T.+D.+Meek&title=Inhibitors+of+Endothelin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of endothelin</span></div><div class="casAuthors">Webb, Maria L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-67</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 308 refs.  Topics discussed include: endothelin genes, peptide ligands of endothelin receptors, endothelin receptors, endothelin receptor antagonists, and endothelin receptor antagonists in relation to human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHDMCX3YR6brVg90H21EOLACvtfcHk0lj4vM6EtJ-9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSnuw%253D%253D&md5=9a6c3ac08eec42654f68e14bfc475e73</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C17%3A%3AAID-MED2%3E3.0.CO%3B2-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C17%253A%253AAID-MED2%253E3.0.CO%253B2-W%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DInhibitors%2520of%2520Endothelin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D17%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">At the heart of tissue: endothelin system and end-organ damage</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1042%2FCS20100222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20712600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKiu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=453-463&author=M.+Iglarzauthor=M.+Clozel&title=At+the+heart+of+tissue%3A+endothelin+system+and+end-organ+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">At the heart of tissue: endothelin system and end-organ damage</span></div><div class="casAuthors">Iglarz, Marc; Clozel, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11/12</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  ET (endothelin)-1 was first described as a potent vasoconstrictor.  Since then, many other deleterious properties mediated via its two receptors, ETA and ETB, have been described, such as inflammation, fibrosis and hyperplasia.  These effects, combined with a wide tissue distribution of the ET system, its up-regulation in pathol. situations and a local autocrine/paracrine activity due to a high tissue receptor binding, make the tissue ET system a key local player in end-organ damage.  Furthermore, ET-1 interacts in tissues with other systems such as the RAAS (renin-angiotensin-aldosterone system) to exert its effects.  In numerous genetically modified animal models, non-specific or organ-targeted ET-1 overexpression causes intense organ damage, esp. hypertrophy and fibrosis, in the absence of hemodynamic changes, confirming a local activity of the ET system.  ET receptor antagonists have been shown to prevent and sometimes reverse these tissue alterations in an organ-specific manner, leading to long-term benefits and an improvement in survival in different animal models.  Potential for such benefits going beyond a pure hemodynamic effect have also been suggested by clin. trial results in which ET receptor antagonism decreased the occurrence of new digital ulcers in patients with systemic sclerosis and delayed the time to clin. worsening in patients with PAH (pulmonary arterial hypertension).  The tissue ET system allows therapeutic interventions to provide organ selectivity and beneficial effects in diseases assocd. with tissue inflammation, hypertrophy or fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWlakqf8kUGrVg90H21EOLACvtfcHk0lj4vM6EtJ-9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKiu7%252FE&md5=0bf1a676f4ff0a2c4f19c2ad9b6d8706</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FCS20100222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20100222%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DAt%2520the%2520heart%2520of%2520tissue%253A%2520endothelin%2520system%2520and%2520end-organ%2520damage%26jtitle%3DClin.%2520Sci.%26date%3D2010%26volume%3D119%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Khimji, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockey, D. C.</span><span> </span><span class="NLM_article-title">Endothelin—biology and disease</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1615</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.cellsig.2010.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20466059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVelu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=1615-1625&author=A.-K.+Khimjiauthor=D.+C.+Rockey&title=Endothelin%E2%80%94biology+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-Biology and disease</span></div><div class="casAuthors">Khimji, Al-karim; Rockey, Don C.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1615-1625</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Endothelins are important mediators of physiol. and pathophysiol. processes including cardiovascular disorders, pulmonary disease, renal diseases and many others.  Addnl., endothelins are involved in many other important processes such as development, cancer biol., wound healing, and even neurotransmission.  Here, we review the cell and mol. biol. as well as the prominent pathophysiol. aspects of the endothelin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5S08G6AAPbVg90H21EOLACvtfcHk0lj4vM6EtJ-9SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVelu7rP&md5=a9c41b926c945c5540b0443eae18ade8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2010.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2010.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DKhimji%26aufirst%3DA.-K.%26aulast%3DRockey%26aufirst%3DD.%2BC.%26atitle%3DEndothelin%25E2%2580%2594biology%2520and%2520disease%26jtitle%3DCell.%2520Signalling%26date%3D2010%26volume%3D22%26spage%3D1615%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, G. A.</span><span> </span><span class="NLM_article-title">Are There Different ET<sub>B</sub> Receptors Mediating Constriction and Relaxation?</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">S262</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=S262-S264&author=M.+Clozelauthor=G.+A.+Gray&title=Are+There+Different+ETB+Receptors+Mediating+Constriction+and+Relaxation%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DG.%2BA.%26atitle%3DAre%2520There%2520Different%2520ETB%2520Receptors%2520Mediating%2520Constriction%2520and%2520Relaxation%253F%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1995%26volume%3D26%26spage%3DS262%26epage%3DS264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himeno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, M.</span><span> </span><span class="NLM_article-title">Endothelin-1 Binding to Endothelin Receptors in the Rat Anterior Pituitary Gland: Possible Formation of an ET<sub>A</sub>–ET<sub>B</sub> Receptor Heterodimer</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1023%2FA%3A1019822107048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=12363203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlGhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=207-226&author=N.+Haradaauthor=A.+Himenoauthor=K.+Shigematsuauthor=K.+Sumikawaauthor=M.+Niwa&title=Endothelin-1+Binding+to+Endothelin+Receptors+in+the+Rat+Anterior+Pituitary+Gland%3A+Possible+Formation+of+an+ETA%E2%80%93ETB+Receptor+Heterodimer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-1 Binding to Endothelin Receptors in the Rat Anterior Pituitary Gland: Possible Formation of an ETA-ETB Receptor Heterodimer</span></div><div class="casAuthors">Harada, Noboru; Himeno, Akihiko; Shigematsu, Kazuto; Sumikawa, Kohji; Niwa, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-226</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Interaction in the recognition of endothelin-1 (ET-1), a typical bivalent ET receptor-ligand, between ETA and ETB receptors was investigated in the rat anterior pituitary gland, using the authors' quant. receptor autoradiog. method with tissue sections preserving the cell-membrane structure and ET receptor-related compds. 2.  In satn. binding studies with increasing concns. (0.77-200 pM) of 125I-ET-1 (nonselective bivalent radioligand), 125I-ET-1 binding to the rat anterior pituitary gland was saturable and single with a KD of 71 pM and a Bmax of 120 fmol mg-1.  When 1.0 μM BQ-123 (ETA antagonist) was added to the incubation buffer, binding parameters were 8.3 pM of KD and 8.0 fmol mg-1 of Bmax, whereas 10 nM sarafotoxin S6c (ETB agonist) exerted little change in these binding parameters (KD, 72 pM; Bmax, 110 fmol mg-1). 3.  Competition binding studies with a fixed amt. (3.8 pM) of 125I-ET-1 revealed that when 1.0 μM BQ-123 was present in the incubation buffer, ETB receptor-related compds. such as sarafotoxin S6c, ET-3, IRL1620 (ETB agonist), and BQ-788 (ETB antagonist) competitively inhibited 125I-ET-1 binding with Kis of 140, 18, 350 pM, and 14 nM, resp., however, these compds. were not significant competitors for 125I-ET-1 binding in the case of absence of BQ-123. 4.  In cold-ligand satn. studies with a fixed amt. (390 pM) of 125I-IRL 1620 (ETB radioligand), IRL1620 bound to a single population of the ETB receptor, and no change was obsd. in binding characteristics in the presence of 1.0 μM BQ-123. 125I-IRL1620 binding was competitively inhibited by ET-1 and ET-3 in the absence of BQ-123, with Kis of 20 and 29 pM, resp., the affinities being much the same as those of 29 nM, in the presence of 1.0 μM BQ-123. 5.  Two non-bivalent ETA antagonists, BQ-123 and PD151242, were highly sensitive and full competitors for 125I-ET-1 binding (5.0 pM), in the presence of 10 nM sarafotoxin S6c. 6.  Taken together with the present finding that mRNAs encoding the rat ETA and the ETB receptors are expressed in the anterior pituitary gland, the authors tentatively conclude that although there are ETA and ETB receptors with a functional binding capability for ET receptor-ligands, the ETB receptor does not independently recognize ET-1 without the aid of the ETA receptor.  If this thesis is tenable, then ET-1 can bridge between the two receptors to form an ETA-ETB receptor heterodimer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMH5H5SLxsJbVg90H21EOLACvtfcHk0ljScs2um-3GOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlGhtb8%253D&md5=7c565ce95da6ae525aefdc132847c860</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1023%2FA%3A1019822107048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1019822107048%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DHimeno%26aufirst%3DA.%26aulast%3DShigematsu%26aufirst%3DK.%26aulast%3DSumikawa%26aufirst%3DK.%26aulast%3DNiwa%26aufirst%3DM.%26atitle%3DEndothelin-1%2520Binding%2520to%2520Endothelin%2520Receptors%2520in%2520the%2520Rat%2520Anterior%2520Pituitary%2520Gland%253A%2520Possible%2520Formation%2520of%2520an%2520ETA%25E2%2580%2593ETB%2520Receptor%2520Heterodimer%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D22%26spage%3D207%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gregan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jürgensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papsdorf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furkert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksche, A.</span><span> </span><span class="NLM_article-title">Ligand-Dependent Differences in the Internalization of Endothelin A and Endothelin B Receptor Heterodimers</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">27679</span><span class="NLM_x">–</span> <span class="NLM_lpage">27987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=27679-27987&author=B.+Greganauthor=J.+J%C3%BCrgensenauthor=G.+Papsdorfauthor=J.+Furkertauthor=M.+Schaeferauthor=M.+Beyermannauthor=W.+Rosenthalauthor=A.+Oksche&title=Ligand-Dependent+Differences+in+the+Internalization+of+Endothelin+A+and+Endothelin+B+Receptor+Heterodimers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregan%26aufirst%3DB.%26aulast%3DJ%25C3%25BCrgensen%26aufirst%3DJ.%26aulast%3DPapsdorf%26aufirst%3DG.%26aulast%3DFurkert%26aufirst%3DJ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DRosenthal%26aufirst%3DW.%26aulast%3DOksche%26aufirst%3DA.%26atitle%3DLigand-Dependent%2520Differences%2520in%2520the%2520Internalization%2520of%2520Endothelin%2520A%2520and%2520Endothelin%2520B%2520Receptor%2520Heterodimers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D27679%26epage%3D27987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sauvageau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, J.</span><span> </span><span class="NLM_article-title">Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary arterial hypertension: Role of ET<sub>B</sub>-receptor expression levels</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.pupt.2009.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=19489130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=311-317&author=S.+Sauvageauauthor=E.+Thorinauthor=L.+Villeneuveauthor=J.+Dupuis&title=Change+in+pharmacological+effect+of+endothelin+receptor+antagonists+in+rats+with+pulmonary+arterial+hypertension%3A+Role+of+ETB-receptor+expression+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels</span></div><div class="casAuthors">Sauvageau, Stephanie; Thorin, Eric; Villeneuve, Louis; Dupuis, Jocelyn</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endothelin (ET) system is activated in pulmonary arterial hypertension (PAH).  The therapeutic value of pharmacol. blockade of ET receptors has been demonstrated in various animal models and led to the current approval and continued development of these drugs for the therapy of human PAH.  However, we currently incompletely comprehend what local modifications of this system occur as a consequence of PAH, particularly in small resistance arteries, and how this could affect the pharmacol. response to ET receptor antagonists with various selectivities for the receptor subtypes.  Therefore, the purposes of this study were to evaluate potential modifications of the pharmacol. of the ET system in rat pulmonary resistance arteries from monocrotaline (MCT)-induced pulmonary arterial hypertension.  ET-1 levels were quantified by ELISA.  PreproET-1, ETA and ETB receptor mRNA expressions were quantified in pulmonary resistance arteries using Q-PCR, while protein expression was evaluated by Western blots.  Reactivity to ET-1 of isolated pulmonary resistance arteries was measured in the presence of ETA (A-147627), ETB (A-192621) and dual ETA/B (bosentan) receptor antagonists.  In rats with PAH, plasma ET-1 increased (p < 0.001) while pulmonary levels were reduced (p < 0.05).  In PAH arteries, preproET-1 (p < 0.05) and ETB receptor (p < 0.001) gene expressions were reduced, as were ETB receptor protein levels (p < 0.05).  ET-1 induced similar vasoconstrictions in both groups.  In arteries from sham animals, neither bosentan nor the ETA or the ETB receptor antagonists modified the response.  In arteries from PAH rats, however, bosentan and the ETA receptor antagonist potently reduced the maximal contraction, while bosentan also reduced sensitivity (p < 0.01).  The effectiveness of both selective ETA and dual ETA/B receptor antagonists is markedly increased in PAH.  Down-regulation of pulmonary resistance arteries ETB receptor may contribute to this finding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSCTWs0n5Tc7Vg90H21EOLACvtfcHk0lgylaV-Wp9ISA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ygsbg%253D&md5=f16fa20fed234b8752b315f71505270b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2009.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2009.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DSauvageau%26aufirst%3DS.%26aulast%3DThorin%26aufirst%3DE.%26aulast%3DVilleneuve%26aufirst%3DL.%26aulast%3DDupuis%26aufirst%3DJ.%26atitle%3DChange%2520in%2520pharmacological%2520effect%2520of%2520endothelin%2520receptor%2520antagonists%2520in%2520rats%2520with%2520pulmonary%2520arterial%2520hypertension%253A%2520Role%2520of%2520ETB-receptor%2520expression%2520levels%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2009%26volume%3D22%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">Mechanisms of ET-1-induced Endothelial Dysfunction</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=621-628&author=M.+Iglarzauthor=M.+Clozel&title=Mechanisms+of+ET-1-induced+Endothelial+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520ET-1-induced%2520Endothelial%2520Dysfunction%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Dagassan, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=147-153&author=P.+H.+Dagassanauthor=V.+Breuauthor=M.+Clozelauthor=A.+K%C3%BCnzliauthor=P.+Vogtauthor=M.+Turinaauthor=W.+Kiowskiauthor=J.-P.+Clozel&title=Up-Regulation+of+Endothelin-B+Receptors+in+Atherosclerotic+Human+Coronary+Arteries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDagassan%26aufirst%3DP.%2BH.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DA.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DTurina%26aufirst%3DM.%26aulast%3DKiowski%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DUp-Regulation%2520of%2520Endothelin-B%2520Receptors%2520in%2520Atherosclerotic%2520Human%2520Coronary%2520Arteries%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D147%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Abraham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vancheeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashwood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantelides, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi-wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, C. M.</span><span> </span><span class="NLM_article-title">Increased Levels of Endothelin-1 and Differential Endothelin Type A and B Receptor Expression in Scleroderma-Associated Fibrotic Lung Disease</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=9284832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A280%3ADyaK2svjtVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1997&pages=831-841&author=D.+J.+Abrahamauthor=R.+Vancheeswaranauthor=M.+R.+Dashwoodauthor=V.+S.+Rajkumarauthor=P.+Pantelidesauthor=X.+Shi-wenauthor=R.+M.+du+Boisauthor=C.+M.+Black&title=Increased+Levels+of+Endothelin-1+and+Differential+Endothelin+Type+A+and+B+Receptor+Expression+in+Scleroderma-Associated+Fibrotic+Lung+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease</span></div><div class="casAuthors">Abraham D J; Vancheeswaran R; Dashwood M R; Rajkumar V S; Pantelides P; Xu S W; du Bois R M; Black C M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">831-41</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">In addition to their vasoactive action, endothelins are potent peptides in the regulation of both cell proliferation and the turnover of extracellular matrix.  Using immunohistochemical, autoradiographic, and molecular analyses, we have studied the localization and expression of endothelin-1 and endothelin A (ETA) and B (ETB) receptors in scleroderma-associated fibrotic lung disease.  Increased ET-1 immunoreactivity was found in sclerotic tissue compared with control and was associated with the vasculature, pulmonary interstitium, and bronchial and alveolar epithelium.  Microautoradiographic analysis after 125I-labeled ET-1 binding showed a two- to threefold increase in the expression of total ET-1 receptors in scleroderma lung tissue localized to the alveolar epithelium and the pulmonary interstitium which was composed of mainly fibroblastic cells with macrophages and some microvessels.  RNAse protection assay revealed significantly reduced ETA receptor and slightly raised ETB message levels in systemic sclerosis lung.  Surface expression of functional ET receptors was examined by targeted receptor blocking using mixed and receptor-subtype-selective ligands.  A consistent decrease in ETA receptor binding sites was noted primarily within the interstitium and vasculature, in contrast to a slight increase in ETB receptors.  Elevated ET-1 and the cell-specific pattern of endothelin receptor expression suggest that the endothelins may represent important mediators that influence the pathology of scleroderma-associated lung disease and other fibrotic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRW2tdWuFW21w2ofyr07jXfW6udTcc2eZufFKV4V1UMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svjtVOhtw%253D%253D&md5=4f3c5592ecb8eba7f2d35d253cb1511a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26aulast%3DVancheeswaran%26aufirst%3DR.%26aulast%3DDashwood%26aufirst%3DM.%2BR.%26aulast%3DRajkumar%26aufirst%3DV.%2BS.%26aulast%3DPantelides%26aufirst%3DP.%26aulast%3DShi-wen%26aufirst%3DX.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DBlack%26aufirst%3DC.%2BM.%26atitle%3DIncreased%2520Levels%2520of%2520Endothelin-1%2520and%2520Differential%2520Endothelin%2520Type%2520A%2520and%2520B%2520Receptor%2520Expression%2520in%2520Scleroderma-Associated%2520Fibrotic%2520Lung%2520Disease%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1997%26volume%3D151%26spage%3D831%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lausberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, H.-J.</span><span> </span><span class="NLM_article-title">Selective Upregulation of Endothelin B Receptor Gene Expression in Severe Pulmonary Hypertension</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2002&pages=1034-1036&author=M.+Bauerauthor=H.+Wilkensauthor=F.+Langerauthor=S.+O.+Schneiderauthor=H.+Lausbergauthor=H.-J.+Sch%C3%A4fers&title=Selective+Upregulation+of+Endothelin+B+Receptor+Gene+Expression+in+Severe+Pulmonary+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DWilkens%26aufirst%3DH.%26aulast%3DLanger%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DS.%2BO.%26aulast%3DLausberg%26aufirst%3DH.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DH.-J.%26atitle%3DSelective%2520Upregulation%2520of%2520Endothelin%2520B%2520Receptor%2520Gene%2520Expression%2520in%2520Severe%2520Pulmonary%2520Hypertension%26jtitle%3DCirculation%26date%3D2002%26volume%3D105%26spage%3D1034%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Saleh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maghazachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaid, A.</span><span> </span><span class="NLM_article-title">Elevated Expresseion of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis: Possible Involvement of Proinflammatory Cytokines</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1165%2Fajrcmb.16.2.9032126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=9032126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=187-193&author=D.+Salehauthor=K.+Furukawaauthor=M.-S.+Tsaoauthor=A.+Maghazachiauthor=B.+Corrinauthor=M.+Yanagisawaauthor=P.+J.+Barnesauthor=A.+Giaid&title=Elevated+Expresseion+of+Endothelin-1+and+Endothelin-converting+Enzyme-1+in+Idiopathic+Pulmonary+Fibrosis%3A+Possible+Involvement+of+Proinflammatory+Cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines</span></div><div class="casAuthors">Saleh, Dina; Furukawa, Kanako; Tsao, Ming-Sound; Maghazachi, Azzam; Corrin, Bryan; Yanagisawa, Masashi; Barnes, Peter J.; Giaid, Adel</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymically converted from a biol. inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE).  Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immuno-histochem. and in situ hybridization.  In normal lungs, focal moderate expression of all three mols. is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells.  Serous bronchial glands also expressed ET-1 and ECE-1.  In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells.  ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity.  To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by RIA and Northern blot.  Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression.  TNFα resulted in a significant increase in ECE-1 mRNA expression.  These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF.  In addn., increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCRJWk-b6j2bVg90H21EOLACvtfcHk0ljLrB_PuKrtZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVemsrw%253D&md5=5d2b25d5f90201a7e09e022995adefee</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.16.2.9032126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.16.2.9032126%26sid%3Dliteratum%253Aachs%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DMaghazachi%26aufirst%3DA.%26aulast%3DCorrin%26aufirst%3DB.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DGiaid%26aufirst%3DA.%26atitle%3DElevated%2520Expresseion%2520of%2520Endothelin-1%2520and%2520Endothelin-converting%2520Enzyme-1%2520in%2520Idiopathic%2520Pulmonary%2520Fibrosis%253A%2520Possible%2520Involvement%2520of%2520Proinflammatory%2520Cytokines%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1997%26volume%3D16%26spage%3D187%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lehrke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldherr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span> </span><span class="NLM_article-title">Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11675408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotl2lsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=2321-2329&author=I.+Lehrkeauthor=R.+Waldherrauthor=E.+Ritzauthor=J.+Wagner&title=Renal+endothelin-1+and+endothelin+receptor+type+B+expression+in+glomerular+diseases+with+proteinuria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria</span></div><div class="casAuthors">Lehrke, Ingo; Waldherr, Rudiger; Ritz, Eberhard; Wagner, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2321-2329</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The endothelin (ET) system has been studied extensively in exptl. models of progressive chronic renal disease, but there is limited information regarding the ET system in renal patients.  First, the expression of human ET-1, as well as ET receptor type A (ET-RA) and ET-RB, was studied in 26 renal biopsies from patients with different renal diseases.  Gene expression was assessed by quant. reverse transcription-PCR.  Second, ET-1 and ET-RB protein expression and localization were examd., by immunohistochem. analyses, among a homogeneous cohort of 16 patients with IgA nephropathy and different degrees of proteinuria.  ET-RB mRNA expression was threefold higher among patients with higher-grade proteinuria [≥2 g/24 h, n = 10; OD ratio (ODR), i.e., wild-type/mutant mRNA ratio, 1.81 ± 0.3], compared with patients with lower-grade proteinuria (<2 g/24 h, n = 8; ODR, 0.63 ± 0.1; P < 0.01) or control subjects (n = 9; ODR, 0.57 ± 0.1; P < 0.01).  ET-1 gene expression was significantly higher among patients with higher-grade proteinuria, compared with patients with lower-grade proteinuria (P < 0.01) or control subjects (P < 0.05).  ET-RA mRNA expression was not different among the groups.  Patients with higher-grade proteinuria who were receiving angiotensin-converting enzyme inhibitors exhibited significantly (P < 0.05) lower ET-1 and ET-RB mRNA expression, which was comparable to that of control subjects.  By using immunohistochem. analyses, an assocn. between proteinuria and expression of ET-1 and ET-RB in proximal tubular epithelial cells and of ET-1 in glomeruli was confirmed in the sep. cohort of patients with IgA nephropathy.  It is concluded that the increased ET-RB and ET-1 mRNA and protein expression obsd. in animal models of renal disease is also demonstrable among patients with renal disease and high-grade proteinuria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI5LjeixZW0bVg90H21EOLACvtfcHk0ljLrB_PuKrtZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotl2lsr4%253D&md5=253ed8e89241dd35a3fe8cec90f74199</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehrke%26aufirst%3DI.%26aulast%3DWaldherr%26aufirst%3DR.%26aulast%3DRitz%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DRenal%2520endothelin-1%2520and%2520endothelin%2520receptor%2520type%2520B%2520expression%2520in%2520glomerular%2520diseases%2520with%2520proteinuria%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2001%26volume%3D12%26spage%3D2321%26epage%3D2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wu-Wong, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padley, R.</span><span> </span><span class="NLM_article-title">Endothelin receptor antagonists: A clinical study up-date</span> <span class="citation_source-journal">Curr. Opin. Cardiovasc. Pulm. Renal Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=339-344&author=J.+R.+Wu-Wongauthor=R.+Padley&title=Endothelin+receptor+antagonists%3A+A+clinical+study+up-date"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu-Wong%26aufirst%3DJ.%2BR.%26aulast%3DPadley%26aufirst%3DR.%26atitle%3DEndothelin%2520receptor%2520antagonists%253A%2520A%2520clinical%2520study%2520up-date%26jtitle%3DCurr.%2520Opin.%2520Cardiovasc.%2520Pulm.%2520Renal%2520Invest.%2520Drugs%26date%3D2000%26volume%3D2%26spage%3D339%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wu, C.</span><span> </span><span class="NLM_article-title">Recent discovery and development of endothelin receptor antagonists</span> <span class="citation_source-journal">Exp. Opin. Ther. Patent</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1517%2F13543776.10.11.1653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvF2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1653-1668&author=C.+Wu&title=Recent+discovery+and+development+of+endothelin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Recent discovery and development of endothelin receptor antagonists</span></div><div class="casAuthors">Wu, Chengde</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1653-1668</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review, with 48 refs.  Endothelin (ET) receptor antagonists, in particular ETA selective or ETA/ETB balanced antagonists, represent a new therapeutic area for serious diseases such as congestive heart failure (CHF) and pulmonary hypertension.  Endothelin antagonists have profound effects on the pulmonary vasculature and the right heart whereas ACE inhibitors primarily affect the peripheral vessel and the left heart.  Therefore, combination of endothelin antagonists and ACE inhibitors may be particularly useful in chronic heart failure.  Pulmonary hypertension represents another unmet medical need where endothelin antagonists, esp. orally-active compds., show great promise.  The importance of this field is evidenced by the no. of compds. in clin. trials and by the no. of patents filed in recent years.  Between Jan. 1997 and Apr. 2000, there are 139 endothelin patents of which 128 are concerned with endothelin receptor antagonists and 11 with endothelin converting enzyme inhibitors.  Of the 128 patents, 93 are about new chem. structures, 16 process, 4 formulation, 14 new use or combination therapy and 1 natural product.  This article focuses on the 93 novel compn. of matter patents in the area of endothelin receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpfcqT7H-g7Vg90H21EOLACvtfcHk0lgR0MpmV15IQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvF2gtL4%253D&md5=1868b5d2d4284556bf2dfa82be654419</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.11.1653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.11.1653%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26atitle%3DRecent%2520discovery%2520and%2520development%2520of%2520endothelin%2520receptor%2520antagonists%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Patent%26date%3D2000%26volume%3D10%26spage%3D1653%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Endothelin Receptor Antagonists: Structures, Synthesis, Selectivity and Therapeutic Applications</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2174%2F0929867023371139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11860362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=349-383&author=C.+Bossauthor=M.+Bolliauthor=T.+Weller&title=Endothelin+Receptor+Antagonists%3A+Structures%2C+Synthesis%2C+Selectivity+and+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin receptor antagonists: structures, synthesis, selectivity and therapeutic applications</span></div><div class="casAuthors">Boss, C.; Bolli, M.; Weller, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-383</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Endothelin (ET) was discovered in 1988 and is the most potent vasoconstrictive peptide known to date.  It exists in three isoforms (ET-1 to ET-3) and acts on two endothelin receptor subtypes, the endothelin-A (ETA)-receptor and the endothelin-B (ETB)-receptor.  Endothelin receptor antagonists are novel therapeutics in clin. development for different cardiovascular, cerebrovascular, and renal diseases.  Several different structural classes of endothelin receptor antagonists have been discovered within the last decade, starting from peptidic- and peptidomimetic structures to small org. mols. suitable as therapeutics for oral administration.  Focussing on the small org. mols., the different structural classes of ET-receptor antagonists are described with respect to synthesis, structure-activity-relationships, receptor-subtype-selectivity profile, and where possible, intended therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS9xVmXL5I2rVg90H21EOLACvtfcHk0lgR0MpmV15IQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7k%253D&md5=68e82605cd51899d20e3794ea836685e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F0929867023371139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371139%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBolli%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DEndothelin%2520Receptor%2520Antagonists%253A%2520Structures%252C%2520Synthesis%252C%2520Selectivity%2520and%2520Therapeutic%2520Applications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D349%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanghi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span> </span><span class="NLM_article-title">Endothelin Receptor Antagonists: An Overview of Their Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=381-408&author=J.+Iqbalauthor=R.+Sanghiauthor=S.+K.+Das&title=Endothelin+Receptor+Antagonists%3A+An+Overview+of+Their+Synthesis+and+Structure%E2%80%93Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DSanghi%26aufirst%3DR.%26aulast%3DDas%26aufirst%3DS.%2BK.%26atitle%3DEndothelin%2520Receptor%2520Antagonists%253A%2520An%2520Overview%2520of%2520Their%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D381%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Aubert, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1517%2F14728220903074570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=19659448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1069-1084&author=J.-D.+Aubertauthor=L.+Juillerat-Jeanneret&title=Therapeutic+potential+of+endothelin+receptor+modulators%3A+lessons+from+human+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials</span></div><div class="casAuthors">Aubert, John-David; Juillerat-Jeanneret, Lucienne</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1069-1084</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The endothelin system, and in particular endothelin receptors, are targets for therapeutic intervention in human diseases.  Endothelin receptor antagonists have reached clin. use for treating pulmonary arterial hypertension, and are under clin. investigation for several other diseases, such as cancer, vasospasm or fibrogenic diseases.  We review the mols. that have been evaluated in the main clin. trials, from the point of view of receptor selectivity and of their chem. characteristics which were important for efficacy in pulmonary hypertension.  We will also discuss future use of antagonists to endothelin receptor(s) in several human diseases and what should be the necessary properties of the future mols. for efficacy in diseases where the presently tested mols. displayed suboptimal efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwp9dwjsEbbVg90H21EOLACvtfcHk0liCSjTHhKXUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaltL8%253D&md5=81343b0ba9cb9b9d4640ddecc4e0d22d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F14728220903074570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903074570%26sid%3Dliteratum%253Aachs%26aulast%3DAubert%26aufirst%3DJ.-D.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DTherapeutic%2520potential%2520of%2520endothelin%2520receptor%2520modulators%253A%2520lessons%2520from%2520human%2520clinical%2520trials%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D1069%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Houde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Orléans-Juste, P.</span><span> </span><span class="NLM_article-title">Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2613</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2174%2F138161211797416101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=21728984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2613-2625&author=M.+Houdeauthor=J.+Labont%C3%A9author=P.+D%E2%80%99Orl%C3%A9ans-Juste&title=Peptide+and+Non-peptide+Antagonists+Targeting+Endothelin+Receptors+in+Physiology+and+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide antagonists targeting endothelin receptors in physiology and pathology</span></div><div class="casAuthors">Houde, Martin; Labonte, Julie; D'Orleans-Juste, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2613-2625</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As for other peptides such as bradykinin, neurokinins, and angiotensins, peptide antagonists for endothelin-1 (ET-1) were early on developed towards the pharmacol. characterization of both ETA and ETB receptors.  Interestingly, unlike the previously mentioned 3 peptides, receptors for ET-1 were cloned and purified prior to the report of ETA and ETB receptor antagonists such as BQ-123 and BQ-788.  The availability of such pharmacol. tools and the use of mol. approaches have certainly fast-tracked the development of non-peptide ET receptor antagonists for clin. applications.  Albeit rapid degrdn. by gastric enzymes and short half life in blood plasma of peptide receptor antagonists limit their use in clin. settings, those mols. were of importance in the identification of mediators and modulators of ET-1 induced properties in vitro and in vivo, as described further in this review.  Peptide antagonists acting selectively or, with equiv. affinities against ETA and ETB receptors were reported prior to the advent of clin. relevant non-peptide blockers such as Bosentan.  Confounding mechanisms involving, for example, the endogenous modulators nitric oxide and prostacyclin as well as allosteric interactions between ET receptor types, were also clarified with the use of peptide antagonists for endothelins.  Finally, peptide antagonists were also used to identify the precise pharmacol. of ET-1 precursors such as big-endothelin-1 and ET-1 (1-31).  The present review will thus attempt to summarize the knowledge to date and future perspectives related to use of peptide antagonists targeting endothelin receptors in physiol. and pathol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMof3XutTAibVg90H21EOLACvtfcHk0liCSjTHhKXUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7rI&md5=e35b4d5b46113bc420d7fdfcb99c729e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F138161211797416101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211797416101%26sid%3Dliteratum%253Aachs%26aulast%3DHoude%26aufirst%3DM.%26aulast%3DLabont%25C3%25A9%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Orl%25C3%25A9ans-Juste%26aufirst%3DP.%26atitle%3DPeptide%2520and%2520Non-peptide%2520Antagonists%2520Targeting%2520Endothelin%2520Receptors%2520in%2520Physiology%2520and%2520Pathology%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D2613%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hoette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, R.</span><span> </span><span class="NLM_article-title">Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension</span> <span class="citation_source-journal">J. Recept., Ligand Channel Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFejsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=113-121&author=S.+Hoetteauthor=D.+S.+O%E2%80%99Callaghanauthor=C.+Jardimauthor=R.+Souza&title=Dual+receptor+blockade+by+bosentan%3A+clinical+experience+in+treatment+of+pulmonary+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension</span></div><div class="casAuthors">Hoette, Susana; O'Callaghan, Dermot S.; Jardim, Carlos; Souza, Rogerio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor, Ligand and Channel Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JRLCA9</span>;
        ISSN:<span class="NLM_cas:issn">1178-699X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Pulmonary hypertension is characterized by an increase in mean pulmonary arterial pressure and right ventricular overload.  Endothelin-1 (ET-1) is a potent vasoconstrictor with an important role in the pathogenesis of pulmonary hypertension.  In addn. to its vasoconstrictive action, ET-1 also stimulates cell proliferation, fibrosis, and inflammation.  The blockade of both receptors involved in the action of ET-1 is beneficial in the treatment of pulmonary hypertension.  The use of endothelin dual receptor blockade leads to improvements in quality of life, functional capacity, and pulmonary hemodynamics in affected patients.  This article reviews the importance of ET-1 in the pathogenesis of pulmonary hypertension and demonstrates the benefits of blockage of the action of ET-1 in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2B7fGp_F_N7Vg90H21EOLACvtfcHk0lj1fbC0RDCVSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFejsr7I&md5=cca7b839d06c78137ad6c4371203f650</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoette%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DD.%2BS.%26aulast%3DJardim%26aufirst%3DC.%26aulast%3DSouza%26aufirst%3DR.%26atitle%3DDual%2520receptor%2520blockade%2520by%2520bosentan%253A%2520clinical%2520experience%2520in%2520treatment%2520of%2520pulmonary%2520hypertension%26jtitle%3DJ.%2520Recept.%252C%2520Ligand%2520Channel%2520Res.%26date%3D2010%26volume%3D3%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dwyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, D.</span><span> </span><span class="NLM_article-title">Bosentan for the treatment of adult pulmonary hypertension</span> <span class="citation_source-journal">Future Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2217%2Ffca.10.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=21174507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=19-37&author=N.+Dwyerauthor=D.+Kilpatrick&title=Bosentan+for+the+treatment+of+adult+pulmonary+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Bosentan for the treatment of adult pulmonary hypertension</span></div><div class="casAuthors">Dwyer, Nathan; Kilpatrick, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-37</span>CODEN:
                <span class="NLM_cas:coden">FCUAAZ</span>;
        ISSN:<span class="NLM_cas:issn">1479-6678</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Pulmonary hypertension is a severe progressive disease with a marked morbidity and a high mortality attributed to right heart failure.  Bosentan, a dual endothelin receptor antagonist, is an effective and well-tolerated oral therapy for the management of pulmonary arterial hypertension (PAH; WHO group 1 pulmonary hypertension).  Bosentan improves cardiopulmonary hemodynamics, exercise capacity, WHO functional class and quality of life, as well as delaying time to clin. worsening in patients with PAH.  This article reviews the role of endothelin-1 in the pathogenesis and progression of PAH, the diagnosis of PAH and the pharmacol. of bosentan, and summarizes the current available evidence for the safety and efficacy of bosentan for the treatment of PAH as a monotherapy and combination therapy, as well as its role in the management of other forms of pulmonary hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYCUB3LMATALVg90H21EOLACvtfcHk0lj1fbC0RDCVSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gt7zE&md5=4ee75ac5b3d840663b4b0656435adb19</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Ffca.10.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffca.10.114%26sid%3Dliteratum%253Aachs%26aulast%3DDwyer%26aufirst%3DN.%26aulast%3DKilpatrick%26aufirst%3DD.%26atitle%3DBosentan%2520for%2520the%2520treatment%2520of%2520adult%2520pulmonary%2520hypertension%26jtitle%3DFuture%2520Cardiol.%26date%3D2011%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>Tracleer; <span class="NLM_publisher-name">European Medicines Agency</span>, <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000401/human_med_001100.jsp&amp;murl=menus/" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000401/human_med_001100.jsp&murl=menus/</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tracleer%3B+European+Medicines+Agency%2C+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fmedicines%2Fhuman%2Fmedicines%2F000401%2Fhuman_med_001100.jsp%26murl%3Dmenus%2F%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTracleer%26pub%3DEuropean%2520Medicines%2520Agency" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Blalock, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulevicius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peshock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, K. M.</span><span> </span><span class="NLM_article-title">Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">J. Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.cardfail.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20142023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=121-127&author=S.+W.+Blalockauthor=S.+Matuleviciusauthor=L.+C.+Mitchellauthor=S.+Reimoldauthor=J.+Warnerauthor=R.+Peshockauthor=F.+Torresauthor=K.+M.+Chin&title=Long-Term+Outcomes+With+Ambrisentan+Monotherapy+in+Pulmonary+Arterial+Hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Blalock, Shannon E.; Matulevicius, Susan; Mitchell, Laura C.; Reimold, Sharon; Warner, John; Peshock, Ronald; Torres, Fernando; Chin, Kelly M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiac Failure</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-127</span>CODEN:
                <span class="NLM_cas:coden">JCFAF9</span>;
        ISSN:<span class="NLM_cas:issn">1071-9164</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: This study evaluated long-term outcomes in patients with pulmonary arterial hypertension (PAH) undergoing treatment with ambrisentan monotherapy, a selective oral endothelin-1 receptor antagonist.  Methods and Results: Patients who participated in the Ambrisentan in Pulmonary Arterial Hypertension: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy Study (ARIES-1) clin. trial and extension phase at our institution were included.  Cardiac catheterization, 6-min walk distance (6MWD), and cardiac magnetic resonance (MRI) data were retrospectively reviewed.  Twelve patients with PAH (11 idiopathic, 1 fenfluramine) had follow-up from 3 to 5.5 years from the initiation of ARIES-1.  Patients received ambrisentan therapy throughout the study period and were on ambrisentan monotherapy for the first 2 years.  At year 1, improvements in median mean pulmonary arterial pressure (PA), cardiac output, and pulmonary vascular resistance (PVR) were seen (P = .02, P = .03, P < .01), and the improvement in PVR persisted at 2 years. 6MWD also improved significantly between baseline (350 m) and 1 and 2 years (397 m, P < .01 and 393 m, P = .01).  Cardiac MRI results were more varied, with an increase in RV ejection fraction from 29% at baseline to 46% at 2 years (P = .02), but other MRI variables did not improve.  Conclusions: Ambrisentan monotherapy led to improvements in catheterization, 6MWD, and RV ejection fraction, and shows promise as a long-term treatment for pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw5QLhdBGibVg90H21EOLACvtfcHk0lisPCYondLyZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyhtbg%253D&md5=e0b48df10bebd838e6944247784fe142</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cardfail.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardfail.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DBlalock%26aufirst%3DS.%2BW.%26aulast%3DMatulevicius%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DL.%2BC.%26aulast%3DReimold%26aufirst%3DS.%26aulast%3DWarner%26aufirst%3DJ.%26aulast%3DPeshock%26aufirst%3DR.%26aulast%3DTorres%26aufirst%3DF.%26aulast%3DChin%26aufirst%3DK.%2BM.%26atitle%3DLong-Term%2520Outcomes%2520With%2520Ambrisentan%2520Monotherapy%2520in%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Card.%2520Failure%26date%3D2010%26volume%3D16%26spage%3D121%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Frampton, J. E.</span><span> </span><span class="NLM_article-title">Ambrisentan</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=215-226&author=J.+E.+Frampton&title=Ambrisentan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrampton%26aufirst%3DJ.%2BE.%26atitle%3DAmbrisentan%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2011%26volume%3D11%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span>Volibris; <span class="NLM_publisher-name">European Medicines Agency</span>, <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000839/human_med_001151.jsp&amp;mid=WC0b01ac058001d124" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000839/human_med_001151.jsp&mid=WC0b01ac058001d124</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Volibris%3B+European+Medicines+Agency%2C+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fmedicines%2Fhuman%2Fmedicines%2F000839%2Fhuman_med_001151.jsp%26mid%3DWC0b01ac058001d124%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVolibris%26pub%3DEuropean%2520Medicines%2520Agency" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Goligorsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iijima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasjletti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaskel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badr, K. F.</span><span> </span><span class="NLM_article-title">Role of Endothelin in the Development of Dahl Hypertension</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S484</span><span class="NLM_x">–</span> <span class="NLM_lpage">S491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1991&pages=S484-S491&author=M.+S.+Goligorskyauthor=K.+Iijimaauthor=M.+Morganauthor=M.+Yanagisawaauthor=T.+Masakiauthor=L.+Linauthor=A.+Nasjlettiauthor=F.+Kaskelauthor=M.+Frazerauthor=K.+F.+Badr&title=Role+of+Endothelin+in+the+Development+of+Dahl+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoligorsky%26aufirst%3DM.%2BS.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DMasaki%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNasjletti%26aufirst%3DA.%26aulast%3DKaskel%26aufirst%3DF.%26aulast%3DFrazer%26aufirst%3DM.%26aulast%3DBadr%26aufirst%3DK.%2BF.%26atitle%3DRole%2520of%2520Endothelin%2520in%2520the%2520Development%2520of%2520Dahl%2520Hypertension%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1991%26volume%3D17%26spage%3DS484%26epage%3DS491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Doucet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptiste, J.</span><span> </span><span class="NLM_article-title">Endothelin Antagonists in Salt-Dependent Hypertension Associated with Renal Insufficiency</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=643-651&author=J.+Doucetauthor=W.+Gonzalezauthor=J.+Baptiste&title=Endothelin+Antagonists+in+Salt-Dependent+Hypertension+Associated+with+Renal+Insufficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoucet%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DW.%26aulast%3DBaptiste%26aufirst%3DJ.%26atitle%3DEndothelin%2520Antagonists%2520in%2520Salt-Dependent%2520Hypertension%2520Associated%2520with%2520Renal%2520Insufficiency%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Schiffrin, E. L.</span><span> </span><span class="NLM_article-title">Role of endothelin-1 in hypertension and vascular disease</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">83S</span><span class="NLM_x">–</span> <span class="NLM_lpage">89S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=83S-89S&author=E.+L.+Schiffrin&title=Role+of+endothelin-1+in+hypertension+and+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffrin%26aufirst%3DE.%2BL.%26atitle%3DRole%2520of%2520endothelin-1%2520in%2520hypertension%2520and%2520vascular%2520disease%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2001%26volume%3D14%26spage%3D83S%26epage%3D89S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fattinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P. J.</span><span> </span><span class="NLM_article-title">The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1067%2Fmcp.2001.114667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11309550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVelsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=223-231&author=K.+Fattingerauthor=C.+Funkauthor=M.+Pantzeauthor=C.+Weberauthor=J.+Reichenauthor=B.+Stiegerauthor=P.+J.+Meier&title=The+endothelin+antagonist+bosentan+inhibits+the+canalicular+bile+salt+export+pump%3A+A+potential+mechanism+for+hepatic+adverse+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions</span></div><div class="casAuthors">Fattinger, Karin; Funk, Christoph; Pantze, Michael; Weber, Cornelia; Reichen, Jurg; Stieger, Bruno; Meier, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">223-231</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">During clin. trials bosentan, the first orally active endothelin receptor antagonist, caused asymptomatic transaminase elevations in some patients.  In this study we investigated whether inhibition of the hepatocanalicular bile salt export pump (rodents, Bsep; humans, BSEP ABCB11) could account for bosentan-induced liver injury.  We reanalyzed the safety database of the bosentan trials for cholestatic liver injury, detd. the cholestatic potency of bosentan in the rat, and studied the effects of bosentan and its metabolites on Bsep-mediated taurocholate transport in vitro.  Bosentan caused dose-dependent and reversible liver injury in 2% to 18% of patients and caused a significant increase of serum bile salt levels (P <.01).  Concomitant administration of glyburide (INN, glibenclamide) enhanced the cholestatic potency of bosentan.  Similar effects were seen in rats, in which serum bile salt levels were increased by glyburide less than by bosentan, which increased the levels less than a combination of bosentan and glyburide.  In vitro, Bsep-mediated taurocholate transport was inhibited by bosentan (inhibition const., -12 μmol/L) and metabolites (inhibition const., -8.5 μmol/L for metabolite Ro 47-8634).  These results indicate that bosentan-induced liver injury is mediated, at least in part, by inhibition of Bsep/BSEP-causing intracellular accumulation of cytotoxic bile salts and bile salt induced liver cell damage.  The data further emphasize the pathophysiol. importance of drug-Bsep interactions in acquired forms of cholestatic liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDluzM7gtwYbVg90H21EOLACvtfcHk0lhFY98RYCPGeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVelsbo%253D&md5=a39a1c82d8b43d54f3768aed505fa270</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2001.114667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2001.114667%26sid%3Dliteratum%253Aachs%26aulast%3DFattinger%26aufirst%3DK.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DPantze%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DReichen%26aufirst%3DJ.%26aulast%3DStieger%26aufirst%3DB.%26aulast%3DMeier%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520endothelin%2520antagonist%2520bosentan%2520inhibits%2520the%2520canalicular%2520bile%2520salt%2520export%2520pump%253A%2520A%2520potential%2520mechanism%2520for%2520hepatic%2520adverse%2520reactions%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2001%26volume%3D69%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">Discovery of Ro 48–5695: A Potent Mixed Endothelin Receptor Antagonist Optimized from Bosentan</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2223</span><span class="NLM_x">–</span> <span class="NLM_lpage">2228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2FS0960-894X%2897%2900400-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlertrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2223-2228&author=W.+Neidhartauthor=V.+Breuauthor=K.+Burriauthor=M.+Clozelauthor=G.+Hirthauthor=U.+Klinkhammerauthor=T.+Gillerauthor=H.+Ramuz&title=Discovery+of+Ro+48%E2%80%935695%3A+A+Potent+Mixed+Endothelin+Receptor+Antagonist+Optimized+from+Bosentan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RO 48-5695: a potent mixed endothelin receptor antagonist optimized from bosentan</span></div><div class="casAuthors">Neidhart, Werner; Breu, Volker; Burri, Kaspar; Clozel, Martine; Hirth, Georges; Klinkhammer, Uwe; Giller, Thomas; Ramuz, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2223-2228</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Implementation of a pyridylcarbamoyl group and an isopropylpyridylsulfonamide substituent as key components in the scaffold of Bosentan resulted in the identification of the potent orally active endothelin receptor antagonist Ro 48-5695 (I).  It shows affinities for ETA and ETB receptors in the low nanomolar range and high functional antagonistic potency in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtfXj0NeXqLVg90H21EOLACvtfcHk0lhFY98RYCPGeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlertrc%253D&md5=ca343c3b1de98df36cd31ac92149a9b5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2897%2900400-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252897%252900400-9%26sid%3Dliteratum%253Aachs%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Ro%252048%25E2%2580%25935695%253A%2520A%2520Potent%2520Mixed%2520Endothelin%2520Receptor%2520Antagonist%2520Optimized%2520from%2520Bosentan%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2223%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Harrington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHoff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. A.</span><span> </span><span class="NLM_article-title">Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/op010234i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=120-124&author=P.+J.+Harringtonauthor=H.+N.+Khatriauthor=B.+S.+DeHoffauthor=M.+R.+Guinnauthor=M.+A.+Boehlerauthor=K.+A.+Glaser&title=Research+and+Development+of+a+Second-Generation+Process+for+Bosentan%2C+an+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fop010234i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop010234i%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BJ.%26aulast%3DKhatri%26aufirst%3DH.%2BN.%26aulast%3DDeHoff%26aufirst%3DB.%2BS.%26aulast%3DGuinn%26aufirst%3DM.%2BR.%26aulast%3DBoehler%26aufirst%3DM.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BA.%26atitle%3DResearch%2520and%2520Development%2520of%2520a%2520Second-Generation%2520Process%2520for%2520Bosentan%252C%2520an%2520Endothelin%2520Receptor%2520Antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bolli, M.; Boss, C.; Fischli, W.; Clozel, M.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Sulfamides and Their Use as Endothelin Receptor Antagonists</span>. WO2002053557, <span class="NLM_month">Jul</span><span class="NLM_day">11</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Bolli&author=C.+Boss&author=W.+Fischli&author=M.+Clozel&author=T.+Weller&title=Novel+Sulfamides+and+Their+Use+as+Endothelin+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Sulfamides%2520and%2520Their%2520Use%2520as%2520Endothelin%2520Receptor%2520Antagonists%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">The Use of Sulfonylamido Pyrimidines Incorporating an Unsaturated Side Chain as Endothelin Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=955-959&author=M.+H.+Bolliauthor=C.+Bossauthor=M.+Clozelauthor=W.+Fischliauthor=P.+Hessauthor=T.+Weller&title=The+Use+of+Sulfonylamido+Pyrimidines+Incorporating+an+Unsaturated+Side+Chain+as+Endothelin+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DThe%2520Use%2520of%2520Sulfonylamido%2520Pyrimidines%2520Incorporating%2520an%2520Unsaturated%2520Side%2520Chain%2520as%2520Endothelin%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D955%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Boss, C.; Fischli, W.; Weller, T.; Clozel, M.; Bolli, M.</span><span> </span><span class="NLM_article-title">Novel Sulfamides</span>. WO2006051502, <span class="NLM_month">May</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+Boss&author=W.+Fischli&author=T.+Weller&author=M.+Clozel&author=M.+Bolli&title=Novel+Sulfamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DNovel%2520Sulfamides%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Burri, K.; Clozel, M.; Fischli, W.; Hirth, G.; Löffler, B. M.; Ramuz, H.</span><span> </span><span class="NLM_article-title">Verwendung von Sulfonamiden als Heilmittel und neue Sulfonamide</span>. EP0510526, <span class="NLM_month">Oct</span><span class="NLM_day">28</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=K.+Burri&author=M.+Clozel&author=W.+Fischli&author=G.+Hirth&author=B.+M.+L%C3%B6ffler&author=H.+Ramuz&title=Verwendung+von+Sulfonamiden+als+Heilmittel+und+neue+Sulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DK.%26atitle%3DVerwendung%2520von%2520Sulfonamiden%2520als%2520Heilmittel%2520und%2520neue%2520Sulfonamide%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Burri, K.; Clozel, M.; Fischli, W.; Hirth, G.; Löffler, B.-M.; Ramuz, H.; Neidhart, W.</span><span> </span><span class="NLM_article-title">Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte</span>. EP0526708, <span class="NLM_month">Feb</span><span class="NLM_day">10</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=K.+Burri&author=M.+Clozel&author=W.+Fischli&author=G.+Hirth&author=B.-M.+L%C3%B6ffler&author=H.+Ramuz&author=W.+Neidhart&title=Sulfonamide%2C+ihre+Herstellung+und+Verwendung+als+Heilmittel+und+Zwischenprodukte"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DK.%26atitle%3DSulfonamide%252C%2520ihre%2520Herstellung%2520und%2520Verwendung%2520als%2520Heilmittel%2520und%2520Zwischenprodukte%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Yamada, K.; Yasuda, K.; Kikkawa, K.; Kohno, R.</span><span> </span><span class="NLM_article-title">Sulfonamide derivative and process for preparing the same</span>. EP0743307, <span class="NLM_month">Nov</span><span class="NLM_day">20</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=K.+Yamada&author=K.+Yasuda&author=K.+Kikkawa&author=R.+Kohno&title=Sulfonamide+derivative+and+process+for+preparing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DSulfonamide%2520derivative%2520and%2520process%2520for%2520preparing%2520the%2520same%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Yamada, K.; Yasuda, K.; Kikkawa, K.; Kohno, R.</span><span> </span><span class="NLM_article-title">Sulfonamide Derivate und Verfahren zu deren Herstellung</span>. EP0959072, <span class="NLM_month">Oct</span><span class="NLM_day">31</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=K.+Yamada&author=K.+Yasuda&author=K.+Kikkawa&author=R.+Kohno&title=Sulfonamide+Derivate+und+Verfahren+zu+deren+Herstellung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DSulfonamide%2520Derivate%2520und%2520Verfahren%2520zu%2520deren%2520Herstellung%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Bolli, M.; Boss, C.; Clozel, M.; Fischli, W.; Weller, T.</span><span> </span><span class="NLM_article-title">Pyrimidine-Sulfamides and Their Use as Endothelin Receptor Antagonist</span>. WO2004050640, <span class="NLM_month">Jun</span><span class="NLM_day">17</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Bolli&author=C.+Boss&author=M.+Clozel&author=W.+Fischli&author=T.+Weller&title=Pyrimidine-Sulfamides+and+Their+Use+as+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DPyrimidine-Sulfamides%2520and%2520Their%2520Use%2520as%2520Endothelin%2520Receptor%2520Antagonist%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyall, J. M.</span><span> </span><span class="NLM_article-title">Pyrimidine Reactions</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1964&pages=794-802&author=D.+J.+Brownauthor=J.+M.+Lyall&title=Pyrimidine+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DLyall%26aufirst%3DJ.%2BM.%26atitle%3DPyrimidine%2520Reactions%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1964%26volume%3D17%26spage%3D794%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Crosby, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthold, R. V.</span><span> </span><span class="NLM_article-title"><i>n</i>-Butyl 5-Chloro-2-pyrimidoxyacetate—A Plant Growth Regulator Analog</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01081a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1960&pages=1916-1919&author=D.+G.+Crosbyauthor=R.+V.+Berthold&title=n-Butyl+5-Chloro-2-pyrimidoxyacetate%E2%80%94A+Plant+Growth+Regulator+Analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo01081a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01081a023%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DD.%2BG.%26aulast%3DBerthold%26aufirst%3DR.%2BV.%26atitle%3Dn-Butyl%25205-Chloro-2-pyrimidoxyacetate%25E2%2580%2594A%2520Plant%2520Growth%2520Regulator%2520Analog%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D25%26spage%3D1916%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Maggiali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barocelli, E.</span><span> </span><span class="NLM_article-title">H1-antihistaminic and antimuscarinic effects of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds</span> <span class="citation_source-journal">Farmaco, Ed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=2901367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaL1cXks1Kgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=277-292&author=C.+Maggialiauthor=G.+Moriniauthor=F.+Mossiniauthor=G.+Moriniauthor=E.+Barocelli&title=H1-antihistaminic+and+antimuscarinic+effects+of+2-+and+4-%5Bbenzyl-%282-dimethylaminoethyl%29amino%5Dpyrimidine+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">H1-antihistaminic and antimuscarinic effects of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds</span></div><div class="casAuthors">Maggiali, C.; Morini, Giovanni; Mossini, F.; Morini, Giuseppina; Barocelli, E.; Impicciatore, M.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco, Edizione Scientifica</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-91</span>CODEN:
                <span class="NLM_cas:coden">FRPSAX</span>;
        ISSN:<span class="NLM_cas:issn">0430-0920</span>.
    </div><div class="casAbstract">Fourteen 2- (I) and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimdidines (II) (in both cases R, R1 and R3 = OMe or H; R2 = SMe, Cl, or H) were prepd.  In tests on the isolated guinea pig ileum, I were more potent than II as antihistaminics, but the only compd. which was a pure H1-antihistaminic was II (R = R1 = OMe; R2 = R3 = H), which had a potency similar to that of tonzylamine.  In the same test system, the only compd. to display a specific antimuscarinic activity (though of low potency) was II (R = R3 = H; R1 = OMe; R2 = Sme).  Structure-activity relations are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvP4souxbTUbVg90H21EOLACvtfcHk0ljujlE9o2A7hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXks1Kgtr8%253D&md5=c35b36da1aab0ff900f66a19e48b5070</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiali%26aufirst%3DC.%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DMossini%26aufirst%3DF.%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DBarocelli%26aufirst%3DE.%26atitle%3DH1-antihistaminic%2520and%2520antimuscarinic%2520effects%2520of%25202-%2520and%25204-%255Bbenzyl-%25282-dimethylaminoethyl%2529amino%255Dpyrimidine%2520compounds%26jtitle%3DFarmaco%252C%2520Ed.%2520Sci.%26date%3D1988%26volume%3D43%26spage%3D277%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wacker, D. A.; Rossi, K. A.; Wang, Y.</span><span> </span><span class="NLM_article-title">Preparation of pyridones as GPR119 G protein-coupled receptor agonists</span>. WO2009012275, <span class="NLM_month">Jan</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+A.+Wacker&author=K.+A.+Rossi&author=Y.+Wang&title=Preparation+of+pyridones+as+GPR119+G+protein-coupled+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520pyridones%2520as%2520GPR119%2520G%2520protein-coupled%2520receptor%2520agonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span> </span><span class="NLM_article-title">Preparation of novel β-trifluoromethyl vinamidinium salt and its synthetic application to trifluoromethylated heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2F0040-4039%2896%2900129-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1CmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1829-1832&author=H.+Yamanakaauthor=T.+Takekawaauthor=K.+Moritaauthor=T.+Ishiharaauthor=J.+T.+Gupton&title=Preparation+of+novel+%CE%B2-trifluoromethyl+vinamidinium+salt+and+its+synthetic+application+to+trifluoromethylated+heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of novel β-trifluoromethyl vinamidinium salt and its synthetic application to trifluoromethylated heterocycles</span></div><div class="casAuthors">Yamanaka, Hiroki; Takekawa, Tadashi; Morita, Kenji; Ishihara, Takashi; Gupton, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1829-32</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">β-Trifluoromethylated vinamidinium salt I was prepd. in high yield by the reaction between 3,3,3-trifluoropropanoic acid and phosphorus oxychloride in N,N-dimethylformamide at 70 °C for 1 h.  I reacted readily with bifunctional nitrogen nucleophiles, such as amidine and hydrazine derivs., in acetonitrile or DMSO to furnish the corresponding trifluoromethylated azaheterocycles, e.g. II and III, in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARGFq6vIgX7Vg90H21EOLACvtfcHk0ljnPFMaCBlU3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1CmsLc%253D&md5=d4d1ee23d789d19175506cb4497b253c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900129-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900129-3%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DTakekawa%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26atitle%3DPreparation%2520of%2520novel%2520%25CE%25B2-trifluoromethyl%2520vinamidinium%2520salt%2520and%2520its%2520synthetic%2520application%2520to%2520trifluoromethylated%2520heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D1829%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Potent and Selective ET-A Antagonists. 2. Discovery and Evaluation of Potent Water Soluble <i>N</i>-(6-(2-Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3369</span><span class="NLM_x">–</span> <span class="NLM_lpage">3377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000538f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3369-3377&author=H.+Morimotoauthor=N.+Ohashiauthor=H.+Shimadzuauthor=E.+Kushiyamaauthor=H.+Kawanishiauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Potent+and+Selective+ET-A+Antagonists.+2.+Discovery+and+Evaluation+of+Potent+Water+Soluble+N-%286-%282-Aryloxy%29ethoxy%29-4-pyrimidinyl%29sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm000538f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000538f%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DKushiyama%26aufirst%3DE.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DPotent%2520and%2520Selective%2520ET-A%2520Antagonists.%25202.%2520Discovery%2520and%2520Evaluation%2520of%2520Potent%2520Water%2520Soluble%2520N-%25286-%25282-Aryloxy%2529ethoxy%2529-4-pyrimidinyl%2529sulfonamide%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3369%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassal, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=759-761&author=M.+Clozelauthor=V.+Breuauthor=K.+Burriauthor=J.-M.+Cassalauthor=W.+Fischliauthor=G.+A.+Grayauthor=G.+Hirthauthor=B.-M.+L%C3%B6fflerauthor=M.+M%C3%BCllerauthor=W.+Neidhartauthor=H.+Ramuz&title=Pathophysiological+role+of+endothelin+revealed+by+the+first+orally+active+endothelin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DCassal%26aufirst%3DJ.-M.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DG.%2BA.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.-M.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DPathophysiological%2520role%2520of%2520endothelin%2520revealed%2520by%2520the%2520first%2520orally%2520active%2520endothelin%2520receptor%2520antagonist%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D759%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">The Discovery of Nonpeptide Endothelin Receptor Antagonists. Progression towards Bosentan</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ygtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=519-524&author=W.+Neidhartauthor=V.+Breuauthor=D.+Burauthor=K.+Burriauthor=M.+Clozelauthor=G.+Hirthauthor=M.+M%C3%BCllerauthor=H.+P.+Wesselauthor=H.+Ramuz&title=The+Discovery+of+Nonpeptide+Endothelin+Receptor+Antagonists.+Progression+towards+Bosentan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of nonpeptide endothelin receptor antagonists. Progression towards bosentan</span></div><div class="casAuthors">Neidhart, Werner; Breu, Volker; Bur, Daniel; Burri, Kaspar; Clozel, Martine; Hirth, Georges; Mueller, Marcel; Wessel, Hans P.; Ramuz, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">519-524</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Neue Schweizerische Chemische Gesellschaft</span>)
        </div><div class="casAbstract">A review with 23 refs., describing the development of a novel class of nonpeptide endothelin receptor antagonists based on a lead file screening with special investigations on bosentan in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR6LsyBs_RyLVg90H21EOLACvtfcHk0lilh6rpQEJ6zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ygtLo%253D&md5=4c38eb56ca6997fe10b92799f87cd120</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DWessel%26aufirst%3DH.%2BP.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DThe%2520Discovery%2520of%2520Nonpeptide%2520Endothelin%2520Receptor%2520Antagonists.%2520Progression%2520towards%2520Bosentan%26jtitle%3DChimia%26date%3D1996%26volume%3D50%26spage%3D519%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Breu, V.; Burri, K.; Cassal, J.-M.; Clozel, M.; Hirth, G.; Löffler, B.-M.; Müller, M.; Neidhart, W.; Ramuz, H.</span><span> </span><span class="NLM_article-title">Novel Sulfonamides</span>. WO9619459, <span class="NLM_month">Jun</span><span class="NLM_day">27</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=V.+Breu&author=K.+Burri&author=J.-M.+Cassal&author=M.+Clozel&author=G.+Hirth&author=B.-M.+L%C3%B6ffler&author=M.+M%C3%BCller&author=W.+Neidhart&author=H.+Ramuz&title=Novel+Sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreu%26aufirst%3DV.%26atitle%3DNovel%2520Sulfonamides%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Potent and Selective ET-A Antagonists. 1. Synthesis and Structure–Activity Relationship of <i>N</i>-(6-(2-Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3355</span><span class="NLM_x">–</span> <span class="NLM_lpage">3368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0102304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3355-3368&author=H.+Morimotoauthor=H.+Shimadzuauthor=E.+Kushiyamaauthor=H.+Kawanishiauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Potent+and+Selective+ET-A+Antagonists.+1.+Synthesis+and+Structure%E2%80%93Activity+Relationship+of+N-%286-%282-Aryloxy%29ethoxy%29-4-pyrimidinyl%29sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm0102304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0102304%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DKushiyama%26aufirst%3DE.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DPotent%2520and%2520Selective%2520ET-A%2520Antagonists.%25201.%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520N-%25286-%25282-Aryloxy%2529ethoxy%2529-4-pyrimidinyl%2529sulfonamide%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3355%26epage%3D3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Modifications and Structure–Activity Relationships at the 2-Position of 4-Sulfonamidopyrimidine Derivatives as Potent Endothelin Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=81-84&author=H.+Morimotoauthor=H.+Shimadzuauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Modifications+and+Structure%E2%80%93Activity+Relationships+at+the+2-Position+of+4-Sulfonamidopyrimidine+Derivatives+as+Potent+Endothelin+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DModifications%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520at%2520the%25202-Position%2520of%25204-Sulfonamidopyrimidine%2520Derivatives%2520as%2520Potent%2520Endothelin%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Brockway, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, S. H.</span><span> </span><span class="NLM_article-title">A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat via Radio-Telemetry</span> <span class="citation_source-journal">Clin. Exp. Hypertens.—Theory Pract</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">A13</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.3109%2F10641969109042094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A13&publication_year=1991&pages=885-895&author=B.+P.+Brockwayauthor=P.+A.+Millsauthor=S.+H.+Azar&title=A+New+Method+for+Continuous+Chronic+Measurement+and+Recording+of+Blood+Pressure%2C+Heart+Rate+and+Activity+in+the+Rat+via+Radio-Telemetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F10641969109042094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969109042094%26sid%3Dliteratum%253Aachs%26aulast%3DBrockway%26aufirst%3DB.%2BP.%26aulast%3DMills%26aufirst%3DP.%2BA.%26aulast%3DAzar%26aufirst%3DS.%2BH.%26atitle%3DA%2520New%2520Method%2520for%2520Continuous%2520Chronic%2520Measurement%2520and%2520Recording%2520of%2520Blood%2520Pressure%252C%2520Heart%2520Rate%2520and%2520Activity%2520in%2520the%2520Rat%2520via%2520Radio-Telemetry%26jtitle%3DClin.%2520Exp.%2520Hypertens.%25E2%2580%2594Theory%2520Pract%26date%3D1991%26volume%3DA13%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Guiol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledoussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgé, J.-M.</span><span> </span><span class="NLM_article-title">A Radiotelemetry System for Chronic Measurement of Blood Pressure and Heart Rate in the Unrestrained Rat Validation of the Method</span> <span class="citation_source-journal">J. Pharmcol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2F1056-8719%2892%2990054-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=1482791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1992&pages=99-105&author=C.+Guiolauthor=C.+Ledoussalauthor=J.-M.+Surg%C3%A9&title=A+Radiotelemetry+System+for+Chronic+Measurement+of+Blood+Pressure+and+Heart+Rate+in+the+Unrestrained+Rat+Validation+of+the+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A radiotelemetry system for chronic measurement of blood pressure and heart rate in the unrestrained rat validation of the method</span></div><div class="casAuthors">Guiol C; Ledoussal C; Surge J M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-105</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">Chronic measurements of systemic arterial blood pressure and heart rate via a chronically implanted telemetric transmitter in unrestrained rats, was validated in a three-phase study.  In the first part, week-to-week variability of systolic, diastolic, and mean arterial pressures, and heart rate was found to be minimal over the course of nine weeks.  In the second part, the reproducibility of cardiovascular response to three successive administration of sotalol, an antihypertensive agent, was studied.  In the last part, cardiovascular parameters determined by telemetry were compared to those obtained by direct arterial catheterization and showed a good linear correlation between those two methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8i2XCcqJVRr5oR8RchjrrfW6udTcc2eYKoEAjWw-m3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D&md5=f501e12d4c69e9c5d9bbf7a85d1d5224</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2892%2990054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252892%252990054-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuiol%26aufirst%3DC.%26aulast%3DLedoussal%26aufirst%3DC.%26aulast%3DSurg%25C3%25A9%26aufirst%3DJ.-M.%26atitle%3DA%2520Radiotelemetry%2520System%2520for%2520Chronic%2520Measurement%2520of%2520Blood%2520Pressure%2520and%2520Heart%2520Rate%2520in%2520the%2520Unrestrained%2520Rat%2520Validation%2520of%2520the%2520Method%26jtitle%3DJ.%2520Pharmcol.%2520Toxicol.%2520Methods%26date%3D1992%26volume%3D28%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Telemetry monitoring of pulmonary arterial pressure in freely moving rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1027-1032&author=P.+Hessauthor=M.+Clozelauthor=J.-P.+Clozel&title=Telemetry+monitoring+of+pulmonary+arterial+pressure+in+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DTelemetry%2520monitoring%2520of%2520pulmonary%2520arterial%2520pressure%2520in%2520freely%2520moving%2520rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1996%26volume%3D81%26spage%3D1027%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capeleto, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1124%2Fjpet.108.142976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18780830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=736-745&author=M.+Iglarzauthor=C.+Binkertauthor=K.+Morrisonauthor=W.+Fischliauthor=J.+Gatfieldauthor=A.+Treiberauthor=T.+Wellerauthor=M.+H.+Bolliauthor=C.+Bossauthor=S.+Buchmannauthor=B.+Capeletoauthor=P.+Hessauthor=C.+Qiuauthor=M.+Clozel&title=Pharmacology+of+Macitentan%2C+an+Orally+Active+Tissue-Targeting+Dual+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist</span></div><div class="casAuthors">Iglarz, Marc; Binkert, Christoph; Morrison, Keith; Fischli, Walter; Gatfield, John; Treiber, Alexander; Weller, Thomas; Bolli, Martin H.; Boss, Christoph; Buchmann, Stephan; Capeleto, Bruno; Hess, Patrick; Qiu, Changbin; Clozel, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">736-745</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Macitentan, also called Actelion-1 or ACT-064992 [N-[5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl]-N'-propylaminosulfonamide],is a new dual ETA/ETB endothelin (ET) receptor antagonist designed for tissue targeting.  Selection of macitentan was based on inhibitory potency on both ET receptors and optimization of physicochem. properties to achieve high affinity for lipophilic milieu.  In vivo, macitentan is metabolized into a major and pharmacol. active metabolite, ACT-132577.  Macitentan and its metabolite antagonized the specific binding of ET-1 on membranes of cells overexpressing ETA and ETB receptors and blunted ET-1-induced calcium mobilization in various natural cell lines, with inhibitory consts. within the nanomolar range.  In functional assays, macitentan and ACT-132577 inhibited ET-1-induced contractions in isolated endothelium-denuded rat aorta (ETA receptors) and sarafotoxin S6c-induced contractions in isolated rat trachea (ETB receptors).  In rats with pulmonary hypertension, macitentan prevented both the increase of pulmonary pressure and the right ventricle hypertrophy, and it markedly improved survival.  In diabetic rats, chronic administration of macitentan decreased blood pressure and proteinuria and prevented end-organ damage (renal vascular hypertrophy and structural injury).  In conclusion, macitentan, by its tissue-targeting properties and dual antagonism of ET receptors, protects against end-organ damage in diabetes and improves survival in pulmonary hypertensive rats.  This profile makes macitentan a new agent to treat cardiovascular disorders assocd. with chronic tissue ET system activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIo4YPpTRKFrVg90H21EOLACvtfcHk0lgpVJ_Wm8s2kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvO&md5=00d0f8e55081e3851b8f9b5740b8d419</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142976%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DMorrison%26aufirst%3DK.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DCapeleto%26aufirst%3DB.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520Macitentan%252C%2520an%2520Orally%2520Active%2520Tissue-Targeting%2520Dual%2520Endothelin%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D736%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Sidharta, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Giersbergen, P. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span> </span><span class="NLM_article-title">Macitentan: entry-into-humans study with a new endothelin receptor antagonist</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=977-984&author=P.+N.+Sidhartaauthor=P.+L.+M.+van+Giersbergenauthor=A.+Halabiauthor=J.+Dingemanse&title=Macitentan%3A+entry-into-humans+study+with+a+new+endothelin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidharta%26aufirst%3DP.%2BN.%26aulast%3Dvan%2BGiersbergen%26aufirst%3DP.%2BL.%2BM.%26aulast%3DHalabi%26aufirst%3DA.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DMacitentan%253A%2520entry-into-humans%2520study%2520with%2520a%2520new%2520endothelin%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D977%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Gabbay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, K.</span><span> </span><span class="NLM_article-title">Review of bosentan in the management of pulmonary arterial hypertension</span> <span class="citation_source-journal">Vasc. Health Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18200808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=887-900&author=E.+Gabbayauthor=J.+Fraserauthor=K.+McNeil&title=Review+of+bosentan+in+the+management+of+pulmonary+arterial+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Review of bosentan in the management of pulmonary arterial hypertension</span></div><div class="casAuthors">Gabbay, Eli; Fraser, John; McNeil, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-900</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The dual endothelin receptor antagonist, bosentan, is an orally active therapy, which is effective in the treatment of pulmonary arterial hypertension (PAH).  This review critically appraises the evidence for the efficacy of bosentan in idiopathic and familial PAH, in PAH assocd. with connective tissue disease and in PAH which may develop in assocn. with other conditions.  Data from the pivotal placebo controlled studies and their open labeled extensions as well as long term survival and quality of life data is presented.  Data is also presented on the potential benefit of bosentan in patients with inoperable chronic thromboembolic pulmonary hypertension.  The safety and tolerability of bosentan as well as drug interactions are discussed.  Dosage recommendations in adults and pediatrics are presented.  An algorithm is provided to guide the reader in monitoring potential increases in alanine and aspartate transaminase levels that may occur with bosentan use and the dose adjustments that are recommended as a result of any increase in the levels of these enzymes are shown.  Finally, the role of bosentan as part of combination therapy in PAH is examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyWSGo0bulf7Vg90H21EOLACvtfcHk0lgJYN6TjJ18YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKqsLo%253D&md5=d5bba2c592c2653f383961d729db921b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabbay%26aufirst%3DE.%26aulast%3DFraser%26aufirst%3DJ.%26aulast%3DMcNeil%26aufirst%3DK.%26atitle%3DReview%2520of%2520bosentan%2520in%2520the%2520management%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2007%26volume%3D3%26spage%3D887%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, G. M.</span><span> </span><span class="NLM_article-title">Bosentan—A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-350&author=S.+Dhillonauthor=G.+M.+Keating&title=Bosentan%E2%80%94A+Review+of+its+Use+in+the+Management+of+Mildly+Symptomatic+Pulmonary+Arterial+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DKeating%26aufirst%3DG.%2BM.%26atitle%3DBosentan%25E2%2580%2594A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Mildly%2520Symptomatic%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2009%26volume%3D9%26spage%3D331%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Dhillon, S.</span><span> </span><span class="NLM_article-title">Bosentan—A Review of its Use in the Management of Digital Ulcers Associated with Systemic Sclerosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2005</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2005-2024&author=S.+Dhillon&title=Bosentan%E2%80%94A+Review+of+its+Use+in+the+Management+of+Digital+Ulcers+Associated+with+Systemic+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DBosentan%25E2%2580%2594A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Digital%2520Ulcers%2520Associated%2520with%2520Systemic%2520Sclerosis%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2005%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span>Study of ACT-064992 on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension; <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT00660179" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00660179</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+ACT-064992+on+Morbidity+and+Mortality+in+Patients+With+Symptomatic+Pulmonary+Arterial+Hypertension%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00660179%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DStudy%2520of%2520ACT-064992%2520on%2520Morbidity%2520and%2520Mortality%2520in%2520Patients%2520With%2520Symptomatic%2520Pulmonary%2520Arterial%2520Hypertension%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span>Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-1); <span class="NLM_publisher-name">ClinicalTrials.gov</span>,, <a href="http://clinicaltrials.gov/ct2/show/NCT01474109" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01474109</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+for+the+Treatment+of+Digital+Ulcers+in+Systemic+Sclerosis+Patients+%28DUAL-1%29%3B+ClinicalTrials.gov%2C%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01474109%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520for%2520the%2520Treatment%2520of%2520Digital%2520Ulcers%2520in%2520Systemic%2520Sclerosis%2520Patients%2520%2528DUAL-1%2529%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span>Macitentan for the Treatment of Digital Ulcers in System Sclerosis Patients (DUAL-2); <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT01474122" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01474122</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+for+the+Treatment+of+Digital+Ulcers+in+System+Sclerosis+Patients+%28DUAL-2%29%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01474122%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520for%2520the%2520Treatment%2520of%2520Digital%2520Ulcers%2520in%2520System%2520Sclerosis%2520Patients%2520%2528DUAL-2%2529%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span>Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma; <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT01499251" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01499251</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+in+Combo+With+Dose-dense+Temozolomide+in+Patients+With+Recurrent+Glioblastoma%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01499251%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520in%2520Combo%2520With%2520Dose-dense%2520Temozolomide%2520in%2520Patients%2520With%2520Recurrent%2520Glioblastoma%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Zhong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbs, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span> </span><span class="NLM_article-title">Active-Site-Directed Modification of Subtilisin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00006a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=2259-2263&author=Z.+Zhongauthor=J.+A.+Bibbsauthor=W.+Yuanauthor=C.-H.+Wong&title=Active-Site-Directed+Modification+of+Subtilisin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00006a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00006a052%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DBibbs%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DC.-H.%26atitle%3DActive-Site-Directed%2520Modification%2520of%2520Subtilisin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 95 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wei Zheng, Zhen Wang, Xiangrui Jiang, Qingjie Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Jingshan Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15153-15186. <a href="https://doi.org/10.1021/acs.jmedchem.0c01093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeted%252BDrugs%252Bfor%252BTreatment%252Bof%252BPulmonary%252BArterial%252BHypertension%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%252BPerspectives%26aulast%3DZheng%26aufirst%3DWei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26062020%26date%3D14122020%26volume%3D63%26issue%3D24%26spage%3D15153%26epage%3D15186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">R. Thomas Simons, Georgia E. Scott, Anastasia Gant Kanegusuku, <span class="NLM_string-name hlFld-ContribAuthor">Jennifer L. Roizen</span>. </span><span class="cited-content_cbyCitation_article-title">Photochemically Mediated Nickel-Catalyzed Synthesis of N-(Hetero)aryl Sulfamides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (10)
                                     , 6380-6391. <a href="https://doi.org/10.1021/acs.joc.0c00139" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00139%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhotochemically%252BMediated%252BNickel-Catalyzed%252BSynthesis%252Bof%252BN-%252528Hetero%252529aryl%252BSulfamides%26aulast%3DSimons%26aufirst%3DR.%2BThomas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18012020%26date%3D04052020%26date%3D21042020%26volume%3D85%26issue%3D10%26spage%3D6380%26epage%3D6391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John-David  Aubert</span> and <span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>  . </span><span class="cited-content_cbyCitation_article-title">Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8168-8188. <a href="https://doi.org/10.1021/acs.jmedchem.5b01781" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01781%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEndothelin-Receptor%252BAntagonists%252Bbeyond%252BPulmonary%252BArterial%252BHypertension%25253A%252BCancer%252Band%252BFibrosis%26aulast%3DAubert%26aufirst%3DJohn-David%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14112015%26date%3D15062016%26date%3D22092016%26date%3D07062016%26volume%3D59%26issue%3D18%26spage%3D8168%26epage%3D8188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan P.  Blum</span>, <span class="hlFld-ContribAuthor ">Lukas  Schäffer</span>, <span class="hlFld-ContribAuthor ">Dieter  Schollmeyer</span>, <span class="hlFld-ContribAuthor ">Siegfried R.  Waldvogel</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical synthesis of sulfamides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (39)
                                     , 4775-4778. <a href="https://doi.org/10.1039/D1CC01428E" title="DOI URL">https://doi.org/10.1039/D1CC01428E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CC01428E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CC01428E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DElectrochemical%252Bsynthesis%252Bof%252Bsulfamides%26aulast%3DBlum%26aufirst%3DStephan%2BP.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D39%26spage%3D4775%26epage%3D4778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongrong  Li</span>, <span class="hlFld-ContribAuthor ">Yanxian  Jin</span>, <span class="hlFld-ContribAuthor ">Binbin  Yu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Xu</span>, <span class="hlFld-ContribAuthor ">Xianlang  Chen</span>, <span class="hlFld-ContribAuthor ">Deman  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Solubility determination and thermodynamic properties calculation of macitentan in mixtures of ethyl acetate and alcohols. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Chemical Thermodynamics</span><span> <strong>2021,</strong> <em>156 </em>, 106344. <a href="https://doi.org/10.1016/j.jct.2020.106344" title="DOI URL">https://doi.org/10.1016/j.jct.2020.106344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jct.2020.106344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jct.2020.106344%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Chemical%2520Thermodynamics%26atitle%3DSolubility%252Bdetermination%252Band%252Bthermodynamic%252Bproperties%252Bcalculation%252Bof%252Bmacitentan%252Bin%252Bmixtures%252Bof%252Bethyl%252Bacetate%252Band%252Balcohols%26aulast%3DLi%26aufirst%3DRongrong%26date%3D2021%26volume%3D156%26spage%3D106344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yutaka  Koyama</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin ETB Receptor-Mediated Astrocytic Activation: Pathological Roles in Brain Disorders. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 4333. <a href="https://doi.org/10.3390/ijms22094333" title="DOI URL">https://doi.org/10.3390/ijms22094333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22094333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22094333%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEndothelin%252BETB%252BReceptor-Mediated%252BAstrocytic%252BActivation%25253A%252BPathological%252BRoles%252Bin%252BBrain%252BDisorders%26aulast%3DKoyama%26aufirst%3DYutaka%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D4333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elmas Begum  Cakmak</span>, <span class="hlFld-ContribAuthor ">Belma  Zengin Kurt</span>, <span class="hlFld-ContribAuthor ">Dilek  Ozturk Civelek</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Fatih  Sonmez</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Mustafa  Kucukislamoglu</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline-sulfamoyl carbamates/sulfamide derivatives: Synthesis, cytotoxicity, carbonic anhydrase activity, and molecular modelling studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104778. <a href="https://doi.org/10.1016/j.bioorg.2021.104778" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104778</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104778%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DQuinoline-sulfamoyl%252Bcarbamates%25252Fsulfamide%252Bderivatives%25253A%252BSynthesis%25252C%252Bcytotoxicity%25252C%252Bcarbonic%252Banhydrase%252Bactivity%25252C%252Band%252Bmolecular%252Bmodelling%252Bstudies%26aulast%3DCakmak%26aufirst%3DElmas%2BBegum%26date%3D2021%26volume%3D110%26spage%3D104778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Qian  Luo</span>, <span class="hlFld-ContribAuthor ">Yufei  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Dai</span>, <span class="hlFld-ContribAuthor ">Qing  Xia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Wei‐Hua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Radical N−H Activation: the Unprecedented Harnessing of Formamide with S
              8
              for N−S−N Bonds Construction. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 771-775. <a href="https://doi.org/10.1002/ajoc.202000692" title="DOI URL">https://doi.org/10.1002/ajoc.202000692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000692%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSelective%252BRadical%252BN%2525E2%252588%252592H%252BActivation%25253A%252Bthe%252BUnprecedented%252BHarnessing%252Bof%252BFormamide%252Bwith%252BS%252B8%252Bfor%252BN%2525E2%252588%252592S%2525E2%252588%252592N%252BBonds%252BConstruction%26aulast%3DYu%26aufirst%3DXiang%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D771%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel D.  Griggs</span>, <span class="hlFld-ContribAuthor ">Alejandro  Martin-Roncero</span>, <span class="hlFld-ContribAuthor ">Adam  Nelson</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Marsden</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective side-chain amination of 2-alkyl azacycles by radical translocation: total synthesis of tetraponerine T8. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (7)
                                     , 919-922. <a href="https://doi.org/10.1039/D0CC07625B" title="DOI URL">https://doi.org/10.1039/D0CC07625B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC07625B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC07625B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRegioselective%252Bside-chain%252Bamination%252Bof%252B2-alkyl%252Bazacycles%252Bby%252Bradical%252Btranslocation%25253A%252Btotal%252Bsynthesis%252Bof%252Btetraponerine%252BT8%26aulast%3DGriggs%26aufirst%3DSamuel%2BD.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D7%26spage%3D919%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaden J.  Jun</span>, <span class="hlFld-ContribAuthor ">Xiang‐Qun  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Implementation of Diverse Synthetic and Strategic Approaches to Biologically Active Sulfamides. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (3)
                                     , 430-469. <a href="https://doi.org/10.1002/slct.202004765" title="DOI URL">https://doi.org/10.1002/slct.202004765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202004765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202004765%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DImplementation%252Bof%252BDiverse%252BSynthetic%252Band%252BStrategic%252BApproaches%252Bto%252BBiologically%252BActive%252BSulfamides%26aulast%3DJun%26aufirst%3DJaden%2BJ.%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D3%26spage%3D430%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Zebadúa</span>, <span class="hlFld-ContribAuthor ">Andrea Priscila  Hernández-Pérez</span>, <span class="hlFld-ContribAuthor ">Antonio  García</span>, <span class="hlFld-ContribAuthor ">Nayeli  Zayas</span>, <span class="hlFld-ContribAuthor ">Julio  Sandoval</span>, <span class="hlFld-ContribAuthor ">Julio  López</span>, <span class="hlFld-ContribAuthor ">Tomás  Pulido</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan in the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Future Cardiology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (1)
                                     , 49-58. <a href="https://doi.org/10.2217/fca-2020-0012" title="DOI URL">https://doi.org/10.2217/fca-2020-0012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fca-2020-0012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffca-2020-0012%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Cardiology%26atitle%3DMacitentan%252Bin%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DZebad%25C3%25BAa%26aufirst%3DRodrigo%26date%3D2021%26volume%3D17%26issue%3D1%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Argen  Mamazhakypov</span>, <span class="hlFld-ContribAuthor ">Astrid  Weiß</span>, <span class="hlFld-ContribAuthor ">Sven  Zukunft</span>, <span class="hlFld-ContribAuthor ">Akylbek  Sydykov</span>, <span class="hlFld-ContribAuthor ">Baktybek  Kojonazarov</span>, <span class="hlFld-ContribAuthor ">Jochen  Wilhelm</span>, <span class="hlFld-ContribAuthor ">Christina  Vroom</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Petrovic</span>, <span class="hlFld-ContribAuthor ">Djuro  Kosanovic</span>, <span class="hlFld-ContribAuthor ">Norbert  Weissmann</span>, <span class="hlFld-ContribAuthor ">Werner  Seeger</span>, <span class="hlFld-ContribAuthor ">Ingrid  Fleming</span>, <span class="hlFld-ContribAuthor ">Marc  Iglarz</span>, <span class="hlFld-ContribAuthor ">Friedrich  Grimminger</span>, <span class="hlFld-ContribAuthor ">Hossein A.  Ghofrani</span>, <span class="hlFld-ContribAuthor ">Soni S.  Pullamsetti</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Schermuly</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Circulation</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 204589402094728. <a href="https://doi.org/10.1177/2045894020947283" title="DOI URL">https://doi.org/10.1177/2045894020947283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2045894020947283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2045894020947283%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Circulation%26atitle%3DEffects%252Bof%252Bmacitentan%252Band%252Btadalafil%252Bmonotherapy%252Bor%252Btheir%252Bcombination%252Bon%252Bthe%252Bright%252Bventricle%252Band%252Bplasma%252Bmetabolites%252Bin%252Bpulmonary%252Bhypertensive%252Brats%26aulast%3DMamazhakypov%26aufirst%3DArgen%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D204589402094728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuhiro  Tahara</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Dobashi</span>, <span class="hlFld-ContribAuthor ">Keiichi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Masanori  Funauchi</span>, <span class="hlFld-ContribAuthor ">Masaru  Hatano</span>, <span class="hlFld-ContribAuthor ">Satoshi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Shuji  Joho</span>, <span class="hlFld-ContribAuthor ">Yasuki  Kihara</span>, <span class="hlFld-ContribAuthor ">Takahisa  Kondo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Matsushita</span>, <span class="hlFld-ContribAuthor ">Tohru  Minamino</span>, <span class="hlFld-ContribAuthor ">Norifumi  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Okano</span>, <span class="hlFld-ContribAuthor ">Yukio  Ozaki</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Saji</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sakai</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanabe</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hidehiro  Yamada</span>, <span class="hlFld-ContribAuthor ">Koichiro  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Motonori  Hatta</span>, <span class="hlFld-ContribAuthor ">Shigetake  Sasayama</span>. </span><span class="cited-content_cbyCitation_article-title">Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients. </span><span class="cited-content_cbyCitation_journal-name">Current Medical Research and Opinion</span><span> <strong>2020,</strong> <em>36 </em>
                                    (6)
                                     , 921-928. <a href="https://doi.org/10.1080/03007995.2020.1756234" title="DOI URL">https://doi.org/10.1080/03007995.2020.1756234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03007995.2020.1756234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03007995.2020.1756234%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medical%2520Research%2520and%2520Opinion%26atitle%3DLong-term%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%252Bwith%252Bmacitentan%252Bin%252BJapanese%252Bpatients%26aulast%3DTahara%26aufirst%3DNobuhiro%26date%3D2020%26date%3D2020%26volume%3D36%26issue%3D6%26spage%3D921%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ebru  Aypar</span>, <span class="hlFld-ContribAuthor ">Dursun  Alehan</span>, <span class="hlFld-ContribAuthor ">Tevfik  Karagöz</span>, <span class="hlFld-ContribAuthor ">Hakan  Aykan</span>, <span class="hlFld-ContribAuthor ">İlker  Ertugrul</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension: extended study results. </span><span class="cited-content_cbyCitation_journal-name">Cardiology in the Young</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 681-685. <a href="https://doi.org/10.1017/S1047951120000773" title="DOI URL">https://doi.org/10.1017/S1047951120000773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S1047951120000773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS1047951120000773%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiology%2520in%2520the%2520Young%26atitle%3DClinical%252Befficacy%252Band%252Bsafety%252Bof%252Bswitch%252Bfrom%252Bbosentan%252Bto%252Bmacitentan%252Bin%252Bchildren%252Band%252Byoung%252Badults%252Bwith%252Bpulmonary%252Barterial%252Bhypertension%25253A%252Bextended%252Bstudy%252Bresults%26aulast%3DAypar%26aufirst%3DEbru%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D681%26epage%3D685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Mercurio</span>, <span class="hlFld-ContribAuthor ">Anna  Bianco</span>, <span class="hlFld-ContribAuthor ">Giacomo  Campi</span>, <span class="hlFld-ContribAuthor ">Alessandra  Cuomo</span>, <span class="hlFld-ContribAuthor ">Nermin  Diab</span>, <span class="hlFld-ContribAuthor ">Angela  Mancini</span>, <span class="hlFld-ContribAuthor ">Paolo  Parrella</span>, <span class="hlFld-ContribAuthor ">Mario  Petretta</span>, <span class="hlFld-ContribAuthor ">Paul M.  Hassoun</span>, <span class="hlFld-ContribAuthor ">Domenico  Bonaduce</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (16)
                                     , 2844-2864. <a href="https://doi.org/10.2174/0929867325666180201095743" title="DOI URL">https://doi.org/10.2174/0929867325666180201095743</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180201095743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180201095743%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DNew%252BDrugs%25252C%252BTherapeutic%252BStrategies%25252C%252Band%252BFuture%252BDirection%252Bfor%252Bthe%252BTreatment%252Bof%252BPulmonary%252BArterial%252BHypertension%26aulast%3DMercurio%26aufirst%3DValentina%26date%3D2019%26volume%3D26%26issue%3D16%26spage%3D2844%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Flores</span>, <span class="hlFld-ContribAuthor ">Ana T.  Caro</span>, <span class="hlFld-ContribAuthor ">Alberto  Mendoza</span>. </span><span class="cited-content_cbyCitation_article-title">Initial experience in children with the use of macitentan in pulmonary arterial hypertension after side effects with other endothelin receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Progress in Pediatric Cardiology</span><span> <strong>2019,</strong> <em>52 </em>, 55-56. <a href="https://doi.org/10.1016/j.ppedcard.2018.11.004" title="DOI URL">https://doi.org/10.1016/j.ppedcard.2018.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ppedcard.2018.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ppedcard.2018.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Pediatric%2520Cardiology%26atitle%3DInitial%252Bexperience%252Bin%252Bchildren%252Bwith%252Bthe%252Buse%252Bof%252Bmacitentan%252Bin%252Bpulmonary%252Barterial%252Bhypertension%252Bafter%252Bside%252Beffects%252Bwith%252Bother%252Bendothelin%252Breceptor%252Bantagonists%26aulast%3DFlores%26aufirst%3DMarta%26date%3D2019%26volume%3D52%26spage%3D55%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catharina  Belge</span>, <span class="hlFld-ContribAuthor ">Marion  Delcroix</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Respiratory Disease</span><span> <strong>2019,</strong> <em>13 </em>, 175346661882344. <a href="https://doi.org/10.1177/1753466618823440" title="DOI URL">https://doi.org/10.1177/1753466618823440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753466618823440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753466618823440%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Respiratory%2520Disease%26atitle%3DTreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%252Bwith%252Bthe%252Bdual%252Bendothelin%252Breceptor%252Bantagonist%252Bmacitentan%25253A%252Bclinical%252Bevidence%252Band%252Bexperience%26aulast%3DBelge%26aufirst%3DCatharina%26date%3D2019%26date%3D2019%26volume%3D13%26spage%3D175346661882344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxana  Sulica</span>, <span class="hlFld-ContribAuthor ">Swathi  Sangli</span>, <span class="hlFld-ContribAuthor ">Aloke  Chakravarti</span>, <span class="hlFld-ContribAuthor ">David  Steiger</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Circulation</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     , 204589401982694. <a href="https://doi.org/10.1177/2045894019826944" title="DOI URL">https://doi.org/10.1177/2045894019826944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2045894019826944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2045894019826944%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Circulation%26atitle%3DClinical%252Band%252Bhemodynamic%252Bbenefit%252Bof%252Bmacitentan%252Band%252Briociguat%252Bupfront%252Bcombination%252Bin%252Bpatients%252Bwith%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DSulica%26aufirst%3DRoxana%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D204589401982694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosamaria  Lappano</span>, <span class="hlFld-ContribAuthor ">Yves  Jacquot</span>, <span class="hlFld-ContribAuthor ">Marcello  Maggiolini</span>. </span><span class="cited-content_cbyCitation_article-title">GPCR Modulation in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (12)
                                     , 3840. <a href="https://doi.org/10.3390/ijms19123840" title="DOI URL">https://doi.org/10.3390/ijms19123840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19123840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19123840%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DGPCR%252BModulation%252Bin%252BBreast%252BCancer%26aulast%3DLappano%26aufirst%3DRosamaria%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D12%26spage%3D3840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charmaine C. W.  Lo</span>, <span class="hlFld-ContribAuthor ">Seyed M.  Moosavi</span>, <span class="hlFld-ContribAuthor ">Kristen J.  Bubb</span>. </span><span class="cited-content_cbyCitation_article-title">The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphys.2018.01167" title="DOI URL">https://doi.org/10.3389/fphys.2018.01167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2018.01167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2018.01167%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DThe%252BRegulation%252Bof%252BPulmonary%252BVascular%252BTone%252Bby%252BNeuropeptides%252Band%252Bthe%252BImplications%252Bfor%252BPulmonary%252BHypertension%26aulast%3DLo%26aufirst%3DCharmaine%2BC.%2BW.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  VANĚČKOVÁ</span>, <span class="hlFld-ContribAuthor ">S.  HOJNÁ</span>, <span class="hlFld-ContribAuthor ">M.  KADLECOVÁ</span>, <span class="hlFld-ContribAuthor ">Z.  VERNEROVÁ</span>, <span class="hlFld-ContribAuthor ">L.  KOPKAN</span>, <span class="hlFld-ContribAuthor ">L.  ČERVENKA</span>, <span class="hlFld-ContribAuthor ">J.  ZICHA</span>. </span><span class="cited-content_cbyCitation_article-title">Renoprotective Effects of ETA Receptor Antagonists Therapy in Experimental Non-Diabetic Chronic Kidney Disease: Is There Still Hope for the Future?. </span><span class="cited-content_cbyCitation_journal-name">Physiological Research</span><span> <strong>2018,</strong> <em> </em>, S55-S67. <a href="https://doi.org/10.33549/physiolres.933898" title="DOI URL">https://doi.org/10.33549/physiolres.933898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.33549/physiolres.933898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.33549%2Fphysiolres.933898%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Research%26atitle%3DRenoprotective%252BEffects%252Bof%252BETA%252BReceptor%252BAntagonists%252BTherapy%252Bin%252BExperimental%252BNon-Diabetic%252BChronic%252BKidney%252BDisease%25253A%252BIs%252BThere%252BStill%252BHope%252Bfor%252Bthe%252BFuture%25253F%26aulast%3DVAN%25C4%259A%25C4%258CKOV%25C3%2581%26aufirst%3DI.%26date%3D2018%26date%3D2018%26spage%3DS55%26epage%3DS67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ebru  Aypar</span>, <span class="hlFld-ContribAuthor ">Dursun  Alehan</span>, <span class="hlFld-ContribAuthor ">Tevfik  Karagöz</span>, <span class="hlFld-ContribAuthor ">Hayrettin Hakan  Aykan</span>, <span class="hlFld-ContribAuthor ">İlker  Ertugrul</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Cardiology in the Young</span><span> <strong>2018,</strong> <em>28 </em>
                                    (4)
                                     , 542-547. <a href="https://doi.org/10.1017/S1047951117002542" title="DOI URL">https://doi.org/10.1017/S1047951117002542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S1047951117002542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS1047951117002542%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiology%2520in%2520the%2520Young%26atitle%3DClinical%252Befficacy%252Band%252Bsafety%252Bof%252Bswitch%252Bfrom%252Bbosentan%252Bto%252Bmacitentan%252Bin%252Bchildren%252Band%252Byoung%252Badults%252Bwith%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DAypar%26aufirst%3DEbru%26date%3D2018%26date%3D2017%26volume%3D28%26issue%3D4%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal M.  Jagtap</span>, <span class="hlFld-ContribAuthor ">Navnath C.  Niphade</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar T.  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Gorakshanath B.  Shinde</span>, <span class="hlFld-ContribAuthor ">Raghunath B.  Toche</span>, <span class="hlFld-ContribAuthor ">Divyesh R.  Joshi</span>, <span class="hlFld-ContribAuthor ">Vijayavitthal T.  Mathad</span>. </span><span class="cited-content_cbyCitation_article-title">Improved and single-pot process for the synthesis of macitentan, an endothelin receptor antagonist, via lithium amide-mediated nucleophilic substitution. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2018,</strong> <em>149 </em>
                                    (3)
                                     , 653-661. <a href="https://doi.org/10.1007/s00706-017-2098-2" title="DOI URL">https://doi.org/10.1007/s00706-017-2098-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-017-2098-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-017-2098-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DImproved%252Band%252Bsingle-pot%252Bprocess%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bmacitentan%25252C%252Ban%252Bendothelin%252Breceptor%252Bantagonist%25252C%252Bvia%252Blithium%252Bamide-mediated%252Bnucleophilic%252Bsubstitution%26aulast%3DJagtap%26aufirst%3DKunal%2BM.%26date%3D2018%26date%3D2018%26volume%3D149%26issue%3D3%26spage%3D653%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung Ho  Jun</span>, <span class="hlFld-ContribAuthor ">Vineet  Kumar</span>, <span class="hlFld-ContribAuthor ">Thomas S.  Dexheimer</span>, <span class="hlFld-ContribAuthor ">Iwona  Wedlich</span>, <span class="hlFld-ContribAuthor ">Marc C.  Nicklaus</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Sanjay V.  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition activity of novel piperidinyl sulfamides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2018,</strong> <em>111 </em>, 337-348. <a href="https://doi.org/10.1016/j.ejps.2017.10.017" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DSynthesis%25252C%252Banti-cancer%252Bscreening%252Band%252Btyrosyl-DNA%252Bphosphodiesterase%252B1%252B%252528Tdp1%252529%252Binhibition%252Bactivity%252Bof%252Bnovel%252Bpiperidinyl%252Bsulfamides%26aulast%3DJun%26aufirst%3DJung%2BHo%26date%3D2018%26volume%3D111%26spage%3D337%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wataru  Shihoya</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Nishizawa</span>, <span class="hlFld-ContribAuthor ">Keitaro  Yamashita</span>, <span class="hlFld-ContribAuthor ">Asuka  Inoue</span>, <span class="hlFld-ContribAuthor ">Kunio  Hirata</span>, <span class="hlFld-ContribAuthor ">Francois Marie Ngako  Kadji</span>, <span class="hlFld-ContribAuthor ">Akiko  Okuta</span>, <span class="hlFld-ContribAuthor ">Kazutoshi  Tani</span>, <span class="hlFld-ContribAuthor ">Junken  Aoki</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Fujiyoshi</span>, <span class="hlFld-ContribAuthor ">Tomoko  Doi</span>, <span class="hlFld-ContribAuthor ">Osamu  Nureki</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2017,</strong> <em>24 </em>
                                    (9)
                                     , 758-764. <a href="https://doi.org/10.1038/nsmb.3450" title="DOI URL">https://doi.org/10.1038/nsmb.3450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nsmb.3450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnsmb.3450%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DX-ray%252Bstructures%252Bof%252Bendothelin%252BETB%252Breceptor%252Bbound%252Bto%252Bclinical%252Bantagonist%252Bbosentan%252Band%252Bits%252Banalog%26aulast%3DShihoya%26aufirst%3DWataru%26date%3D2017%26date%3D2017%26volume%3D24%26issue%3D9%26spage%3D758%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiovascular System (C). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-50. <a href="https://doi.org/10.1002/14356007.a05_289.pub3" title="DOI URL">https://doi.org/10.1002/14356007.a05_289.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_289.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_289.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DCardiovascular%252BSystem%252B%252528C%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D50%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew Gibson  Burbank</span>, <span class="hlFld-ContribAuthor ">Ahmad  Sharanek</span>, <span class="hlFld-ContribAuthor ">Audrey  Burban</span>, <span class="hlFld-ContribAuthor ">Hervé  Mialanne</span>, <span class="hlFld-ContribAuthor ">Hélène  Aerts</span>, <span class="hlFld-ContribAuthor ">Christiane  Guguen-Guillouzo</span>, <span class="hlFld-ContribAuthor ">Richard John  Weaver</span>, <span class="hlFld-ContribAuthor ">André  Guillouzo</span>. </span><span class="cited-content_cbyCitation_article-title">From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2017,</strong> <em>157 </em>
                                    (2)
                                     , 451-464. <a href="https://doi.org/10.1093/toxsci/kfx062" title="DOI URL">https://doi.org/10.1093/toxsci/kfx062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfx062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfx062%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DFrom%252Bthe%252BCover%25253A%252BMechanisticInsights%252Bin%252BCytotoxic%252Band%252BCholestatic%252BPotential%252Bof%252Bthe%252BEndothelial%252BReceptor%252BAntagonists%252BUsing%252BHepaRG%252BCells%26aulast%3DBurbank%26aufirst%3DMatthew%2BGibson%26date%3D2017%26date%3D2017%26volume%3D157%26issue%3D2%26spage%3D451%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majid  Nami</span>, <span class="hlFld-ContribAuthor ">Sara Nasiri  Sovari</span>, <span class="hlFld-ContribAuthor ">Yaghoub  Haghighatnia</span>, <span class="hlFld-ContribAuthor ">Minoo  Dabiri</span>, <span class="hlFld-ContribAuthor ">Peyman  Salehi</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2017,</strong> <em>49 </em>
                                    (3)
                                     , 258-264. <a href="https://doi.org/10.1080/00304948.2017.1320921" title="DOI URL">https://doi.org/10.1080/00304948.2017.1320921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2017.1320921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2017.1320921%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DA%252BNovel%252BSynthesis%252Bof%252BMacitentan%25252C%252Ban%252BEndothelin%252BReceptor%252BAntagonist%26aulast%3DNami%26aufirst%3DMajid%26date%3D2017%26date%3D2017%26volume%3D49%26issue%3D3%26spage%3D258%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriaki  Emoto</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 153-169. <a href="https://doi.org/10.1007/978-981-287-840-3_12" title="DOI URL">https://doi.org/10.1007/978-981-287-840-3_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-287-840-3_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-287-840-3_12%26sid%3Dliteratum%253Aachs%26atitle%3DEndothelin%252BReceptor%252BAntagonist%26aulast%3DEmoto%26aufirst%3DNoriaki%26date%3D2017%26date%3D2017%26spage%3D153%26epage%3D169%26pub%3DSpringer%2520Singapore%26atitle%3DDiagnosis%252Band%252BTreatment%252Bof%252BPulmonary%252BHypertension%26aulast%3DFukumoto%26aufirst%3DYoshihiro%26date%3D2017%26volume%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.H.  Bolli</span>, <span class="hlFld-ContribAuthor ">C.  Boss</span>, <span class="hlFld-ContribAuthor ">J.  Gatfield</span>, <span class="hlFld-ContribAuthor ">M.  Iglarz</span>, <span class="hlFld-ContribAuthor ">A.  Treiber</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Macitentan—A Standard Medicinal Chemistry Program?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 252-283. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12455-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12455-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12455-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12455-2%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BMacitentan%2525E2%252580%252594A%252BStandard%252BMedicinal%252BChemistry%252BProgram%25253F%26aulast%3DBolli%26aufirst%3DM.H.%26date%3D2017%26spage%3D252%26epage%3D283%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Karmazyn</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin-1 as a Cardiac-Derived Autocrine, Paracrine and Intracrine Factor in Heart Health and Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 59-85. <a href="https://doi.org/10.1016/B978-0-12-803111-7.00003-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803111-7.00003-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803111-7.00003-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803111-7.00003-8%26sid%3Dliteratum%253Aachs%26atitle%3DEndothelin-1%252Bas%252Ba%252BCardiac-Derived%252BAutocrine%25252C%252BParacrine%252Band%252BIntracrine%252BFactor%252Bin%252BHeart%252BHealth%252Band%252BDisease%26aulast%3DKarmazyn%26aufirst%3DM.%26date%3D2017%26spage%3D59%26epage%3D85%26pub%3DElsevier%26atitle%3DEndocrinology%252Bof%252Bthe%252BHeart%252Bin%252BHealth%252Band%252BDisease%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella S  Hahn</span>, <span class="hlFld-ContribAuthor ">Mina  Makaryus</span>, <span class="hlFld-ContribAuthor ">Arunabh  Talwar</span>, <span class="hlFld-ContribAuthor ">Mangala  Narasimhan</span>, <span class="hlFld-ContribAuthor ">Gulrukh  Zaidi</span>. </span><span class="cited-content_cbyCitation_article-title">A review of therapeutic agents for the management of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Respiratory Disease</span><span> <strong>2017,</strong> <em>11 </em>
                                    (1)
                                     , 46-63. <a href="https://doi.org/10.1177/1753465816665289" title="DOI URL">https://doi.org/10.1177/1753465816665289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753465816665289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753465816665289%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Respiratory%2520Disease%26atitle%3DA%252Breview%252Bof%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Bmanagement%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DHahn%26aufirst%3DStella%2BS%26date%3D2017%26date%3D2016%26volume%3D11%26issue%3D1%26spage%3D46%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuya  Takahashi</span>, <span class="hlFld-ContribAuthor ">Ritsuko  Horie</span>, <span class="hlFld-ContribAuthor ">Yoshinari  Yokoyama</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and clinical profile of a novel dual endothelin receptor antagonist, macitentan (Opsumit®). </span><span class="cited-content_cbyCitation_journal-name">Folia Pharmacologica Japonica</span><span> <strong>2017,</strong> <em>149 </em>
                                    (1)
                                     , 49-58. <a href="https://doi.org/10.1254/fpj.149.49" title="DOI URL">https://doi.org/10.1254/fpj.149.49</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1254/fpj.149.49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1254%2Ffpj.149.49%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Pharmacologica%2520Japonica%26atitle%3DPharmacological%252Band%252Bclinical%252Bprofile%252Bof%252Ba%252Bnovel%252Bdual%252Bendothelin%252Breceptor%252Bantagonist%25252C%252Bmacitentan%252B%252528Opsumit%2525C2%2525AE%252529%26aulast%3DTakahashi%26aufirst%3DShuya%26date%3D2017%26volume%3D149%26issue%3D1%26spage%3D49%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gillian M.  Keating</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan: A Review in Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Cardiovascular Drugs</span><span> <strong>2016,</strong> <em>16 </em>
                                    (6)
                                     , 453-460. <a href="https://doi.org/10.1007/s40256-016-0188-x" title="DOI URL">https://doi.org/10.1007/s40256-016-0188-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40256-016-0188-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40256-016-0188-x%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Cardiovascular%2520Drugs%26atitle%3DMacitentan%25253A%252BA%252BReview%252Bin%252BPulmonary%252BArterial%252BHypertension%26aulast%3DKeating%26aufirst%3DGillian%2BM.%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D6%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michele  Correale</span>, <span class="hlFld-ContribAuthor ">Stefano  Zicchino</span>, <span class="hlFld-ContribAuthor ">Ilenia  Monaco</span>, <span class="hlFld-ContribAuthor ">Natale Daniele  Brunetti</span>, <span class="hlFld-ContribAuthor ">Matteo  Di Biase</span>. </span><span class="cited-content_cbyCitation_article-title">Association therapy with macitentan added to sildenafil in a thalassemic patient with pulmonary hypertension. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cardiology</span><span> <strong>2016,</strong> <em>220 </em>, 80-81. <a href="https://doi.org/10.1016/j.ijcard.2016.06.133" title="DOI URL">https://doi.org/10.1016/j.ijcard.2016.06.133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijcard.2016.06.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijcard.2016.06.133%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cardiology%26atitle%3DAssociation%252Btherapy%252Bwith%252Bmacitentan%252Badded%252Bto%252Bsildenafil%252Bin%252Ba%252Bthalassemic%252Bpatient%252Bwith%252Bpulmonary%252Bhypertension%26aulast%3DCorreale%26aufirst%3DMichele%26date%3D2016%26volume%3D220%26spage%3D80%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martine  Clozel</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</span><span> <strong>2016,</strong> <em>311 </em>
                                    (4)
                                     , R721-R726. <a href="https://doi.org/10.1152/ajpregu.00475.2015" title="DOI URL">https://doi.org/10.1152/ajpregu.00475.2015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpregu.00475.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpregu.00475.2015%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Regulatory%252C%2520Integrative%2520and%2520Comparative%2520Physiology%26atitle%3DEndothelin%252Bresearch%252Band%252Bthe%252Bdiscovery%252Bof%252Bmacitentan%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DClozel%26aufirst%3DMartine%26date%3D2016%26volume%3D311%26issue%3D4%26spage%3DR721%26epage%3DR726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth A.W.  Chan</span>, <span class="hlFld-ContribAuthor ">Barbara  Buckley</span>, <span class="hlFld-ContribAuthor ">Aimen K.  Farraj</span>, <span class="hlFld-ContribAuthor ">Leslie C.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2016,</strong> <em>165 </em>, 63-78. <a href="https://doi.org/10.1016/j.pharmthera.2016.05.006" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2016.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2016.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2016.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252Bheart%252Bas%252Ban%252Bextravascular%252Btarget%252Bof%252Bendothelin-1%252Bin%252Bparticulate%252Bmatter-induced%252Bcardiac%252Bdysfunction%26aulast%3DChan%26aufirst%3DElizabeth%2BA.W.%26date%3D2016%26volume%3D165%26spage%3D63%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Boss</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>. </span><span class="cited-content_cbyCitation_article-title">From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (15)
                                     , 3381-3394. <a href="https://doi.org/10.1016/j.bmcl.2016.06.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFrom%252Bbosentan%252B%252528Tracleer%2525C2%2525AE%252529%252Bto%252Bmacitentan%252B%252528Opsumit%2525C2%2525AE%252529%25253A%252BThe%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DBoss%26aufirst%3DChristoph%26date%3D2016%26volume%3D26%26issue%3D15%26spage%3D3381%26epage%3D3394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loïc  Pantaine</span>, <span class="hlFld-ContribAuthor ">François  Richard</span>, <span class="hlFld-ContribAuthor ">Jérôme  Marrot</span>, <span class="hlFld-ContribAuthor ">Xavier  Moreau</span>, <span class="hlFld-ContribAuthor ">Vincent  Coeffard</span>, <span class="hlFld-ContribAuthor ">Christine  Greck</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Unsymmetrical Sulfamides
              via
              a Lossen-Like Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (12)
                                     , 2012-2016. <a href="https://doi.org/10.1002/adsc.201501139" title="DOI URL">https://doi.org/10.1002/adsc.201501139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201501139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201501139%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BSynthesis%252Bof%252BUnsymmetrical%252BSulfamides%252Bvia%252Ba%252BLossen-Like%252BRearrangement%26aulast%3DPantaine%26aufirst%3DLo%25C3%25AFc%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D12%26spage%3D2012%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noémie  Hurst</span>, <span class="hlFld-ContribAuthor ">Matthias  Pellek</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>. </span><span class="cited-content_cbyCitation_article-title">Lack of Pharmacokinetic Interactions Between Macitentan and a Combined Oral Contraceptive in Healthy Female Subjects. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Pharmacology</span><span> <strong>2016,</strong> <em>56 </em>
                                    (6)
                                     , 669-674. <a href="https://doi.org/10.1002/jcph.639" title="DOI URL">https://doi.org/10.1002/jcph.639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcph.639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcph.639%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DLack%252Bof%252BPharmacokinetic%252BInteractions%252BBetween%252BMacitentan%252Band%252Ba%252BCombined%252BOral%252BContraceptive%252Bin%252BHealthy%252BFemale%252BSubjects%26aulast%3DHurst%26aufirst%3DNo%25C3%25A9mie%26date%3D2016%26date%3D2015%26volume%3D56%26issue%3D6%26spage%3D669%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Surendra  Dawadi</span>, <span class="hlFld-ContribAuthor ">Courtney C.  Aldrich</span>. </span><span class="cited-content_cbyCitation_article-title">N
              -(
              tert
              -Butoxycarbonyl)sulfamoyl Chloride. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-3. <a href="https://doi.org/10.1002/047084289X.rn01906" title="DOI URL">https://doi.org/10.1002/047084289X.rn01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01906%26sid%3Dliteratum%253Aachs%26atitle%3DN%252B-%252528%252Btert%252B-Butoxycarbonyl%252529sulfamoyl%252BChloride%26aulast%3DDawadi%26aufirst%3DSurendra%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D3%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Tommaso  Miraval</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Jacques-Alexis  Funel</span>, <span class="hlFld-ContribAuthor ">Jerome  Segrestaa</span>, <span class="hlFld-ContribAuthor ">Swen  Seeland</span>. </span><span class="cited-content_cbyCitation_article-title">The metabolism of the dual endothelin receptor antagonist macitentan in rat and dog. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2016,</strong> <em>46 </em>
                                    (3)
                                     , 253-267. <a href="https://doi.org/10.3109/00498254.2015.1070302" title="DOI URL">https://doi.org/10.3109/00498254.2015.1070302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2015.1070302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2015.1070302%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DThe%252Bmetabolism%252Bof%252Bthe%252Bdual%252Bendothelin%252Breceptor%252Bantagonist%252Bmacitentan%252Bin%252Brat%252Band%252Bdog%26aulast%3DTreiber%26aufirst%3DAlexander%26date%3D2016%26date%3D2015%26volume%3D46%26issue%3D3%26spage%3D253%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing  Wang</span>, <span class="hlFld-ContribAuthor ">Yuxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Zhixin  Ai</span>, <span class="hlFld-ContribAuthor ">Yanling  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuhong  Xiang</span>, <span class="hlFld-ContribAuthor ">Yanjiang  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2016,</strong> <em>17 </em>
                                    (3)
                                     , 389. <a href="https://doi.org/10.3390/ijms17030389" title="DOI URL">https://doi.org/10.3390/ijms17030389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms17030389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms17030389%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252BDual%252BETA%25252FETB%252BReceptor%252BAntagonists%252Bfrom%252BTraditional%252BChinese%252BHerbs%252Bthrough%252Bin%252BSilico%252Band%252Bin%252BVitro%252BScreening%26aulast%3DWang%26aufirst%3DXing%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D3%26spage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuhiro  Tahara</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Dobashi</span>, <span class="hlFld-ContribAuthor ">Keiichi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Masanori  Funauchi</span>, <span class="hlFld-ContribAuthor ">Masaru  Hatano</span>, <span class="hlFld-ContribAuthor ">Satoshi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Shuji  Joho</span>, <span class="hlFld-ContribAuthor ">Yasuki  Kihara</span>, <span class="hlFld-ContribAuthor ">Takeshi  Kimura</span>, <span class="hlFld-ContribAuthor ">Takahisa  Kondo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Matsushita</span>, <span class="hlFld-ContribAuthor ">Tohru  Minamino</span>, <span class="hlFld-ContribAuthor ">Norifumi  Nakanishi</span>, <span class="hlFld-ContribAuthor ">Yukio  Ozaki</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Saji</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sakai</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanabe</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hidehiro  Yamada</span>, <span class="hlFld-ContribAuthor ">Koichiro  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Shigetake  Sasayama</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and Safety of a Novel Endothelin Receptor Antagonist, Macitentan, in Japanese Patients With Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Circulation Journal</span><span> <strong>2016,</strong> <em>80 </em>
                                    (6)
                                     , 1478-1483. <a href="https://doi.org/10.1253/circj.CJ-15-1305" title="DOI URL">https://doi.org/10.1253/circj.CJ-15-1305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1253/circj.CJ-15-1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1253%2Fcircj.CJ-15-1305%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%2520Journal%26atitle%3DEfficacy%252Band%252BSafety%252Bof%252Ba%252BNovel%252BEndothelin%252BReceptor%252BAntagonist%25252C%252BMacitentan%25252C%252Bin%252BJapanese%252BPatients%252BWith%252BPulmonary%252BArterial%252BHypertension%26aulast%3DTahara%26aufirst%3DNobuhiro%26date%3D2016%26volume%3D80%26issue%3D6%26spage%3D1478%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. N.  Avdeev</span>. </span><span class="cited-content_cbyCitation_article-title">The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Terapevticheskii arkhiv</span><span> <strong>2016,</strong> <em>88 </em>
                                    (7)
                                     , 89. <a href="https://doi.org/10.17116/terarkh201688789-97" title="DOI URL">https://doi.org/10.17116/terarkh201688789-97</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.17116/terarkh201688789-97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.17116%2Fterarkh201688789-97%26sid%3Dliteratum%253Aachs%26jtitle%3DTerapevticheskii%2520arkhiv%26atitle%3DThe%252Bnew%252Bendothelin%252Breceptor%252Bantagonist%252Bmacitentan%25253A%252BProspects%252Bfor%252Btherapy%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DAvdeev%26aufirst%3DS.%2BN.%26date%3D2016%26volume%3D88%26issue%3D7%26spage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshinari  YOKOYAMA</span>, <span class="hlFld-ContribAuthor ">Jasper  DINGEMANSE</span>, <span class="hlFld-ContribAuthor ">Motonori  HATTA</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  FUKASE</span>. </span><span class="cited-content_cbyCitation_article-title">Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of Macitentan, a New Endothelin Receptor Antagonist, in Healthy Japanese Male Subjects . </span><span class="cited-content_cbyCitation_journal-name">Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics</span><span> <strong>2016,</strong> <em>47 </em>
                                    (4)
                                     , 143-150. <a href="https://doi.org/10.3999/jscpt.47.143" title="DOI URL">https://doi.org/10.3999/jscpt.47.143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3999/jscpt.47.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3999%2Fjscpt.47.143%26sid%3Dliteratum%253Aachs%26jtitle%3DRinsho%2520yakuri%252FJapanese%2520Journal%2520of%2520Clinical%2520Pharmacology%2520and%2520Therapeutics%26atitle%3DTolerability%25252C%252BSafety%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamics%252Bof%252BMacitentan%25252C%252Ba%252BNew%252BEndothelin%252BReceptor%252BAntagonist%25252C%252Bin%252BHealthy%252BJapanese%252BMale%252BSubjects%26aulast%3DYOKOYAMA%26aufirst%3DYoshinari%26date%3D2016%26volume%3D47%26issue%3D4%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Michel</span>, <span class="hlFld-ContribAuthor ">Joaquin  De Haro</span>, <span class="hlFld-ContribAuthor ">Silvia  Bleda</span>, <span class="hlFld-ContribAuthor ">Ilsem V.  Laime</span>, <span class="hlFld-ContribAuthor ">Jhenifer  Uyaguari</span>, <span class="hlFld-ContribAuthor ">Francisco  Acin</span>. </span><span class="cited-content_cbyCitation_article-title">Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb Ischemia. </span><span class="cited-content_cbyCitation_journal-name">Clinical Medicine Insights: Cardiology</span><span> <strong>2016,</strong> <em>10 </em>, CMC.S38448. <a href="https://doi.org/10.4137/CMC.S38448" title="DOI URL">https://doi.org/10.4137/CMC.S38448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4137/CMC.S38448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4137%2FCMC.S38448%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Medicine%2520Insights%253A%2520Cardiology%26atitle%3DRationale%252Band%252BDesign%252Bof%252BRandomized%252BClinical%252BTrial%252Bfor%252Bthe%252BAssessment%252Bof%252BMacitentan%252BEfficiency%252Bas%252BCoadjuvant%252BTreatment%252Bto%252BOpen%252Band%252BEndovascular%252BRevascularization%252Bin%252BCritical%252BLimb%252BIschemia%26aulast%3DMichel%26aufirst%3DIgnacio%26date%3D2016%26date%3D2016%26volume%3D10%26spage%3DCMC.S38448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Iglarz</span>, <span class="hlFld-ContribAuthor ">Kyle  Landskroner</span>, <span class="hlFld-ContribAuthor ">Yasmina  Bauer</span>, <span class="hlFld-ContribAuthor ">Magali  Vercauteren</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Berengère  Renault</span>, <span class="hlFld-ContribAuthor ">Rolf  Studer</span>, <span class="hlFld-ContribAuthor ">Enrico  Vezzali</span>, <span class="hlFld-ContribAuthor ">Diego  Freti</span>, <span class="hlFld-ContribAuthor ">Hakim  Hadana</span>, <span class="hlFld-ContribAuthor ">Manuela  Schläpfer</span>, <span class="hlFld-ContribAuthor ">Christophe  Cattaneo</span>, <span class="hlFld-ContribAuthor ">Céline  Bortolamiol</span>, <span class="hlFld-ContribAuthor ">Edgar  Weber</span>, <span class="hlFld-ContribAuthor ">Brian R.  Whitby</span>, <span class="hlFld-ContribAuthor ">Stéphane  Delahaye</span>, <span class="hlFld-ContribAuthor ">Daniel  Wanner</span>, <span class="hlFld-ContribAuthor ">Pauline  Steiner</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Martine  Clozel</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology</span><span> <strong>2015,</strong> <em>66 </em>
                                    (5)
                                     , 457-467. <a href="https://doi.org/10.1097/FJC.0000000000000296" title="DOI URL">https://doi.org/10.1097/FJC.0000000000000296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FJC.0000000000000296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFJC.0000000000000296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%26atitle%3DComparison%252Bof%252BMacitentan%252Band%252BBosentan%252Bon%252BRight%252BVentricular%252BRemodeling%252Bin%252Ba%252BRat%252BModel%252Bof%252BNon-vasoreactive%252BPulmonary%252BHypertension%26aulast%3DIglarz%26aufirst%3DMarc%26date%3D2015%26volume%3D66%26issue%3D5%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mona  Selej</span>, <span class="hlFld-ContribAuthor ">Alain J.  Romero</span>, <span class="hlFld-ContribAuthor ">Richard N.  Channick</span>, <span class="hlFld-ContribAuthor ">Martine  Clozel</span>. </span><span class="cited-content_cbyCitation_article-title">Development of macitentan for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2015,</strong> <em>1358 </em>
                                    (1)
                                     , 68-81. <a href="https://doi.org/10.1111/nyas.12856" title="DOI URL">https://doi.org/10.1111/nyas.12856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.12856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.12856%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DDevelopment%252Bof%252Bmacitentan%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DSelej%26aufirst%3DMona%26date%3D2015%26date%3D2015%26volume%3D1358%26issue%3D1%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixiu  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaomeng  He</span>, <span class="hlFld-ContribAuthor ">Huqun  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Chen</span>, <span class="hlFld-ContribAuthor ">Weiyong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous determination of macitentan and its active metabolite in human plasma by liquid chromatography-tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2015,</strong> <em>1002 </em>, 358-363. <a href="https://doi.org/10.1016/j.jchromb.2015.07.053" title="DOI URL">https://doi.org/10.1016/j.jchromb.2015.07.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2015.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2015.07.053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DSimultaneous%252Bdetermination%252Bof%252Bmacitentan%252Band%252Bits%252Bactive%252Bmetabolite%252Bin%252Bhuman%252Bplasma%252Bby%252Bliquid%252Bchromatography-tandem%252Bmass%252Bspectrometry%26aulast%3DYu%26aufirst%3DLixiu%26date%3D2015%26volume%3D1002%26spage%3D358%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swanny  Perrin</span>, <span class="hlFld-ContribAuthor ">Marie-Camille  Chaumais</span>, <span class="hlFld-ContribAuthor ">Caroline  O’Connell</span>, <span class="hlFld-ContribAuthor ">David  Amar</span>, <span class="hlFld-ContribAuthor ">Laurent  Savale</span>, <span class="hlFld-ContribAuthor ">Xavier  Jaïs</span>, <span class="hlFld-ContribAuthor ">David  Montani</span>, <span class="hlFld-ContribAuthor ">Marc  Humbert</span>, <span class="hlFld-ContribAuthor ">Gérald  Simonneau</span>, <span class="hlFld-ContribAuthor ">Olivier  Sitbon</span>. </span><span class="cited-content_cbyCitation_article-title">New pharmacotherapy options for pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2015,</strong> <em>16 </em>
                                    (14)
                                     , 2113-2131. <a href="https://doi.org/10.1517/14656566.2015.1074177" title="DOI URL">https://doi.org/10.1517/14656566.2015.1074177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14656566.2015.1074177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14656566.2015.1074177%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DNew%252Bpharmacotherapy%252Boptions%252Bfor%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DPerrin%26aufirst%3DSwanny%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D14%26spage%3D2113%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claire Y  Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan for the Treatment of Pulmonary Arterial Hypertension: A Review of the Literature for the Recently Approved Endothelin Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Pharmacy & Pharmacology International Journal</span><span> <strong>2015,</strong> <em>2 </em>
                                    (5)
                                     <a href="https://doi.org/10.15406/ppij.2015.02.00035" title="DOI URL">https://doi.org/10.15406/ppij.2015.02.00035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15406/ppij.2015.02.00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15406%2Fppij.2015.02.00035%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacy%2520%2526%2520Pharmacology%2520International%2520Journal%26atitle%3DMacitentan%252Bfor%252Bthe%252BTreatment%252Bof%252BPulmonary%252BArterial%252BHypertension%25253A%252BA%252BReview%252Bof%252Bthe%252BLiterature%252Bfor%252Bthe%252BRecently%252BApproved%252BEndothelin%252BReceptor%252BAntagonist%26aulast%3DChan%26aufirst%3DClaire%2BY%26date%3D2015%26date%3D2015%26volume%3D2%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">A.  Treiber</span>, <span class="hlFld-ContribAuthor ">J.  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2015,</strong> <em>54 </em>
                                    (5)
                                     , 457-471. <a href="https://doi.org/10.1007/s40262-015-0255-5" title="DOI URL">https://doi.org/10.1007/s40262-015-0255-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-015-0255-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-015-0255-5%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DClinical%252BPharmacokinetics%252Band%252BPharmacodynamics%252Bof%252Bthe%252BEndothelin%252BReceptor%252BAntagonist%252BMacitentan%26aulast%3DSidharta%26aufirst%3DP.%2BN.%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D5%26spage%3D457%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong X.  Ding</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Leverett</span>, <span class="hlFld-ContribAuthor ">Robert E.  Kyne</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Fink</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to the 2013 new drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (9)
                                     , 1895-1922. <a href="https://doi.org/10.1016/j.bmc.2015.02.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.02.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.02.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.02.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bthe%252B2013%252Bnew%252Bdrugs%26aulast%3DDing%26aufirst%3DHong%2BX.%26date%3D2015%26volume%3D23%26issue%3D9%26spage%3D1895%26epage%3D1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia N  Sidharta</span>, <span class="hlFld-ContribAuthor ">Stephan  Krähenbühl</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and pharmacodynamic evaluation of macitentan, a novel endothelin receptor antagonist for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (3)
                                     , 437-449. <a href="https://doi.org/10.1517/17425255.2015.1000859" title="DOI URL">https://doi.org/10.1517/17425255.2015.1000859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17425255.2015.1000859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17425255.2015.1000859%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DPharmacokinetic%252Band%252Bpharmacodynamic%252Bevaluation%252Bof%252Bmacitentan%25252C%252Ba%252Bnovel%252Bendothelin%252Breceptor%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DSidharta%26aufirst%3DPatricia%2BN%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D3%26spage%3D437%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Rosenkranz</span>. </span><span class="cited-content_cbyCitation_article-title">Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options. </span><span class="cited-content_cbyCitation_journal-name">Clinical Research in Cardiology</span><span> <strong>2015,</strong> <em>104 </em>
                                    (3)
                                     , 197-207. <a href="https://doi.org/10.1007/s00392-014-0765-4" title="DOI URL">https://doi.org/10.1007/s00392-014-0765-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00392-014-0765-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00392-014-0765-4%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Research%2520in%2520Cardiology%26atitle%3DPulmonary%252Bhypertension%252B2015%25253A%252Bcurrent%252Bdefinitions%25252C%252Bterminology%25252C%252Band%252Bnovel%252Btreatment%252Boptions%26aulast%3DRosenkranz%26aufirst%3DStephan%26date%3D2015%26date%3D2014%26volume%3D104%26issue%3D3%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine A.  Lyseng-Williamson</span>, <span class="hlFld-ContribAuthor ">Lily P. H.  Yang</span>, <span class="hlFld-ContribAuthor ">Sohita  Dhillon</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan: a guide to its use in the treatment of pulmonary arterial hypertension in adults of WHO functional class II or III in the EU. </span><span class="cited-content_cbyCitation_journal-name">Drugs & Therapy Perspectives</span><span> <strong>2015,</strong> <em>31 </em>
                                    (3)
                                     , 83-88. <a href="https://doi.org/10.1007/s40267-014-0180-y" title="DOI URL">https://doi.org/10.1007/s40267-014-0180-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40267-014-0180-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40267-014-0180-y%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520%2526%2520Therapy%2520Perspectives%26atitle%3DMacitentan%25253A%252Ba%252Bguide%252Bto%252Bits%252Buse%252Bin%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%252Bin%252Badults%252Bof%252BWHO%252Bfunctional%252Bclass%252BII%252Bor%252BIII%252Bin%252Bthe%252BEU%26aulast%3DLyseng-Williamson%26aufirst%3DKatherine%2BA.%26date%3D2015%26date%3D2014%26volume%3D31%26issue%3D3%26spage%3D83%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Camille  Chaumais</span>, <span class="hlFld-ContribAuthor ">Christophe  Guignabert</span>, <span class="hlFld-ContribAuthor ">Laurent  Savale</span>, <span class="hlFld-ContribAuthor ">Xavier  Jaïs</span>, <span class="hlFld-ContribAuthor ">Athénaïs  Boucly</span>, <span class="hlFld-ContribAuthor ">David  Montani</span>, <span class="hlFld-ContribAuthor ">Gérald  Simonneau</span>, <span class="hlFld-ContribAuthor ">Marc  Humbert</span>, <span class="hlFld-ContribAuthor ">Olivier  Sitbon</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Cardiovascular Drugs</span><span> <strong>2015,</strong> <em>15 </em>
                                    (1)
                                     , 13-26. <a href="https://doi.org/10.1007/s40256-014-0095-y" title="DOI URL">https://doi.org/10.1007/s40256-014-0095-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40256-014-0095-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40256-014-0095-y%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Cardiovascular%2520Drugs%26atitle%3DClinical%252BPharmacology%252Bof%252BEndothelin%252BReceptor%252BAntagonists%252BUsed%252Bin%252Bthe%252BTreatment%252Bof%252BPulmonary%252BArterial%252BHypertension%26aulast%3DChaumais%26aufirst%3DMarie-Camille%26date%3D2015%26date%3D2014%26volume%3D15%26issue%3D1%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Josanna  Rodriguez-Lopez</span>, <span class="hlFld-ContribAuthor ">Richard N.  Channick</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 341-354. <a href="https://doi.org/10.1007/978-1-4939-2636-7_14" title="DOI URL">https://doi.org/10.1007/978-1-4939-2636-7_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2636-7_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2636-7_14%26sid%3Dliteratum%253Aachs%26atitle%3DEndothelin%252BReceptor%252BAntagonists%26aulast%3DRodriguez-Lopez%26aufirst%3DJosanna%26date%3D2015%26spage%3D341%26epage%3D354%26pub%3DSpringer%2520New%2520York%26atitle%3DDiagnosis%252Band%252BManagement%252Bof%252BPulmonary%252BHypertension%26aulast%3DKlinger%26aufirst%3DJames%2BR.%26date%3D2015%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmin  Shao</span>, <span class="hlFld-ContribAuthor ">Laura  Price</span>, <span class="hlFld-ContribAuthor ">Stephen John  Wort</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Biological Aspects, Therapeutic Targets and New Treatment Strategies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 37-80. <a href="https://doi.org/10.1007/978-3-319-13581-6_2" title="DOI URL">https://doi.org/10.1007/978-3-319-13581-6_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-13581-6_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-13581-6_2%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BBiological%252BAspects%25252C%252BTherapeutic%252BTargets%252Band%252BNew%252BTreatment%252BStrategies%26aulast%3DShao%26aufirst%3DDongmin%26date%3D2015%26spage%3D37%26epage%3D80%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTreatment%252Bof%252BPulmonary%252BHypertension%26aulast%3DMadden%26aufirst%3DBrendan%26date%3D2015%26volume%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Rosanò</span>, <span class="hlFld-ContribAuthor ">Roberta  Cianfrocca</span>, <span class="hlFld-ContribAuthor ">Piera  Tocci</span>, <span class="hlFld-ContribAuthor ">Francesca  Spinella</span>, <span class="hlFld-ContribAuthor ">Valeriana  Di Castro</span>, <span class="hlFld-ContribAuthor ">Valentina  Caprara</span>, <span class="hlFld-ContribAuthor ">Elisa  Semprucci</span>, <span class="hlFld-ContribAuthor ">Gabriella  Ferrandina</span>, <span class="hlFld-ContribAuthor ">Pier Giorgio  Natali</span>, <span class="hlFld-ContribAuthor ">Anna  Bagnato</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin A Receptor/β-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2014,</strong> <em>74 </em>
                                    (24)
                                     , 7453-7464. <a href="https://doi.org/10.1158/0008-5472.CAN-13-3133" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-13-3133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-13-3133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-13-3133%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DEndothelin%252BA%252BReceptor%25252F%2525CE%2525B2-Arrestin%252BSignaling%252Bto%252Bthe%252BWnt%252BPathway%252BRenders%252BOvarian%252BCancer%252BCells%252BResistant%252Bto%252BChemotherapy%26aulast%3DRosan%25C3%25B2%26aufirst%3DLaura%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D24%26spage%3D7453%26epage%3D7464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J J  Maguire</span>, <span class="hlFld-ContribAuthor ">A P  Davenport</span>. </span><span class="cited-content_cbyCitation_article-title"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="a4e1cac0cbd0ccc1c8cdcae49691">[email protected]</a> – new agonists, antagonists, inhibitors and emerging research frontiers:
              IUPHAR R
              eview 12. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2014,</strong> <em>171 </em>
                                    (24)
                                     , 5555-5572. <a href="https://doi.org/10.1111/bph.12874" title="DOI URL">https://doi.org/10.1111/bph.12874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12874%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DEndothelin%25254025%252B%2525E2%252580%252593%252Bnew%252Bagonists%25252C%252Bantagonists%25252C%252Binhibitors%252Band%252Bemerging%252Bresearch%252Bfrontiers%25253A%252BIUPHAR%252BR%252Beview%252B12%26aulast%3DMaguire%26aufirst%3DJ%2BJ%26date%3D2014%26date%3D2014%26volume%3D171%26issue%3D24%26spage%3D5555%26epage%3D5572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Namita  Sood</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2014,</strong> <em>15 </em>
                                    (18)
                                     , 2733-2739. <a href="https://doi.org/10.1517/14656566.2014.980403" title="DOI URL">https://doi.org/10.1517/14656566.2014.980403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14656566.2014.980403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14656566.2014.980403%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DMacitentan%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DSood%26aufirst%3DNamita%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D18%26spage%3D2733%26epage%3D2739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roly J.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Martin D.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Synthesis of Atropisomeric Biaryls: A Cation-Directed Nucleophilic Aromatic Substitution Reaction. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (47)
                                     , 13036-13040. <a href="https://doi.org/10.1002/ange.201408205" title="DOI URL">https://doi.org/10.1002/ange.201408205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408205%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCatalytic%252BEnantioselective%252BSynthesis%252Bof%252BAtropisomeric%252BBiaryls%25253A%252BA%252BCation-Directed%252BNucleophilic%252BAromatic%252BSubstitution%252BReaction%26aulast%3DArmstrong%26aufirst%3DRoly%2BJ.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D47%26spage%3D13036%26epage%3D13040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roly J.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Martin D.  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Enantioselective Synthesis of Atropisomeric Biaryls: A Cation-Directed Nucleophilic Aromatic Substitution Reaction. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (47)
                                     , 12822-12826. <a href="https://doi.org/10.1002/anie.201408205" title="DOI URL">https://doi.org/10.1002/anie.201408205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408205%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCatalytic%252BEnantioselective%252BSynthesis%252Bof%252BAtropisomeric%252BBiaryls%25253A%252BA%252BCation-Directed%252BNucleophilic%252BAromatic%252BSubstitution%252BReaction%26aulast%3DArmstrong%26aufirst%3DRoly%2BJ.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D47%26spage%3D12822%26epage%3D12826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Byung Ju  Kang</span>, <span class="hlFld-ContribAuthor ">Sang-Do  Lee</span>, <span class="hlFld-ContribAuthor ">Yeon-Mok  Oh</span>, <span class="hlFld-ContribAuthor ">Jae Seung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Heart & Lung</span><span> <strong>2014,</strong> <em>43 </em>
                                    (6)
                                     , 561-568. <a href="https://doi.org/10.1016/j.hrtlng.2014.07.003" title="DOI URL">https://doi.org/10.1016/j.hrtlng.2014.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.hrtlng.2014.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.hrtlng.2014.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DHeart%2520%2526%2520Lung%26atitle%3DImproved%252Bsurvival%252Bof%252BKorean%252Bpatients%252Bwith%252Bidiopathic%252Bpulmonary%252Barterial%252Bhypertension%252Bafter%252Bthe%252Bintroduction%252Bof%252Btargeted%252Btherapies%26aulast%3DKang%26aufirst%3DByung%2BJu%26date%3D2014%26volume%3D43%26issue%3D6%26spage%3D561%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Iglarz</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bossu</span>, <span class="hlFld-ContribAuthor ">Daniel  Wanner</span>, <span class="hlFld-ContribAuthor ">Céline  Bortolamiol</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Martine  Clozel</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2014,</strong> <em>118 </em>
                                    (2)
                                     , 333-339. <a href="https://doi.org/10.1016/j.lfs.2014.02.018" title="DOI URL">https://doi.org/10.1016/j.lfs.2014.02.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2014.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2014.02.018%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DComparison%252Bof%252Bpharmacological%252Bactivity%252Bof%252Bmacitentan%252Band%252Bbosentan%252Bin%252Bpreclinical%252Bmodels%252Bof%252Bsystemic%252Band%252Bpulmonary%252Bhypertension%26aulast%3DIglarz%26aufirst%3DMarc%26date%3D2014%26volume%3D118%26issue%3D2%26spage%3D333%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gareth R.  Howell</span>, <span class="hlFld-ContribAuthor ">Katharine H.  MacNicoll</span>, <span class="hlFld-ContribAuthor ">Catherine E.  Braine</span>, <span class="hlFld-ContribAuthor ">Ileana  Soto</span>, <span class="hlFld-ContribAuthor ">Danilo G.  Macalinao</span>, <span class="hlFld-ContribAuthor ">Gregory L.  Sousa</span>, <span class="hlFld-ContribAuthor ">Simon W.M.  John</span>. </span><span class="cited-content_cbyCitation_article-title">Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2014,</strong> <em>71 </em>, 44-52. <a href="https://doi.org/10.1016/j.nbd.2014.07.016" title="DOI URL">https://doi.org/10.1016/j.nbd.2014.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2014.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2014.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DCombinatorial%252Btargeting%252Bof%252Bearly%252Bpathways%252Bprofoundly%252Binhibits%252Bneurodegeneration%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bglaucoma%26aulast%3DHowell%26aufirst%3DGareth%2BR.%26date%3D2014%26volume%3D71%26spage%3D44%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li Young  Ahn</span>, <span class="hlFld-ContribAuthor ">Sung Eun  Kim</span>, <span class="hlFld-ContribAuthor ">SoJeong  Yi</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Kyoung Soo  Lim</span>, <span class="hlFld-ContribAuthor ">In-Jin  Jang</span>, <span class="hlFld-ContribAuthor ">Kyung-Sang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Cardiovascular Drugs</span><span> <strong>2014,</strong> <em>14 </em>
                                    (5)
                                     , 377-385. <a href="https://doi.org/10.1007/s40256-014-0081-4" title="DOI URL">https://doi.org/10.1007/s40256-014-0081-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40256-014-0081-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40256-014-0081-4%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Cardiovascular%2520Drugs%26atitle%3DPharmacokinetic%2525E2%252580%252593Pharmacodynamic%252BRelationships%252Bof%252BMacitentan%25252C%252Ba%252BNew%252BEndothelin%252BReceptor%252BAntagonist%25252C%252BAfter%252BMultiple%252BDosing%252Bin%252BHealthy%252BKorean%252BSubjects%26aulast%3DAhn%26aufirst%3DLi%2BYoung%26date%3D2014%26date%3D2014%26volume%3D14%26issue%3D5%26spage%3D377%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Lindegger</span>, <span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">Kathrin  Reseski</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Pharmacology & Therapeutics</span><span> <strong>2014,</strong> <em>29 </em>
                                    (1)
                                     , 41-48. <a href="https://doi.org/10.1016/j.pupt.2014.04.007" title="DOI URL">https://doi.org/10.1016/j.pupt.2014.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pupt.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pupt.2014.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DMacitentan%25252C%252Ba%252Bdual%252Bendothelin%252Breceptor%252Bantagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%25252C%252Bdoes%252Bnot%252Baffect%252Bcardiac%252Brepolarization%252Bin%252Bhealthy%252Bsubjects%26aulast%3DLindegger%26aufirst%3DNicolas%26date%3D2014%26volume%3D29%26issue%3D1%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Celia  Mueller Grandjean</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, . </span><span class="cited-content_cbyCitation_article-title">Distinct ETA Receptor Binding Mode of Macitentan As Determined by Site Directed Mutagenesis. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (9)
                                     , e107809. <a href="https://doi.org/10.1371/journal.pone.0107809" title="DOI URL">https://doi.org/10.1371/journal.pone.0107809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0107809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0107809%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DDistinct%252BETA%252BReceptor%252BBinding%252BMode%252Bof%252BMacitentan%252BAs%252BDetermined%252Bby%252BSite%252BDirected%252BMutagenesis%26aulast%3DGatfield%26aufirst%3DJohn%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D9%26spage%3De107809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sohita  Dhillon</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2014,</strong> <em>74 </em>
                                    (13)
                                     , 1495-1507. <a href="https://doi.org/10.1007/s40265-014-0266-9" title="DOI URL">https://doi.org/10.1007/s40265-014-0266-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-014-0266-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-014-0266-9%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMacitentan%25253A%252BA%252BReview%252Bof%252BIts%252BUse%252Bin%252BPatients%252Bwith%252BPulmonary%252BArterial%252BHypertension%26aulast%3DDhillon%26aufirst%3DSohita%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D13%26spage%3D1495%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hilary M  DuBrock</span>, <span class="hlFld-ContribAuthor ">Richard N  Channick</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Respiratory Medicine</span><span> <strong>2014,</strong> <em>8 </em>
                                    (4)
                                     , 393-399. <a href="https://doi.org/10.1586/17476348.2014.937708" title="DOI URL">https://doi.org/10.1586/17476348.2014.937708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17476348.2014.937708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17476348.2014.937708%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Respiratory%2520Medicine%26atitle%3DMacitentan%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DDuBrock%26aufirst%3DHilary%2BM%26date%3D2014%26date%3D2014%26volume%3D8%26issue%3D4%26spage%3D393%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent  Richard</span>. </span><span class="cited-content_cbyCitation_article-title">L’endothéline : de la découverte aux avancées pharmacothérapeutiques. </span><span class="cited-content_cbyCitation_journal-name">La Presse Médicale</span><span> <strong>2014,</strong> <em>43 </em>
                                    (7-8)
                                     , 742-755. <a href="https://doi.org/10.1016/j.lpm.2014.01.015" title="DOI URL">https://doi.org/10.1016/j.lpm.2014.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lpm.2014.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lpm.2014.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DLa%2520Presse%2520M%25C3%25A9dicale%26atitle%3DL%2525E2%252580%252599endoth%2525C3%2525A9line%2525C2%2525A0%25253A%252Bde%252Bla%252Bd%2525C3%2525A9couverte%252Baux%252Bavanc%2525C3%2525A9es%252Bpharmacoth%2525C3%2525A9rapeutiques%26aulast%3DRichard%26aufirst%3DVincent%26date%3D2014%26volume%3D43%26issue%3D7-8%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Päivi  Äänismaa</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Stephane  Delahaye</span>, <span class="hlFld-ContribAuthor ">Marianne  Treher</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Patricia  Sidharta</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan Does Not Interfere with Hepatic Bile Salt Transport. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2014,</strong> <em>350 </em>
                                    (1)
                                     , 130-143. <a href="https://doi.org/10.1124/jpet.114.214106" title="DOI URL">https://doi.org/10.1124/jpet.114.214106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.214106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.214106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DMacitentan%252BDoes%252BNot%252BInterfere%252Bwith%252BHepatic%252BBile%252BSalt%252BTransport%26aulast%3DTreiber%26aufirst%3DAlexander%26date%3D2014%26date%3D2014%26volume%3D350%26issue%3D1%26spage%3D130%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megan  Clarke</span>, <span class="hlFld-ContribAuthor ">Claire  Walter</span>, <span class="hlFld-ContribAuthor ">Richa  Agarwal</span>, <span class="hlFld-ContribAuthor ">Manreet  Kanwar</span>, <span class="hlFld-ContribAuthor ">Raymond L  Benza</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan (Opsumit) for the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2014,</strong> <em>7 </em>
                                    (4)
                                     , 415-421. <a href="https://doi.org/10.1586/17512433.2014.919849" title="DOI URL">https://doi.org/10.1586/17512433.2014.919849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17512433.2014.919849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17512433.2014.919849%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DMacitentan%252B%252528Opsumit%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DClarke%26aufirst%3DMegan%26date%3D2014%26date%3D2014%26volume%3D7%26issue%3D4%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karim  Said</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan in pulmonary arterial hypertension: The SERAPHIN trial. </span><span class="cited-content_cbyCitation_journal-name">Global Cardiology Science and Practice</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (2)
                                     , 20. <a href="https://doi.org/10.5339/gcsp.2014.20" title="DOI URL">https://doi.org/10.5339/gcsp.2014.20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5339/gcsp.2014.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5339%2Fgcsp.2014.20%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Cardiology%2520Science%2520and%2520Practice%26atitle%3DMacitentan%252Bin%252Bpulmonary%252Barterial%252Bhypertension%25253A%252BThe%252BSERAPHIN%252Btrial%26aulast%3DSaid%26aufirst%3DKarim%26date%3D2014%26volume%3D2014%26issue%3D2%26spage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian H.  Chester</span>, <span class="hlFld-ContribAuthor ">Magdi H.  Yacoub</span>. </span><span class="cited-content_cbyCitation_article-title">The role of endothelin-1 in pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Global Cardiology Science and Practice</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (2)
                                     , 29. <a href="https://doi.org/10.5339/gcsp.2014.29" title="DOI URL">https://doi.org/10.5339/gcsp.2014.29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5339/gcsp.2014.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5339%2Fgcsp.2014.29%26sid%3Dliteratum%253Aachs%26jtitle%3DGlobal%2520Cardiology%2520Science%2520and%2520Practice%26atitle%3DThe%252Brole%252Bof%252Bendothelin-1%252Bin%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DChester%26aufirst%3DAdrian%2BH.%26date%3D2014%26volume%3D2014%26issue%3D2%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandru  Steriade</span>, <span class="hlFld-ContribAuthor ">Andrei  Seferian</span>, <span class="hlFld-ContribAuthor ">Xavier  Jaïs</span>, <span class="hlFld-ContribAuthor ">Laurent  Savale</span>, <span class="hlFld-ContribAuthor ">Etienne-Marie  Jutant</span>, <span class="hlFld-ContribAuthor ">Florence  Parent</span>, <span class="hlFld-ContribAuthor ">Olivier  Sitbon</span>, <span class="hlFld-ContribAuthor ">Marc  Humbert</span>, <span class="hlFld-ContribAuthor ">Gerald  Simonneau</span>, <span class="hlFld-ContribAuthor ">David  Montani</span>. </span><span class="cited-content_cbyCitation_article-title">The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Therapeutic Advances in Respiratory Disease</span><span> <strong>2014,</strong> <em>8 </em>
                                    (3)
                                     , 84-92. <a href="https://doi.org/10.1177/1753465814530182" title="DOI URL">https://doi.org/10.1177/1753465814530182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1753465814530182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1753465814530182%26sid%3Dliteratum%253Aachs%26jtitle%3DTherapeutic%2520Advances%2520in%2520Respiratory%2520Disease%26atitle%3DThe%252Bpotential%252Bfor%252Bmacitentan%25252C%252Ba%252Bnew%252Bdual%252Bendothelin%252Breceptor%252Bantagonist%25252C%252Bin%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DSteriade%26aufirst%3DAlexandru%26date%3D2014%26date%3D2014%26volume%3D8%26issue%3D3%26spage%3D84%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene S.  Hong</span>, <span class="hlFld-ContribAuthor ">Holly V.  Coe</span>, <span class="hlFld-ContribAuthor ">Linda M.  Catanzaro</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan for the Treatment of Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Annals of Pharmacotherapy</span><span> <strong>2014,</strong> <em>48 </em>
                                    (4)
                                     , 538-547. <a href="https://doi.org/10.1177/1060028013518900" title="DOI URL">https://doi.org/10.1177/1060028013518900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1060028013518900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1060028013518900%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Pharmacotherapy%26atitle%3DMacitentan%252Bfor%252Bthe%252BTreatment%252Bof%252BPulmonary%252BArterial%252BHypertension%26aulast%3DHong%26aufirst%3DIrene%2BS.%26date%3D2014%26date%3D2014%26volume%3D48%26issue%3D4%26spage%3D538%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Patricia N  Sidharta</span>, <span class="hlFld-ContribAuthor ">Willis C  Maddrey</span>, <span class="hlFld-ContribAuthor ">Lewis J  Rubin</span>, <span class="hlFld-ContribAuthor ">Hani  Mickail</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Safety</span><span> <strong>2014,</strong> <em>13 </em>
                                    (3)
                                     , 391-405. <a href="https://doi.org/10.1517/14740338.2014.859674" title="DOI URL">https://doi.org/10.1517/14740338.2014.859674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14740338.2014.859674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14740338.2014.859674%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Safety%26atitle%3DEfficacy%25252C%252Bsafety%252Band%252Bclinical%252Bpharmacology%252Bof%252Bmacitentan%252Bin%252Bcomparison%252Bto%252Bother%252Bendothelin%252Breceptor%252Bantagonists%252Bin%252Bthe%252Btreatment%252Bof%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DDingemanse%26aufirst%3DJasper%26date%3D2014%26date%3D2013%26volume%3D13%26issue%3D3%26spage%3D391%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Rosenkranz</span>. </span><span class="cited-content_cbyCitation_article-title">Cor pulmonale und pulmonale Hypertonie. </span><span class="cited-content_cbyCitation_journal-name">Herz</span><span> <strong>2014,</strong> <em>39 </em>
                                    (1)
                                     , 58-65. <a href="https://doi.org/10.1007/s00059-014-4058-5" title="DOI URL">https://doi.org/10.1007/s00059-014-4058-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00059-014-4058-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00059-014-4058-5%26sid%3Dliteratum%253Aachs%26jtitle%3DHerz%26atitle%3DCor%252Bpulmonale%252Bund%252Bpulmonale%252BHypertonie%26aulast%3DRosenkranz%26aufirst%3DS.%26date%3D2014%26date%3D2014%26volume%3D39%26issue%3D1%26spage%3D58%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Montani</span>, <span class="hlFld-ContribAuthor ">Marie-Camille  Chaumais</span>, <span class="hlFld-ContribAuthor ">Christophe  Guignabert</span>, <span class="hlFld-ContribAuthor ">Sven  Günther</span>, <span class="hlFld-ContribAuthor ">Barbara  Girerd</span>, <span class="hlFld-ContribAuthor ">Xavier  Jaïs</span>, <span class="hlFld-ContribAuthor ">Vincent  Algalarrondo</span>, <span class="hlFld-ContribAuthor ">Laura C.  Price</span>, <span class="hlFld-ContribAuthor ">Laurent  Savale</span>, <span class="hlFld-ContribAuthor ">Olivier  Sitbon</span>, <span class="hlFld-ContribAuthor ">Gérald  Simonneau</span>, <span class="hlFld-ContribAuthor ">Marc  Humbert</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted therapies in pulmonary arterial hypertension. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2014,</strong> <em>141 </em>
                                    (2)
                                     , 172-191. <a href="https://doi.org/10.1016/j.pharmthera.2013.10.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2013.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2013.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2013.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTargeted%252Btherapies%252Bin%252Bpulmonary%252Barterial%252Bhypertension%26aulast%3DMontani%26aufirst%3DDavid%26date%3D2014%26volume%3D141%26issue%3D2%26spage%3D172%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saman  Ahmed</span>, <span class="hlFld-ContribAuthor ">Harold I.  Palevsky</span>. </span><span class="cited-content_cbyCitation_article-title">Pulmonary Arterial Hypertension Related to Connective Tissue Disease. </span><span class="cited-content_cbyCitation_journal-name">Rheumatic Disease Clinics of North America</span><span> <strong>2014,</strong> <em>40 </em>
                                    (1)
                                     , 103-124. <a href="https://doi.org/10.1016/j.rdc.2013.10.001" title="DOI URL">https://doi.org/10.1016/j.rdc.2013.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.rdc.2013.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.rdc.2013.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DRheumatic%2520Disease%2520Clinics%2520of%2520North%2520America%26atitle%3DPulmonary%252BArterial%252BHypertension%252BRelated%252Bto%252BConnective%252BTissue%252BDisease%26aulast%3DAhmed%26aufirst%3DSaman%26date%3D2014%26volume%3D40%26issue%3D1%26spage%3D103%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trina  Patel</span>, <span class="hlFld-ContribAuthor ">Kate  McKeage</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan: First Global Approval. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2014,</strong> <em>74 </em>
                                    (1)
                                     , 127-133. <a href="https://doi.org/10.1007/s40265-013-0156-6" title="DOI URL">https://doi.org/10.1007/s40265-013-0156-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-013-0156-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-013-0156-6%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DMacitentan%25253A%252BFirst%252BGlobal%252BApproval%26aulast%3DPatel%26aufirst%3DTrina%26date%3D2014%26date%3D2013%26volume%3D74%26issue%3D1%26spage%3D127%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanne  Bronson</span>, <span class="hlFld-ContribAuthor ">Amelia  Black</span>, <span class="hlFld-ContribAuthor ">Murali  Dhar</span>, <span class="hlFld-ContribAuthor ">Bruce  Ellsworth</span>, <span class="hlFld-ContribAuthor ">J.  Robert Merritt</span>. </span><span class="cited-content_cbyCitation_article-title">To Market, To Market—2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 437-508. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00027-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00027-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00027-4%26sid%3Dliteratum%253Aachs%26atitle%3DTo%252BMarket%25252C%252BTo%252BMarket%2525E2%252580%2525942013%26aulast%3DBronson%26aufirst%3DJoanne%26date%3D2014%26spage%3D437%26epage%3D508%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshihiro  Aoki</span>, <span class="hlFld-ContribAuthor ">Ikumi  Hyohdoh</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Furuichi</span>, <span class="hlFld-ContribAuthor ">Sawako  Ozawa</span>, <span class="hlFld-ContribAuthor ">Fumio  Watanabe</span>, <span class="hlFld-ContribAuthor ">Masayuki  Matsushita</span>, <span class="hlFld-ContribAuthor ">Masahiro  Sakaitani</span>, <span class="hlFld-ContribAuthor ">Kazutomo  Ori</span>, <span class="hlFld-ContribAuthor ">Kenji  Takanashi</span>, <span class="hlFld-ContribAuthor ">Naoki  Harada</span>, <span class="hlFld-ContribAuthor ">Yasushi  Tomii</span>, <span class="hlFld-ContribAuthor ">Mitsuyasu  Tabo</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Yoshinari</span>, <span class="hlFld-ContribAuthor ">Yuko  Aoki</span>, <span class="hlFld-ContribAuthor ">Nobuo  Shimma</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Iikura</span>. </span><span class="cited-content_cbyCitation_article-title">The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6223-6227. <a href="https://doi.org/10.1016/j.bmcl.2013.10.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bsulfamide%252Bmoiety%252Baffords%252Bhigher%252Binhibitory%252Bactivity%252Band%252Boral%252Bbioavailability%252Bto%252Ba%252Bseries%252Bof%252Bcoumarin%252Bdual%252Bselective%252BRAF%25252FMEK%252Binhibitors%26aulast%3DAoki%26aufirst%3DToshihiro%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6223%26epage%3D6227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Montani</span>. </span><span class="cited-content_cbyCitation_article-title">Actualités thérapeutiques dans l’hypertension artérielle pulmonaire. </span><span class="cited-content_cbyCitation_journal-name">Revue des Maladies Respiratoires Actualités</span><span> <strong>2013,</strong> <em>5 </em>
                                    (4)
                                     , 295-300. <a href="https://doi.org/10.1016/S1877-1203(13)70415-4" title="DOI URL">https://doi.org/10.1016/S1877-1203(13)70415-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1877-1203(13)70415-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1877-1203%2813%2970415-4%26sid%3Dliteratum%253Aachs%26jtitle%3DRevue%2520des%2520Maladies%2520Respiratoires%2520Actualit%25C3%25A9s%26atitle%3DActualit%2525C3%2525A9s%252Bth%2525C3%2525A9rapeutiques%252Bdans%252Bl%2525E2%252580%252599hypertension%252Bart%2525C3%2525A9rielle%252Bpulmonaire%26aulast%3DMontani%26aufirst%3DD.%26date%3D2013%26volume%3D5%26issue%3D4%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I  Brochu</span>, <span class="hlFld-ContribAuthor ">M  Houde</span>, <span class="hlFld-ContribAuthor ">L  Desbiens</span>, <span class="hlFld-ContribAuthor ">E  Simard</span>, <span class="hlFld-ContribAuthor ">F  Gobeil</span>, <span class="hlFld-ContribAuthor ">W  Semaan</span>, <span class="hlFld-ContribAuthor ">G  Bkaily</span>, <span class="hlFld-ContribAuthor ">P  D'Orléans-Juste</span>. </span><span class="cited-content_cbyCitation_article-title">High salt-induced hypertension in B
              2
              knockout mice is corrected by the ET
              A
              antagonist, A127722. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (2)
                                     , 266-277. <a href="https://doi.org/10.1111/bph.12259" title="DOI URL">https://doi.org/10.1111/bph.12259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12259%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DHigh%252Bsalt-induced%252Bhypertension%252Bin%252BB%252B2%252Bknockout%252Bmice%252Bis%252Bcorrected%252Bby%252Bthe%252BET%252BA%252Bantagonist%25252C%252BA127722%26aulast%3DBrochu%26aufirst%3DI%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D2%26spage%3D266%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomás  Pulido</span>, <span class="hlFld-ContribAuthor ">Igor  Adzerikho</span>, <span class="hlFld-ContribAuthor ">Richard N.  Channick</span>, <span class="hlFld-ContribAuthor ">Marion  Delcroix</span>, <span class="hlFld-ContribAuthor ">Nazzareno  Galiè</span>, <span class="hlFld-ContribAuthor ">Hossein-Ardeschir  Ghofrani</span>, <span class="hlFld-ContribAuthor ">Pavel  Jansa</span>, <span class="hlFld-ContribAuthor ">Zhi-Cheng  Jing</span>, <span class="hlFld-ContribAuthor ">Franck-Olivier  Le Brun</span>, <span class="hlFld-ContribAuthor ">Sanjay  Mehta</span>, <span class="hlFld-ContribAuthor ">Camilla M.  Mittelholzer</span>, <span class="hlFld-ContribAuthor ">Loïc  Perchenet</span>, <span class="hlFld-ContribAuthor ">B.K.S.  Sastry</span>, <span class="hlFld-ContribAuthor ">Olivier  Sitbon</span>, <span class="hlFld-ContribAuthor ">Rogério  Souza</span>, <span class="hlFld-ContribAuthor ">Adam  Torbicki</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zeng</span>, <span class="hlFld-ContribAuthor ">Lewis J.  Rubin</span>, <span class="hlFld-ContribAuthor ">Gérald  Simonneau</span>. </span><span class="cited-content_cbyCitation_article-title">Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. </span><span class="cited-content_cbyCitation_journal-name">New England Journal of Medicine</span><span> <strong>2013,</strong> <em>369 </em>
                                    (9)
                                     , 809-818. <a href="https://doi.org/10.1056/NEJMoa1213917" title="DOI URL">https://doi.org/10.1056/NEJMoa1213917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1056/NEJMoa1213917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1056%2FNEJMoa1213917%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520England%2520Journal%2520of%2520Medicine%26atitle%3DMacitentan%252Band%252BMorbidity%252Band%252BMortality%252Bin%252BPulmonary%252BArterial%252BHypertension%26aulast%3DPulido%26aufirst%3DTom%25C3%25A1s%26date%3D2013%26volume%3D369%26issue%3D9%26spage%3D809%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>, <span class="hlFld-ContribAuthor ">Paul L. M.  van Giersbergen</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Pharmacology</span><span> <strong>2013,</strong> <em>68 </em>, n/a-n/a. <a href="https://doi.org/10.1002/jcph.152" title="DOI URL">https://doi.org/10.1002/jcph.152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcph.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcph.152%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DSafety%25252C%252Btolerability%25252C%252Bpharmacokinetics%25252C%252Band%252Bpharmacodynamics%252Bof%252Bmacitentan%25252C%252Ban%252Bendothelin%252Breceptor%252Bantagonist%25252C%252Bin%252Ban%252Bascending%252Bmultiple-dose%252Bstudy%252Bin%252Bhealthy%252Bsubjects%26aulast%3DSidharta%26aufirst%3DPatricia%2BN.%26date%3D2013%26date%3D2013%26volume%3D68%26spage%3Dn%252Fa%26epage%3Dn%252Fa" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Atsmon</span>, <span class="hlFld-ContribAuthor ">Jasper  Dingemanse</span>, <span class="hlFld-ContribAuthor ">Dimitri  Shaikevich</span>, <span class="hlFld-ContribAuthor ">Inna  Volokhov</span>, <span class="hlFld-ContribAuthor ">Patricia N.  Sidharta</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2013,</strong> <em>52 </em>
                                    (8)
                                     , 685-692. <a href="https://doi.org/10.1007/s40262-013-0063-8" title="DOI URL">https://doi.org/10.1007/s40262-013-0063-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-013-0063-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-013-0063-8%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DInvestigation%252Bof%252Bthe%252BEffects%252Bof%252BKetoconazole%252Bon%252Bthe%252BPharmacokinetics%252Bof%252BMacitentan%25252C%252Ba%252BNovel%252BDual%252BEndothelin%252BReceptor%252BAntagonist%25252C%252Bin%252BHealthy%252BSubjects%26aulast%3DAtsmon%26aufirst%3DJacob%26date%3D2013%26date%3D2013%26volume%3D52%26issue%3D8%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johanna  Weiss</span>, <span class="hlFld-ContribAuthor ">Dirk  Theile</span>, <span class="hlFld-ContribAuthor ">Maximilian Alexander  Rüppell</span>, <span class="hlFld-ContribAuthor ">Tobias  Speck</span>, <span class="hlFld-ContribAuthor ">Adriana  Spalwisz</span>, <span class="hlFld-ContribAuthor ">Walter Emil  Haefeli</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>701 </em>
                                    (1-3)
                                     , 168-175. <a href="https://doi.org/10.1016/j.ejphar.2013.01.010" title="DOI URL">https://doi.org/10.1016/j.ejphar.2013.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2013.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2013.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DInteraction%252Bprofile%252Bof%252Bmacitentan%25252C%252Ba%252Bnew%252Bnon-selective%252Bendothelin-1%252Breceptor%252Bantagonist%25252C%252Bin%252Bvitro%26aulast%3DWeiss%26aufirst%3DJohanna%26date%3D2013%26volume%3D701%26issue%3D1-3%26spage%3D168%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martine  Clozel</span>, <span class="hlFld-ContribAuthor ">Alessandro  Maresta</span>, <span class="hlFld-ContribAuthor ">Marc  Humbert</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelin Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 199-227. <a href="https://doi.org/10.1007/978-3-662-45805-1_9" title="DOI URL">https://doi.org/10.1007/978-3-662-45805-1_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-662-45805-1_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-662-45805-1_9%26sid%3Dliteratum%253Aachs%26atitle%3DEndothelin%252BReceptor%252BAntagonists%26aulast%3DClozel%26aufirst%3DMartine%26date%3D2013%26date%3D2013%26spage%3D199%26epage%3D227%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DPharmacotherapy%252Bof%252BPulmonary%252BHypertension%26aulast%3DHumbert%26aufirst%3DMarc%26date%3D2013%26volume%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald E.  Kohan</span>, <span class="hlFld-ContribAuthor ">John G.  Cleland</span>, <span class="hlFld-ContribAuthor ">Lewis J.  Rubin</span>, <span class="hlFld-ContribAuthor ">Dan  Theodorescu</span>, <span class="hlFld-ContribAuthor ">Matthias  Barton</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2012,</strong> <em>91 </em>
                                    (13-14)
                                     , 528-539. <a href="https://doi.org/10.1016/j.lfs.2012.07.034" title="DOI URL">https://doi.org/10.1016/j.lfs.2012.07.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2012.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2012.07.034%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DClinical%252Btrials%252Bwith%252Bendothelin%252Breceptor%252Bantagonists%25253A%252BWhat%252Bwent%252Bwrong%252Band%252Bwhere%252Bcan%252Bwe%252Bimprove%25253F%26aulast%3DKohan%26aufirst%3DDonald%2BE.%26date%3D2012%26volume%3D91%26issue%3D13-14%26spage%3D528%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and in vitro activity of compound <b>1</b>. IC<sub>50</sub> values as measured with a <sup>125</sup>I-ET-1 binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Sulfonamide Endothelin Receptor Antagonists Exemplified with <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) <b>6</b>, NH<sub>3</sub> in MeOH, rt, 16 h, (ii) MeOH, KOtBu, rt 3 h, 83–89% over 2 steps; (b) <b>3</b>, DMSO, rt, then <b>4</b>, rt, 16 h, 89%; (c) ethylene glycol, Na, 2 h, then <b>5</b>, 70–90 °C, 18 h, 73–91%; (d) <b>7</b>, THF, NaH, 1 h, then 2-chloro-5-bromopyrimidine, 75 °C, 2 h, 43%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfamide Potassium Salt Building Blocks<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>tert</i>-BuOH, DCM, 0 °C to rt, 1 h; (b) add mixture prepared in (a) to propylamine, NEt<sub>3</sub>, DCM, 0 °C then 16 h rt; (c) 5 M HCl in dioxane, rt, 4–8 h; (d) MeOH, KOtBu, rt, 3 h, 46–98% over 4 steps.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis of Sulfamide Endothelin Receptor Antagonists Exemplified with <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>14</b>, DMSO, rt, <b>13</b>, rt, 24–72 h, 83–93% (b) ethylene glycol, DME, KOtBu, 10 min, then <b>15</b>, 100 °C, 18–24h, 86–89%; (c) <b>16</b>, THF, NaH, 0.5–1 h, then 2-chloro-5-bromopyrimidine, 60–75 °C, 2 h, 88%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure and in vitro activity of compound <b>2</b>. IC<sub>50</sub> values as measured with a <sup>125</sup>I-ET-1 binding assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mean arterial blood pressure (MAP, left) and heart rate (HR, right) recordings in conscious hypertensive Dahl salt-sensitive rats before (control) and after oral administration of 3 mg/kg of compound <b>17</b>. Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curve of mean arterial blood pressure (MAP) reduction and area between curves (ABC) in hypertensive Dahl salt-sensitive rats after oral administration of compound <b>17</b> in 5% arabic gum. Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mean arterial blood pressure (MAP) recordings of a repeated dose experiment administering 1 mg/kg/day of compound <b>17</b> over five consecutive days to hypertensive Dahl salt-sensitive rats equipped with telemetry (ABC = 1842 mmHg·h). Results are expressed as mean ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/medium/jm-2012-009103_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stucture of sulfamide <b>71</b>, a major metabolite of compound <b>17</b> in Wistar rats and Beagle dogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3009103/20140919/images/large/jm-2012-009103_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009103&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32314" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32314" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomobe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span> </span><span class="NLM_article-title">A novel potent vasoconstrictor peptide produced by vascular endothelial cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=1988&pages=411-415&author=M.+Yanagisawaauthor=H.+Kuriharaauthor=S.+Kimuraauthor=Y.+Tomobeauthor=M.+Kobayashiauthor=Y.+Mitsuiauthor=K.+Gotoauthor=T.+Masaki&title=A+novel+potent+vasoconstrictor+peptide+produced+by+vascular+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DTomobe%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMitsui%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DMasaki%26aufirst%3DT.%26atitle%3DA%2520novel%2520potent%2520vasoconstrictor%2520peptide%2520produced%2520by%2520vascular%2520endothelial%2520cells%26jtitle%3DNature%26date%3D1988%26volume%3D332%26spage%3D411%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Battistini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R.</span><span> </span><span class="NLM_article-title">Endothelins: A Quantum Leap Forward</span> <span class="citation_source-journal">Drug News Persp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1995&pages=365-391&author=B.+Battistiniauthor=R.+Botting&title=Endothelins%3A+A+Quantum+Leap+Forward"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBattistini%26aufirst%3DB.%26aulast%3DBotting%26aufirst%3DR.%26atitle%3DEndothelins%253A%2520A%2520Quantum%2520Leap%2520Forward%26jtitle%3DDrug%2520News%2520Persp.%26date%3D1995%26volume%3D8%26spage%3D365%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kohan, D. E.</span><span> </span><span class="NLM_article-title">Endothelin-1 and Hypertension: From Bench to Bedside</span> <span class="citation_source-journal">Curr. Hypertens. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1007%2Fs11906-008-0013-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18367029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFGrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=65-69&author=D.+E.+Kohan&title=Endothelin-1+and+Hypertension%3A+From+Bench+to+Bedside"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-1 and hypertension: from bench to bedside</span></div><div class="casAuthors">Kohan, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Hypertension Reports</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-69</span>CODEN:
                <span class="NLM_cas:coden">CHRUCG</span>;
        ISSN:<span class="NLM_cas:issn">1522-6417</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Endothelin-1 (ET-1) exerts a wide range of biol. effects that can influence systemic blood pressure.  Recent studies indicate that increased activity of the ET system in the vasculature, with resultant activation of primarily ET A receptors, can contribute to hypertension.  In contrast, decreased prodn. of ET-1 in the renal medulla, and reduced activation of collecting duct ET B receptors, can also elevate systemic blood pressure.  Both ET A and combined A/B receptor blockers reduce blood pressure in hypertensive patients.  Several important questions remain with respect to the ET system in hypertension, including how ET receptor antagonists will interact with other antihypertensive agents, which receptor subtypes should be targeted, and what the effect of ET blockade will be on hypertension-related end-organ damage as opposed to blood pressure alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7jPMJMj6Uc7Vg90H21EOLACvtfcHk0lipbfUFHoM7RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFGrsLs%253D&md5=b7b81f0f9b472126c6893649de387320</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs11906-008-0013-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-008-0013-2%26sid%3Dliteratum%253Aachs%26aulast%3DKohan%26aufirst%3DD.%2BE.%26atitle%3DEndothelin-1%2520and%2520Hypertension%253A%2520From%2520Bench%2520to%2520Bedside%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2008%26volume%3D10%26spage%3D65%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Thorin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">The Cardiovascular Physiology and Pharmacology to Endothelin-1</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2010&pages=1-26&author=E.+Thorinauthor=M.+Clozel&title=The+Cardiovascular+Physiology+and+Pharmacology+to+Endothelin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThorin%26aufirst%3DE.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DThe%2520Cardiovascular%2520Physiology%2520and%2520Pharmacology%2520to%2520Endothelin-1%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2010%26volume%3D60%26spage%3D1%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benigni, A.</span><span> </span><span class="NLM_article-title">New Therapeutics that Antagonize Endothelin: Promises and Frustrations</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">986</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=986-1001&author=G.+Remuzziauthor=N.+Pericoauthor=A.+Benigni&title=New+Therapeutics+that+Antagonize+Endothelin%3A+Promises+and+Frustrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DBenigni%26aufirst%3DA.%26atitle%3DNew%2520Therapeutics%2520that%2520Antagonize%2520Endothelin%253A%2520Promises%2520and%2520Frustrations%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D986%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.</span><span> </span><span class="NLM_article-title">Endothelin Receptors as Drug Targets in Chronic Cardiovascular Diseases: The Rationale for Dual Antagonism</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=825-834&author=M.+Clozelauthor=S.+Flores&title=Endothelin+Receptors+as+Drug+Targets+in+Chronic+Cardiovascular+Diseases%3A+The+Rationale+for+Dual+Antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DFlores%26aufirst%3DS.%26atitle%3DEndothelin%2520Receptors%2520as%2520Drug%2520Targets%2520in%2520Chronic%2520Cardiovascular%2520Diseases%253A%2520The%2520Rationale%2520for%2520Dual%2520Antagonism%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2006%26volume%3D67%26spage%3D825%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fonseca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renzoni, E. A.</span><span> </span><span class="NLM_article-title">Endothelin in Pulmonary Fibrosis</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1165%2Frcmb.2009-0388TR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20448055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Grtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2011&pages=1-10&author=C.+Fonsecaauthor=D.+Abrahamauthor=E.+A.+Renzoni&title=Endothelin+in+Pulmonary+Fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin in pulmonary fibrosis</span></div><div class="casAuthors">Fonseca, Carmen; Abraham, David; Renzoni, Elisabetta A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  The endothelin receptor-ligand system includes a family of polypeptides and G-protein-coupled receptors, which, in addn. to their classic activity in the regulation of vascular tone (both directly and through the control of nitric oxide), were implicated in a wide variety of other key biol. processes.  In this regard, the endothelins are potent mitogens and motogens for mesenchymal cells, and can induce cell differentiation, increasing both the synthesis and deposition of extracellular matrix components and contractile ability.  The endothelins are produced as inactive pre-pro-polypeptides, with gene transcription (as well as the proteolytic processing to mature active forms) under the influence of many factors, including cytokines, hypoxia, biomech. and shear stress, pathogen products, and many growth factors.  These complex regulatory events underlie the assocn. and potential role of endothelins in a no. of human diseases affecting many different target organs, including the vasculature (atherosclerosis and hypertension), kidney (renal crisis and chronic kidney disease), heart (coronary heart disease), and lungs (pulmonary fibrosis and pulmonary hypertension).  This review focuses on the biochem. of endothelin and the pathobiol. of endothelin in lung fibrosis, with particular emphasis on idiopathic pulmonary fibrosis, and examines the antifibrotic potential of endothelin receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLmNdPDGlzLVg90H21EOLACvtfcHk0lipbfUFHoM7RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Grtbg%253D&md5=00482558d543a7f59d6e1bea6ddf73ac</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2009-0388TR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2009-0388TR%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DD.%26aulast%3DRenzoni%26aufirst%3DE.%2BA.%26atitle%3DEndothelin%2520in%2520Pulmonary%2520Fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2011%26volume%3D44%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Inoue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span> </span><span class="NLM_article-title">The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">2863</span><span class="NLM_x">–</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=2863-2867&author=A.+Inoueauthor=M.+Yanagisawaauthor=S.+Kimuraauthor=Y.+Kasuyaauthor=T.+Miyauchiauthor=K.+Gotoauthor=T.+Masaki&title=The+human+endothelin+family%3A+three+structurally+and+pharmacologically+distinct+isopeptides+predicted+by+three+separate+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DMiyauchi%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DK.%26aulast%3DMasaki%26aufirst%3DT.%26atitle%3DThe%2520human%2520endothelin%2520family%253A%2520three%2520structurally%2520and%2520pharmacologically%2520distinct%2520isopeptides%2520predicted%2520by%2520three%2520separate%2520genes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1989%26volume%3D86%26spage%3D2863%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Webb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Inhibitors of Endothelin</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C17%3A%3AAID-MED2%3E3.0.CO%3B2-W" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=8979248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=17-67&author=M.+L.+Webbauthor=T.+D.+Meek&title=Inhibitors+of+Endothelin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of endothelin</span></div><div class="casAuthors">Webb, Maria L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-67</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 308 refs.  Topics discussed include: endothelin genes, peptide ligands of endothelin receptors, endothelin receptors, endothelin receptor antagonists, and endothelin receptor antagonists in relation to human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHDMCX3YR6brVg90H21EOLACvtfcHk0lj9vJIEyq-feA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSnuw%253D%253D&md5=9a6c3ac08eec42654f68e14bfc475e73</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C17%3A%3AAID-MED2%3E3.0.CO%3B2-W&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C17%253A%253AAID-MED2%253E3.0.CO%253B2-W%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DInhibitors%2520of%2520Endothelin%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D17%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">At the heart of tissue: endothelin system and end-organ damage</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1042%2FCS20100222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20712600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKiu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=453-463&author=M.+Iglarzauthor=M.+Clozel&title=At+the+heart+of+tissue%3A+endothelin+system+and+end-organ+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">At the heart of tissue: endothelin system and end-organ damage</span></div><div class="casAuthors">Iglarz, Marc; Clozel, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">11/12</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  ET (endothelin)-1 was first described as a potent vasoconstrictor.  Since then, many other deleterious properties mediated via its two receptors, ETA and ETB, have been described, such as inflammation, fibrosis and hyperplasia.  These effects, combined with a wide tissue distribution of the ET system, its up-regulation in pathol. situations and a local autocrine/paracrine activity due to a high tissue receptor binding, make the tissue ET system a key local player in end-organ damage.  Furthermore, ET-1 interacts in tissues with other systems such as the RAAS (renin-angiotensin-aldosterone system) to exert its effects.  In numerous genetically modified animal models, non-specific or organ-targeted ET-1 overexpression causes intense organ damage, esp. hypertrophy and fibrosis, in the absence of hemodynamic changes, confirming a local activity of the ET system.  ET receptor antagonists have been shown to prevent and sometimes reverse these tissue alterations in an organ-specific manner, leading to long-term benefits and an improvement in survival in different animal models.  Potential for such benefits going beyond a pure hemodynamic effect have also been suggested by clin. trial results in which ET receptor antagonism decreased the occurrence of new digital ulcers in patients with systemic sclerosis and delayed the time to clin. worsening in patients with PAH (pulmonary arterial hypertension).  The tissue ET system allows therapeutic interventions to provide organ selectivity and beneficial effects in diseases assocd. with tissue inflammation, hypertrophy or fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWlakqf8kUGrVg90H21EOLACvtfcHk0lj9vJIEyq-feA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKiu7%252FE&md5=0bf1a676f4ff0a2c4f19c2ad9b6d8706</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FCS20100222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20100222%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DAt%2520the%2520heart%2520of%2520tissue%253A%2520endothelin%2520system%2520and%2520end-organ%2520damage%26jtitle%3DClin.%2520Sci.%26date%3D2010%26volume%3D119%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Khimji, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockey, D. C.</span><span> </span><span class="NLM_article-title">Endothelin—biology and disease</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1615</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.cellsig.2010.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20466059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVelu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=1615-1625&author=A.-K.+Khimjiauthor=D.+C.+Rockey&title=Endothelin%E2%80%94biology+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-Biology and disease</span></div><div class="casAuthors">Khimji, Al-karim; Rockey, Don C.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1615-1625</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Endothelins are important mediators of physiol. and pathophysiol. processes including cardiovascular disorders, pulmonary disease, renal diseases and many others.  Addnl., endothelins are involved in many other important processes such as development, cancer biol., wound healing, and even neurotransmission.  Here, we review the cell and mol. biol. as well as the prominent pathophysiol. aspects of the endothelin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5S08G6AAPbVg90H21EOLACvtfcHk0lj9vJIEyq-feA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVelu7rP&md5=a9c41b926c945c5540b0443eae18ade8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2010.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2010.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DKhimji%26aufirst%3DA.-K.%26aulast%3DRockey%26aufirst%3DD.%2BC.%26atitle%3DEndothelin%25E2%2580%2594biology%2520and%2520disease%26jtitle%3DCell.%2520Signalling%26date%3D2010%26volume%3D22%26spage%3D1615%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, G. A.</span><span> </span><span class="NLM_article-title">Are There Different ET<sub>B</sub> Receptors Mediating Constriction and Relaxation?</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">S262</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=S262-S264&author=M.+Clozelauthor=G.+A.+Gray&title=Are+There+Different+ETB+Receptors+Mediating+Constriction+and+Relaxation%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DG.%2BA.%26atitle%3DAre%2520There%2520Different%2520ETB%2520Receptors%2520Mediating%2520Constriction%2520and%2520Relaxation%253F%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1995%26volume%3D26%26spage%3DS262%26epage%3DS264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himeno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, M.</span><span> </span><span class="NLM_article-title">Endothelin-1 Binding to Endothelin Receptors in the Rat Anterior Pituitary Gland: Possible Formation of an ET<sub>A</sub>–ET<sub>B</sub> Receptor Heterodimer</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1023%2FA%3A1019822107048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=12363203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlGhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=207-226&author=N.+Haradaauthor=A.+Himenoauthor=K.+Shigematsuauthor=K.+Sumikawaauthor=M.+Niwa&title=Endothelin-1+Binding+to+Endothelin+Receptors+in+the+Rat+Anterior+Pituitary+Gland%3A+Possible+Formation+of+an+ETA%E2%80%93ETB+Receptor+Heterodimer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin-1 Binding to Endothelin Receptors in the Rat Anterior Pituitary Gland: Possible Formation of an ETA-ETB Receptor Heterodimer</span></div><div class="casAuthors">Harada, Noboru; Himeno, Akihiko; Shigematsu, Kazuto; Sumikawa, Kohji; Niwa, Masami</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-226</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Interaction in the recognition of endothelin-1 (ET-1), a typical bivalent ET receptor-ligand, between ETA and ETB receptors was investigated in the rat anterior pituitary gland, using the authors' quant. receptor autoradiog. method with tissue sections preserving the cell-membrane structure and ET receptor-related compds. 2.  In satn. binding studies with increasing concns. (0.77-200 pM) of 125I-ET-1 (nonselective bivalent radioligand), 125I-ET-1 binding to the rat anterior pituitary gland was saturable and single with a KD of 71 pM and a Bmax of 120 fmol mg-1.  When 1.0 μM BQ-123 (ETA antagonist) was added to the incubation buffer, binding parameters were 8.3 pM of KD and 8.0 fmol mg-1 of Bmax, whereas 10 nM sarafotoxin S6c (ETB agonist) exerted little change in these binding parameters (KD, 72 pM; Bmax, 110 fmol mg-1). 3.  Competition binding studies with a fixed amt. (3.8 pM) of 125I-ET-1 revealed that when 1.0 μM BQ-123 was present in the incubation buffer, ETB receptor-related compds. such as sarafotoxin S6c, ET-3, IRL1620 (ETB agonist), and BQ-788 (ETB antagonist) competitively inhibited 125I-ET-1 binding with Kis of 140, 18, 350 pM, and 14 nM, resp., however, these compds. were not significant competitors for 125I-ET-1 binding in the case of absence of BQ-123. 4.  In cold-ligand satn. studies with a fixed amt. (390 pM) of 125I-IRL 1620 (ETB radioligand), IRL1620 bound to a single population of the ETB receptor, and no change was obsd. in binding characteristics in the presence of 1.0 μM BQ-123. 125I-IRL1620 binding was competitively inhibited by ET-1 and ET-3 in the absence of BQ-123, with Kis of 20 and 29 pM, resp., the affinities being much the same as those of 29 nM, in the presence of 1.0 μM BQ-123. 5.  Two non-bivalent ETA antagonists, BQ-123 and PD151242, were highly sensitive and full competitors for 125I-ET-1 binding (5.0 pM), in the presence of 10 nM sarafotoxin S6c. 6.  Taken together with the present finding that mRNAs encoding the rat ETA and the ETB receptors are expressed in the anterior pituitary gland, the authors tentatively conclude that although there are ETA and ETB receptors with a functional binding capability for ET receptor-ligands, the ETB receptor does not independently recognize ET-1 without the aid of the ETA receptor.  If this thesis is tenable, then ET-1 can bridge between the two receptors to form an ETA-ETB receptor heterodimer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMH5H5SLxsJbVg90H21EOLACvtfcHk0lg4tbv4bL-uGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlGhtb8%253D&md5=7c565ce95da6ae525aefdc132847c860</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1023%2FA%3A1019822107048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1019822107048%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DHimeno%26aufirst%3DA.%26aulast%3DShigematsu%26aufirst%3DK.%26aulast%3DSumikawa%26aufirst%3DK.%26aulast%3DNiwa%26aufirst%3DM.%26atitle%3DEndothelin-1%2520Binding%2520to%2520Endothelin%2520Receptors%2520in%2520the%2520Rat%2520Anterior%2520Pituitary%2520Gland%253A%2520Possible%2520Formation%2520of%2520an%2520ETA%25E2%2580%2593ETB%2520Receptor%2520Heterodimer%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D22%26spage%3D207%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gregan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jürgensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papsdorf, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furkert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksche, A.</span><span> </span><span class="NLM_article-title">Ligand-Dependent Differences in the Internalization of Endothelin A and Endothelin B Receptor Heterodimers</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">27679</span><span class="NLM_x">–</span> <span class="NLM_lpage">27987</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=27679-27987&author=B.+Greganauthor=J.+J%C3%BCrgensenauthor=G.+Papsdorfauthor=J.+Furkertauthor=M.+Schaeferauthor=M.+Beyermannauthor=W.+Rosenthalauthor=A.+Oksche&title=Ligand-Dependent+Differences+in+the+Internalization+of+Endothelin+A+and+Endothelin+B+Receptor+Heterodimers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregan%26aufirst%3DB.%26aulast%3DJ%25C3%25BCrgensen%26aufirst%3DJ.%26aulast%3DPapsdorf%26aufirst%3DG.%26aulast%3DFurkert%26aufirst%3DJ.%26aulast%3DSchaefer%26aufirst%3DM.%26aulast%3DBeyermann%26aufirst%3DM.%26aulast%3DRosenthal%26aufirst%3DW.%26aulast%3DOksche%26aufirst%3DA.%26atitle%3DLigand-Dependent%2520Differences%2520in%2520the%2520Internalization%2520of%2520Endothelin%2520A%2520and%2520Endothelin%2520B%2520Receptor%2520Heterodimers%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D27679%26epage%3D27987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sauvageau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeneuve, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuis, J.</span><span> </span><span class="NLM_article-title">Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary arterial hypertension: Role of ET<sub>B</sub>-receptor expression levels</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.pupt.2009.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=19489130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ygsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=311-317&author=S.+Sauvageauauthor=E.+Thorinauthor=L.+Villeneuveauthor=J.+Dupuis&title=Change+in+pharmacological+effect+of+endothelin+receptor+antagonists+in+rats+with+pulmonary+arterial+hypertension%3A+Role+of+ETB-receptor+expression+levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels</span></div><div class="casAuthors">Sauvageau, Stephanie; Thorin, Eric; Villeneuve, Louis; Dupuis, Jocelyn</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endothelin (ET) system is activated in pulmonary arterial hypertension (PAH).  The therapeutic value of pharmacol. blockade of ET receptors has been demonstrated in various animal models and led to the current approval and continued development of these drugs for the therapy of human PAH.  However, we currently incompletely comprehend what local modifications of this system occur as a consequence of PAH, particularly in small resistance arteries, and how this could affect the pharmacol. response to ET receptor antagonists with various selectivities for the receptor subtypes.  Therefore, the purposes of this study were to evaluate potential modifications of the pharmacol. of the ET system in rat pulmonary resistance arteries from monocrotaline (MCT)-induced pulmonary arterial hypertension.  ET-1 levels were quantified by ELISA.  PreproET-1, ETA and ETB receptor mRNA expressions were quantified in pulmonary resistance arteries using Q-PCR, while protein expression was evaluated by Western blots.  Reactivity to ET-1 of isolated pulmonary resistance arteries was measured in the presence of ETA (A-147627), ETB (A-192621) and dual ETA/B (bosentan) receptor antagonists.  In rats with PAH, plasma ET-1 increased (p < 0.001) while pulmonary levels were reduced (p < 0.05).  In PAH arteries, preproET-1 (p < 0.05) and ETB receptor (p < 0.001) gene expressions were reduced, as were ETB receptor protein levels (p < 0.05).  ET-1 induced similar vasoconstrictions in both groups.  In arteries from sham animals, neither bosentan nor the ETA or the ETB receptor antagonists modified the response.  In arteries from PAH rats, however, bosentan and the ETA receptor antagonist potently reduced the maximal contraction, while bosentan also reduced sensitivity (p < 0.01).  The effectiveness of both selective ETA and dual ETA/B receptor antagonists is markedly increased in PAH.  Down-regulation of pulmonary resistance arteries ETB receptor may contribute to this finding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSCTWs0n5Tc7Vg90H21EOLACvtfcHk0lhxtvYLkjGX9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ygsbg%253D&md5=f16fa20fed234b8752b315f71505270b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2009.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2009.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DSauvageau%26aufirst%3DS.%26aulast%3DThorin%26aufirst%3DE.%26aulast%3DVilleneuve%26aufirst%3DL.%26aulast%3DDupuis%26aufirst%3DJ.%26atitle%3DChange%2520in%2520pharmacological%2520effect%2520of%2520endothelin%2520receptor%2520antagonists%2520in%2520rats%2520with%2520pulmonary%2520arterial%2520hypertension%253A%2520Role%2520of%2520ETB-receptor%2520expression%2520levels%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2009%26volume%3D22%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">Mechanisms of ET-1-induced Endothelial Dysfunction</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=621-628&author=M.+Iglarzauthor=M.+Clozel&title=Mechanisms+of+ET-1-induced+Endothelial+Dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520ET-1-induced%2520Endothelial%2520Dysfunction%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2007%26volume%3D50%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Dagassan, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Künzli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=147-153&author=P.+H.+Dagassanauthor=V.+Breuauthor=M.+Clozelauthor=A.+K%C3%BCnzliauthor=P.+Vogtauthor=M.+Turinaauthor=W.+Kiowskiauthor=J.-P.+Clozel&title=Up-Regulation+of+Endothelin-B+Receptors+in+Atherosclerotic+Human+Coronary+Arteries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDagassan%26aufirst%3DP.%2BH.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DK%25C3%25BCnzli%26aufirst%3DA.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DTurina%26aufirst%3DM.%26aulast%3DKiowski%26aufirst%3DW.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DUp-Regulation%2520of%2520Endothelin-B%2520Receptors%2520in%2520Atherosclerotic%2520Human%2520Coronary%2520Arteries%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D147%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Abraham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vancheeswaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dashwood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajkumar, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantelides, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi-wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Bois, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, C. M.</span><span> </span><span class="NLM_article-title">Increased Levels of Endothelin-1 and Differential Endothelin Type A and B Receptor Expression in Scleroderma-Associated Fibrotic Lung Disease</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=9284832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A280%3ADyaK2svjtVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1997&pages=831-841&author=D.+J.+Abrahamauthor=R.+Vancheeswaranauthor=M.+R.+Dashwoodauthor=V.+S.+Rajkumarauthor=P.+Pantelidesauthor=X.+Shi-wenauthor=R.+M.+du+Boisauthor=C.+M.+Black&title=Increased+Levels+of+Endothelin-1+and+Differential+Endothelin+Type+A+and+B+Receptor+Expression+in+Scleroderma-Associated+Fibrotic+Lung+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease</span></div><div class="casAuthors">Abraham D J; Vancheeswaran R; Dashwood M R; Rajkumar V S; Pantelides P; Xu S W; du Bois R M; Black C M</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">831-41</span>
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    </div><div class="casAbstract">In addition to their vasoactive action, endothelins are potent peptides in the regulation of both cell proliferation and the turnover of extracellular matrix.  Using immunohistochemical, autoradiographic, and molecular analyses, we have studied the localization and expression of endothelin-1 and endothelin A (ETA) and B (ETB) receptors in scleroderma-associated fibrotic lung disease.  Increased ET-1 immunoreactivity was found in sclerotic tissue compared with control and was associated with the vasculature, pulmonary interstitium, and bronchial and alveolar epithelium.  Microautoradiographic analysis after 125I-labeled ET-1 binding showed a two- to threefold increase in the expression of total ET-1 receptors in scleroderma lung tissue localized to the alveolar epithelium and the pulmonary interstitium which was composed of mainly fibroblastic cells with macrophages and some microvessels.  RNAse protection assay revealed significantly reduced ETA receptor and slightly raised ETB message levels in systemic sclerosis lung.  Surface expression of functional ET receptors was examined by targeted receptor blocking using mixed and receptor-subtype-selective ligands.  A consistent decrease in ETA receptor binding sites was noted primarily within the interstitium and vasculature, in contrast to a slight increase in ETB receptors.  Elevated ET-1 and the cell-specific pattern of endothelin receptor expression suggest that the endothelins may represent important mediators that influence the pathology of scleroderma-associated lung disease and other fibrotic conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRW2tdWuFW21w2ofyr07jXfW6udTcc2eZICccjW2Mjrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svjtVOhtw%253D%253D&md5=4f3c5592ecb8eba7f2d35d253cb1511a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DD.%2BJ.%26aulast%3DVancheeswaran%26aufirst%3DR.%26aulast%3DDashwood%26aufirst%3DM.%2BR.%26aulast%3DRajkumar%26aufirst%3DV.%2BS.%26aulast%3DPantelides%26aufirst%3DP.%26aulast%3DShi-wen%26aufirst%3DX.%26aulast%3Ddu%2BBois%26aufirst%3DR.%2BM.%26aulast%3DBlack%26aufirst%3DC.%2BM.%26atitle%3DIncreased%2520Levels%2520of%2520Endothelin-1%2520and%2520Differential%2520Endothelin%2520Type%2520A%2520and%2520B%2520Receptor%2520Expression%2520in%2520Scleroderma-Associated%2520Fibrotic%2520Lung%2520Disease%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1997%26volume%3D151%26spage%3D831%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkens, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lausberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfers, H.-J.</span><span> </span><span class="NLM_article-title">Selective Upregulation of Endothelin B Receptor Gene Expression in Severe Pulmonary Hypertension</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2002&pages=1034-1036&author=M.+Bauerauthor=H.+Wilkensauthor=F.+Langerauthor=S.+O.+Schneiderauthor=H.+Lausbergauthor=H.-J.+Sch%C3%A4fers&title=Selective+Upregulation+of+Endothelin+B+Receptor+Gene+Expression+in+Severe+Pulmonary+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DWilkens%26aufirst%3DH.%26aulast%3DLanger%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DS.%2BO.%26aulast%3DLausberg%26aufirst%3DH.%26aulast%3DSch%25C3%25A4fers%26aufirst%3DH.-J.%26atitle%3DSelective%2520Upregulation%2520of%2520Endothelin%2520B%2520Receptor%2520Gene%2520Expression%2520in%2520Severe%2520Pulmonary%2520Hypertension%26jtitle%3DCirculation%26date%3D2002%26volume%3D105%26spage%3D1034%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Saleh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maghazachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaid, A.</span><span> </span><span class="NLM_article-title">Elevated Expresseion of Endothelin-1 and Endothelin-converting Enzyme-1 in Idiopathic Pulmonary Fibrosis: Possible Involvement of Proinflammatory Cytokines</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1165%2Fajrcmb.16.2.9032126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=9032126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=187-193&author=D.+Salehauthor=K.+Furukawaauthor=M.-S.+Tsaoauthor=A.+Maghazachiauthor=B.+Corrinauthor=M.+Yanagisawaauthor=P.+J.+Barnesauthor=A.+Giaid&title=Elevated+Expresseion+of+Endothelin-1+and+Endothelin-converting+Enzyme-1+in+Idiopathic+Pulmonary+Fibrosis%3A+Possible+Involvement+of+Proinflammatory+Cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines</span></div><div class="casAuthors">Saleh, Dina; Furukawa, Kanako; Tsao, Ming-Sound; Maghazachi, Azzam; Corrin, Bryan; Yanagisawa, Masashi; Barnes, Peter J.; Giaid, Adel</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-193</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">Endothelin-1 (ET-1) is a vasoconstrictor, bronchoconstrictor, and mitogenic peptide which is enzymically converted from a biol. inactive big ET to mature ET (21 amino acid) by the ET-converting enzyme (ECE).  Here, we investigate the expression of ECE-1, big ET-1, and ET-1 in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and compare it to those of normal subjects using immuno-histochem. and in situ hybridization.  In normal lungs, focal moderate expression of all three mols. is localized to airway epithelium, pulmonary endothelium, and airway and vascular smooth muscle cells.  Serous bronchial glands also expressed ET-1 and ECE-1.  In IPF, strong diffuse expression of ECE-1 was seen in airway epithelium, proliferating type II pneumocytes, and in endothelial and inflammatory cells.  ECE-1 immunostaining was colocalized to big ET-1 and ET-1 immunostaining, and correlated with disease activity.  To study regulatory mechanisms of ET-1 and ECE-1 expression, human normal bronchial epithelial (NBE) cells were treated with cytokines and analyzed by RIA and Northern blot.  Incubation of human NBE cells with IL-1α and -β or tumor necrosis factor α (TNFα) resulted in a significant increase in ET-1 release and mRNA expression.  TNFα resulted in a significant increase in ECE-1 mRNA expression.  These findings demonstrated the colocalization of the precursor and active ET-1, and ECE-1 in the same cell, and that ECE-1 expression is elevated in IPF.  In addn., increased expression of ET-1 and ECE-1 in IPF may be mediated by proinflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCRJWk-b6j2bVg90H21EOLACvtfcHk0lhi25zkODYIqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVemsrw%253D&md5=5d2b25d5f90201a7e09e022995adefee</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.16.2.9032126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.16.2.9032126%26sid%3Dliteratum%253Aachs%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DTsao%26aufirst%3DM.-S.%26aulast%3DMaghazachi%26aufirst%3DA.%26aulast%3DCorrin%26aufirst%3DB.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DGiaid%26aufirst%3DA.%26atitle%3DElevated%2520Expresseion%2520of%2520Endothelin-1%2520and%2520Endothelin-converting%2520Enzyme-1%2520in%2520Idiopathic%2520Pulmonary%2520Fibrosis%253A%2520Possible%2520Involvement%2520of%2520Proinflammatory%2520Cytokines%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1997%26volume%3D16%26spage%3D187%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lehrke, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldherr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span> </span><span class="NLM_article-title">Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11675408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotl2lsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=2321-2329&author=I.+Lehrkeauthor=R.+Waldherrauthor=E.+Ritzauthor=J.+Wagner&title=Renal+endothelin-1+and+endothelin+receptor+type+B+expression+in+glomerular+diseases+with+proteinuria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria</span></div><div class="casAuthors">Lehrke, Ingo; Waldherr, Rudiger; Ritz, Eberhard; Wagner, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2321-2329</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The endothelin (ET) system has been studied extensively in exptl. models of progressive chronic renal disease, but there is limited information regarding the ET system in renal patients.  First, the expression of human ET-1, as well as ET receptor type A (ET-RA) and ET-RB, was studied in 26 renal biopsies from patients with different renal diseases.  Gene expression was assessed by quant. reverse transcription-PCR.  Second, ET-1 and ET-RB protein expression and localization were examd., by immunohistochem. analyses, among a homogeneous cohort of 16 patients with IgA nephropathy and different degrees of proteinuria.  ET-RB mRNA expression was threefold higher among patients with higher-grade proteinuria [≥2 g/24 h, n = 10; OD ratio (ODR), i.e., wild-type/mutant mRNA ratio, 1.81 ± 0.3], compared with patients with lower-grade proteinuria (<2 g/24 h, n = 8; ODR, 0.63 ± 0.1; P < 0.01) or control subjects (n = 9; ODR, 0.57 ± 0.1; P < 0.01).  ET-1 gene expression was significantly higher among patients with higher-grade proteinuria, compared with patients with lower-grade proteinuria (P < 0.01) or control subjects (P < 0.05).  ET-RA mRNA expression was not different among the groups.  Patients with higher-grade proteinuria who were receiving angiotensin-converting enzyme inhibitors exhibited significantly (P < 0.05) lower ET-1 and ET-RB mRNA expression, which was comparable to that of control subjects.  By using immunohistochem. analyses, an assocn. between proteinuria and expression of ET-1 and ET-RB in proximal tubular epithelial cells and of ET-1 in glomeruli was confirmed in the sep. cohort of patients with IgA nephropathy.  It is concluded that the increased ET-RB and ET-1 mRNA and protein expression obsd. in animal models of renal disease is also demonstrable among patients with renal disease and high-grade proteinuria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI5LjeixZW0bVg90H21EOLACvtfcHk0lhi25zkODYIqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotl2lsr4%253D&md5=253ed8e89241dd35a3fe8cec90f74199</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehrke%26aufirst%3DI.%26aulast%3DWaldherr%26aufirst%3DR.%26aulast%3DRitz%26aufirst%3DE.%26aulast%3DWagner%26aufirst%3DJ.%26atitle%3DRenal%2520endothelin-1%2520and%2520endothelin%2520receptor%2520type%2520B%2520expression%2520in%2520glomerular%2520diseases%2520with%2520proteinuria%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2001%26volume%3D12%26spage%3D2321%26epage%3D2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wu-Wong, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padley, R.</span><span> </span><span class="NLM_article-title">Endothelin receptor antagonists: A clinical study up-date</span> <span class="citation_source-journal">Curr. Opin. Cardiovasc. Pulm. Renal Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=339-344&author=J.+R.+Wu-Wongauthor=R.+Padley&title=Endothelin+receptor+antagonists%3A+A+clinical+study+up-date"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu-Wong%26aufirst%3DJ.%2BR.%26aulast%3DPadley%26aufirst%3DR.%26atitle%3DEndothelin%2520receptor%2520antagonists%253A%2520A%2520clinical%2520study%2520up-date%26jtitle%3DCurr.%2520Opin.%2520Cardiovasc.%2520Pulm.%2520Renal%2520Invest.%2520Drugs%26date%3D2000%26volume%3D2%26spage%3D339%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wu, C.</span><span> </span><span class="NLM_article-title">Recent discovery and development of endothelin receptor antagonists</span> <span class="citation_source-journal">Exp. Opin. Ther. Patent</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1517%2F13543776.10.11.1653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvF2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1653-1668&author=C.+Wu&title=Recent+discovery+and+development+of+endothelin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Recent discovery and development of endothelin receptor antagonists</span></div><div class="casAuthors">Wu, Chengde</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1653-1668</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review, with 48 refs.  Endothelin (ET) receptor antagonists, in particular ETA selective or ETA/ETB balanced antagonists, represent a new therapeutic area for serious diseases such as congestive heart failure (CHF) and pulmonary hypertension.  Endothelin antagonists have profound effects on the pulmonary vasculature and the right heart whereas ACE inhibitors primarily affect the peripheral vessel and the left heart.  Therefore, combination of endothelin antagonists and ACE inhibitors may be particularly useful in chronic heart failure.  Pulmonary hypertension represents another unmet medical need where endothelin antagonists, esp. orally-active compds., show great promise.  The importance of this field is evidenced by the no. of compds. in clin. trials and by the no. of patents filed in recent years.  Between Jan. 1997 and Apr. 2000, there are 139 endothelin patents of which 128 are concerned with endothelin receptor antagonists and 11 with endothelin converting enzyme inhibitors.  Of the 128 patents, 93 are about new chem. structures, 16 process, 4 formulation, 14 new use or combination therapy and 1 natural product.  This article focuses on the 93 novel compn. of matter patents in the area of endothelin receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpfcqT7H-g7Vg90H21EOLACvtfcHk0lgZLuMHUKarQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvF2gtL4%253D&md5=1868b5d2d4284556bf2dfa82be654419</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.11.1653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.11.1653%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26atitle%3DRecent%2520discovery%2520and%2520development%2520of%2520endothelin%2520receptor%2520antagonists%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Patent%26date%3D2000%26volume%3D10%26spage%3D1653%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Endothelin Receptor Antagonists: Structures, Synthesis, Selectivity and Therapeutic Applications</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2174%2F0929867023371139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11860362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=349-383&author=C.+Bossauthor=M.+Bolliauthor=T.+Weller&title=Endothelin+Receptor+Antagonists%3A+Structures%2C+Synthesis%2C+Selectivity+and+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelin receptor antagonists: structures, synthesis, selectivity and therapeutic applications</span></div><div class="casAuthors">Boss, C.; Bolli, M.; Weller, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-383</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Endothelin (ET) was discovered in 1988 and is the most potent vasoconstrictive peptide known to date.  It exists in three isoforms (ET-1 to ET-3) and acts on two endothelin receptor subtypes, the endothelin-A (ETA)-receptor and the endothelin-B (ETB)-receptor.  Endothelin receptor antagonists are novel therapeutics in clin. development for different cardiovascular, cerebrovascular, and renal diseases.  Several different structural classes of endothelin receptor antagonists have been discovered within the last decade, starting from peptidic- and peptidomimetic structures to small org. mols. suitable as therapeutics for oral administration.  Focussing on the small org. mols., the different structural classes of ET-receptor antagonists are described with respect to synthesis, structure-activity-relationships, receptor-subtype-selectivity profile, and where possible, intended therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS9xVmXL5I2rVg90H21EOLACvtfcHk0lgZLuMHUKarQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Olt7k%253D&md5=68e82605cd51899d20e3794ea836685e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F0929867023371139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867023371139%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBolli%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DEndothelin%2520Receptor%2520Antagonists%253A%2520Structures%252C%2520Synthesis%252C%2520Selectivity%2520and%2520Therapeutic%2520Applications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D349%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Iqbal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanghi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span> </span><span class="NLM_article-title">Endothelin Receptor Antagonists: An Overview of Their Synthesis and Structure–Activity Relationship</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=381-408&author=J.+Iqbalauthor=R.+Sanghiauthor=S.+K.+Das&title=Endothelin+Receptor+Antagonists%3A+An+Overview+of+Their+Synthesis+and+Structure%E2%80%93Activity+Relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DJ.%26aulast%3DSanghi%26aufirst%3DR.%26aulast%3DDas%26aufirst%3DS.%2BK.%26atitle%3DEndothelin%2520Receptor%2520Antagonists%253A%2520An%2520Overview%2520of%2520Their%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D381%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Aubert, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1069</span><span class="NLM_x">–</span> <span class="NLM_lpage">1084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1517%2F14728220903074570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=19659448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1069-1084&author=J.-D.+Aubertauthor=L.+Juillerat-Jeanneret&title=Therapeutic+potential+of+endothelin+receptor+modulators%3A+lessons+from+human+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials</span></div><div class="casAuthors">Aubert, John-David; Juillerat-Jeanneret, Lucienne</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1069-1084</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The endothelin system, and in particular endothelin receptors, are targets for therapeutic intervention in human diseases.  Endothelin receptor antagonists have reached clin. use for treating pulmonary arterial hypertension, and are under clin. investigation for several other diseases, such as cancer, vasospasm or fibrogenic diseases.  We review the mols. that have been evaluated in the main clin. trials, from the point of view of receptor selectivity and of their chem. characteristics which were important for efficacy in pulmonary hypertension.  We will also discuss future use of antagonists to endothelin receptor(s) in several human diseases and what should be the necessary properties of the future mols. for efficacy in diseases where the presently tested mols. displayed suboptimal efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwp9dwjsEbbVg90H21EOLACvtfcHk0lgmw_qT1W1BIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaltL8%253D&md5=81343b0ba9cb9b9d4640ddecc4e0d22d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F14728220903074570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903074570%26sid%3Dliteratum%253Aachs%26aulast%3DAubert%26aufirst%3DJ.-D.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DTherapeutic%2520potential%2520of%2520endothelin%2520receptor%2520modulators%253A%2520lessons%2520from%2520human%2520clinical%2520trials%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D1069%26epage%3D1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Houde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Orléans-Juste, P.</span><span> </span><span class="NLM_article-title">Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2613</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2174%2F138161211797416101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=21728984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=2613-2625&author=M.+Houdeauthor=J.+Labont%C3%A9author=P.+D%E2%80%99Orl%C3%A9ans-Juste&title=Peptide+and+Non-peptide+Antagonists+Targeting+Endothelin+Receptors+in+Physiology+and+Pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide antagonists targeting endothelin receptors in physiology and pathology</span></div><div class="casAuthors">Houde, Martin; Labonte, Julie; D'Orleans-Juste, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2613-2625</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As for other peptides such as bradykinin, neurokinins, and angiotensins, peptide antagonists for endothelin-1 (ET-1) were early on developed towards the pharmacol. characterization of both ETA and ETB receptors.  Interestingly, unlike the previously mentioned 3 peptides, receptors for ET-1 were cloned and purified prior to the report of ETA and ETB receptor antagonists such as BQ-123 and BQ-788.  The availability of such pharmacol. tools and the use of mol. approaches have certainly fast-tracked the development of non-peptide ET receptor antagonists for clin. applications.  Albeit rapid degrdn. by gastric enzymes and short half life in blood plasma of peptide receptor antagonists limit their use in clin. settings, those mols. were of importance in the identification of mediators and modulators of ET-1 induced properties in vitro and in vivo, as described further in this review.  Peptide antagonists acting selectively or, with equiv. affinities against ETA and ETB receptors were reported prior to the advent of clin. relevant non-peptide blockers such as Bosentan.  Confounding mechanisms involving, for example, the endogenous modulators nitric oxide and prostacyclin as well as allosteric interactions between ET receptor types, were also clarified with the use of peptide antagonists for endothelins.  Finally, peptide antagonists were also used to identify the precise pharmacol. of ET-1 precursors such as big-endothelin-1 and ET-1 (1-31).  The present review will thus attempt to summarize the knowledge to date and future perspectives related to use of peptide antagonists targeting endothelin receptors in physiol. and pathol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMof3XutTAibVg90H21EOLACvtfcHk0lgmw_qT1W1BIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7rI&md5=e35b4d5b46113bc420d7fdfcb99c729e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F138161211797416101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211797416101%26sid%3Dliteratum%253Aachs%26aulast%3DHoude%26aufirst%3DM.%26aulast%3DLabont%25C3%25A9%26aufirst%3DJ.%26aulast%3DD%25E2%2580%2599Orl%25C3%25A9ans-Juste%26aufirst%3DP.%26atitle%3DPeptide%2520and%2520Non-peptide%2520Antagonists%2520Targeting%2520Endothelin%2520Receptors%2520in%2520Physiology%2520and%2520Pathology%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D2613%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hoette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, R.</span><span> </span><span class="NLM_article-title">Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension</span> <span class="citation_source-journal">J. Recept., Ligand Channel Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFejsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=113-121&author=S.+Hoetteauthor=D.+S.+O%E2%80%99Callaghanauthor=C.+Jardimauthor=R.+Souza&title=Dual+receptor+blockade+by+bosentan%3A+clinical+experience+in+treatment+of+pulmonary+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Dual receptor blockade by bosentan: clinical experience in treatment of pulmonary hypertension</span></div><div class="casAuthors">Hoette, Susana; O'Callaghan, Dermot S.; Jardim, Carlos; Souza, Rogerio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Receptor, Ligand and Channel Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">JRLCA9</span>;
        ISSN:<span class="NLM_cas:issn">1178-699X</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Pulmonary hypertension is characterized by an increase in mean pulmonary arterial pressure and right ventricular overload.  Endothelin-1 (ET-1) is a potent vasoconstrictor with an important role in the pathogenesis of pulmonary hypertension.  In addn. to its vasoconstrictive action, ET-1 also stimulates cell proliferation, fibrosis, and inflammation.  The blockade of both receptors involved in the action of ET-1 is beneficial in the treatment of pulmonary hypertension.  The use of endothelin dual receptor blockade leads to improvements in quality of life, functional capacity, and pulmonary hemodynamics in affected patients.  This article reviews the importance of ET-1 in the pathogenesis of pulmonary hypertension and demonstrates the benefits of blockage of the action of ET-1 in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2B7fGp_F_N7Vg90H21EOLACvtfcHk0lgmw_qT1W1BIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFejsr7I&md5=cca7b839d06c78137ad6c4371203f650</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoette%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DD.%2BS.%26aulast%3DJardim%26aufirst%3DC.%26aulast%3DSouza%26aufirst%3DR.%26atitle%3DDual%2520receptor%2520blockade%2520by%2520bosentan%253A%2520clinical%2520experience%2520in%2520treatment%2520of%2520pulmonary%2520hypertension%26jtitle%3DJ.%2520Recept.%252C%2520Ligand%2520Channel%2520Res.%26date%3D2010%26volume%3D3%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dwyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, D.</span><span> </span><span class="NLM_article-title">Bosentan for the treatment of adult pulmonary hypertension</span> <span class="citation_source-journal">Future Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.2217%2Ffca.10.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=21174507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=19-37&author=N.+Dwyerauthor=D.+Kilpatrick&title=Bosentan+for+the+treatment+of+adult+pulmonary+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Bosentan for the treatment of adult pulmonary hypertension</span></div><div class="casAuthors">Dwyer, Nathan; Kilpatrick, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Cardiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-37</span>CODEN:
                <span class="NLM_cas:coden">FCUAAZ</span>;
        ISSN:<span class="NLM_cas:issn">1479-6678</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Pulmonary hypertension is a severe progressive disease with a marked morbidity and a high mortality attributed to right heart failure.  Bosentan, a dual endothelin receptor antagonist, is an effective and well-tolerated oral therapy for the management of pulmonary arterial hypertension (PAH; WHO group 1 pulmonary hypertension).  Bosentan improves cardiopulmonary hemodynamics, exercise capacity, WHO functional class and quality of life, as well as delaying time to clin. worsening in patients with PAH.  This article reviews the role of endothelin-1 in the pathogenesis and progression of PAH, the diagnosis of PAH and the pharmacol. of bosentan, and summarizes the current available evidence for the safety and efficacy of bosentan for the treatment of PAH as a monotherapy and combination therapy, as well as its role in the management of other forms of pulmonary hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYCUB3LMATALVg90H21EOLACvtfcHk0li5TxrGk6RgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gt7zE&md5=4ee75ac5b3d840663b4b0656435adb19</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Ffca.10.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffca.10.114%26sid%3Dliteratum%253Aachs%26aulast%3DDwyer%26aufirst%3DN.%26aulast%3DKilpatrick%26aufirst%3DD.%26atitle%3DBosentan%2520for%2520the%2520treatment%2520of%2520adult%2520pulmonary%2520hypertension%26jtitle%3DFuture%2520Cardiol.%26date%3D2011%26volume%3D7%26spage%3D19%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>Tracleer; <span class="NLM_publisher-name">European Medicines Agency</span>, <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000401/human_med_001100.jsp&amp;murl=menus/" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000401/human_med_001100.jsp&murl=menus/</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tracleer%3B+European+Medicines+Agency%2C+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fmedicines%2Fhuman%2Fmedicines%2F000401%2Fhuman_med_001100.jsp%26murl%3Dmenus%2F%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTracleer%26pub%3DEuropean%2520Medicines%2520Agency" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Blalock, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulevicius, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peshock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, K. M.</span><span> </span><span class="NLM_article-title">Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">J. Card. Failure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2Fj.cardfail.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=20142023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyhtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=121-127&author=S.+W.+Blalockauthor=S.+Matuleviciusauthor=L.+C.+Mitchellauthor=S.+Reimoldauthor=J.+Warnerauthor=R.+Peshockauthor=F.+Torresauthor=K.+M.+Chin&title=Long-Term+Outcomes+With+Ambrisentan+Monotherapy+in+Pulmonary+Arterial+Hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Blalock, Shannon E.; Matulevicius, Susan; Mitchell, Laura C.; Reimold, Sharon; Warner, John; Peshock, Ronald; Torres, Fernando; Chin, Kelly M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiac Failure</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-127</span>CODEN:
                <span class="NLM_cas:coden">JCFAF9</span>;
        ISSN:<span class="NLM_cas:issn">1071-9164</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: This study evaluated long-term outcomes in patients with pulmonary arterial hypertension (PAH) undergoing treatment with ambrisentan monotherapy, a selective oral endothelin-1 receptor antagonist.  Methods and Results: Patients who participated in the Ambrisentan in Pulmonary Arterial Hypertension: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy Study (ARIES-1) clin. trial and extension phase at our institution were included.  Cardiac catheterization, 6-min walk distance (6MWD), and cardiac magnetic resonance (MRI) data were retrospectively reviewed.  Twelve patients with PAH (11 idiopathic, 1 fenfluramine) had follow-up from 3 to 5.5 years from the initiation of ARIES-1.  Patients received ambrisentan therapy throughout the study period and were on ambrisentan monotherapy for the first 2 years.  At year 1, improvements in median mean pulmonary arterial pressure (PA), cardiac output, and pulmonary vascular resistance (PVR) were seen (P = .02, P = .03, P < .01), and the improvement in PVR persisted at 2 years. 6MWD also improved significantly between baseline (350 m) and 1 and 2 years (397 m, P < .01 and 393 m, P = .01).  Cardiac MRI results were more varied, with an increase in RV ejection fraction from 29% at baseline to 46% at 2 years (P = .02), but other MRI variables did not improve.  Conclusions: Ambrisentan monotherapy led to improvements in catheterization, 6MWD, and RV ejection fraction, and shows promise as a long-term treatment for pulmonary arterial hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRw5QLhdBGibVg90H21EOLACvtfcHk0li5TxrGk6RgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyhtbg%253D&md5=e0b48df10bebd838e6944247784fe142</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cardfail.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardfail.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DBlalock%26aufirst%3DS.%2BW.%26aulast%3DMatulevicius%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DL.%2BC.%26aulast%3DReimold%26aufirst%3DS.%26aulast%3DWarner%26aufirst%3DJ.%26aulast%3DPeshock%26aufirst%3DR.%26aulast%3DTorres%26aufirst%3DF.%26aulast%3DChin%26aufirst%3DK.%2BM.%26atitle%3DLong-Term%2520Outcomes%2520With%2520Ambrisentan%2520Monotherapy%2520in%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DJ.%2520Card.%2520Failure%26date%3D2010%26volume%3D16%26spage%3D121%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Frampton, J. E.</span><span> </span><span class="NLM_article-title">Ambrisentan</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=215-226&author=J.+E.+Frampton&title=Ambrisentan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrampton%26aufirst%3DJ.%2BE.%26atitle%3DAmbrisentan%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2011%26volume%3D11%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span>Volibris; <span class="NLM_publisher-name">European Medicines Agency</span>, <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000839/human_med_001151.jsp&amp;mid=WC0b01ac058001d124" class="extLink">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000839/human_med_001151.jsp&mid=WC0b01ac058001d124</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Volibris%3B+European+Medicines+Agency%2C+http%3A%2F%2Fwww.ema.europa.eu%2Fema%2Findex.jsp%3Fcurl%3Dpages%2Fmedicines%2Fhuman%2Fmedicines%2F000839%2Fhuman_med_001151.jsp%26mid%3DWC0b01ac058001d124%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DVolibris%26pub%3DEuropean%2520Medicines%2520Agency" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Goligorsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iijima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasjletti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaskel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badr, K. F.</span><span> </span><span class="NLM_article-title">Role of Endothelin in the Development of Dahl Hypertension</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S484</span><span class="NLM_x">–</span> <span class="NLM_lpage">S491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1991&pages=S484-S491&author=M.+S.+Goligorskyauthor=K.+Iijimaauthor=M.+Morganauthor=M.+Yanagisawaauthor=T.+Masakiauthor=L.+Linauthor=A.+Nasjlettiauthor=F.+Kaskelauthor=M.+Frazerauthor=K.+F.+Badr&title=Role+of+Endothelin+in+the+Development+of+Dahl+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoligorsky%26aufirst%3DM.%2BS.%26aulast%3DIijima%26aufirst%3DK.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DMasaki%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNasjletti%26aufirst%3DA.%26aulast%3DKaskel%26aufirst%3DF.%26aulast%3DFrazer%26aufirst%3DM.%26aulast%3DBadr%26aufirst%3DK.%2BF.%26atitle%3DRole%2520of%2520Endothelin%2520in%2520the%2520Development%2520of%2520Dahl%2520Hypertension%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1991%26volume%3D17%26spage%3DS484%26epage%3DS491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Doucet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptiste, J.</span><span> </span><span class="NLM_article-title">Endothelin Antagonists in Salt-Dependent Hypertension Associated with Renal Insufficiency</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=643-651&author=J.+Doucetauthor=W.+Gonzalezauthor=J.+Baptiste&title=Endothelin+Antagonists+in+Salt-Dependent+Hypertension+Associated+with+Renal+Insufficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoucet%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DW.%26aulast%3DBaptiste%26aufirst%3DJ.%26atitle%3DEndothelin%2520Antagonists%2520in%2520Salt-Dependent%2520Hypertension%2520Associated%2520with%2520Renal%2520Insufficiency%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Schiffrin, E. L.</span><span> </span><span class="NLM_article-title">Role of endothelin-1 in hypertension and vascular disease</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">83S</span><span class="NLM_x">–</span> <span class="NLM_lpage">89S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2001&pages=83S-89S&author=E.+L.+Schiffrin&title=Role+of+endothelin-1+in+hypertension+and+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchiffrin%26aufirst%3DE.%2BL.%26atitle%3DRole%2520of%2520endothelin-1%2520in%2520hypertension%2520and%2520vascular%2520disease%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2001%26volume%3D14%26spage%3D83S%26epage%3D89S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fattinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P. J.</span><span> </span><span class="NLM_article-title">The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1067%2Fmcp.2001.114667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=11309550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVelsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=223-231&author=K.+Fattingerauthor=C.+Funkauthor=M.+Pantzeauthor=C.+Weberauthor=J.+Reichenauthor=B.+Stiegerauthor=P.+J.+Meier&title=The+endothelin+antagonist+bosentan+inhibits+the+canalicular+bile+salt+export+pump%3A+A+potential+mechanism+for+hepatic+adverse+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions</span></div><div class="casAuthors">Fattinger, Karin; Funk, Christoph; Pantze, Michael; Weber, Cornelia; Reichen, Jurg; Stieger, Bruno; Meier, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (St. Louis, MO, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">223-231</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">During clin. trials bosentan, the first orally active endothelin receptor antagonist, caused asymptomatic transaminase elevations in some patients.  In this study we investigated whether inhibition of the hepatocanalicular bile salt export pump (rodents, Bsep; humans, BSEP ABCB11) could account for bosentan-induced liver injury.  We reanalyzed the safety database of the bosentan trials for cholestatic liver injury, detd. the cholestatic potency of bosentan in the rat, and studied the effects of bosentan and its metabolites on Bsep-mediated taurocholate transport in vitro.  Bosentan caused dose-dependent and reversible liver injury in 2% to 18% of patients and caused a significant increase of serum bile salt levels (P <.01).  Concomitant administration of glyburide (INN, glibenclamide) enhanced the cholestatic potency of bosentan.  Similar effects were seen in rats, in which serum bile salt levels were increased by glyburide less than by bosentan, which increased the levels less than a combination of bosentan and glyburide.  In vitro, Bsep-mediated taurocholate transport was inhibited by bosentan (inhibition const., -12 μmol/L) and metabolites (inhibition const., -8.5 μmol/L for metabolite Ro 47-8634).  These results indicate that bosentan-induced liver injury is mediated, at least in part, by inhibition of Bsep/BSEP-causing intracellular accumulation of cytotoxic bile salts and bile salt induced liver cell damage.  The data further emphasize the pathophysiol. importance of drug-Bsep interactions in acquired forms of cholestatic liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDluzM7gtwYbVg90H21EOLACvtfcHk0ljg3BfbmvbD-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVelsbo%253D&md5=a39a1c82d8b43d54f3768aed505fa270</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1067%2Fmcp.2001.114667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmcp.2001.114667%26sid%3Dliteratum%253Aachs%26aulast%3DFattinger%26aufirst%3DK.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DPantze%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DReichen%26aufirst%3DJ.%26aulast%3DStieger%26aufirst%3DB.%26aulast%3DMeier%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520endothelin%2520antagonist%2520bosentan%2520inhibits%2520the%2520canalicular%2520bile%2520salt%2520export%2520pump%253A%2520A%2520potential%2520mechanism%2520for%2520hepatic%2520adverse%2520reactions%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2001%26volume%3D69%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">Discovery of Ro 48–5695: A Potent Mixed Endothelin Receptor Antagonist Optimized from Bosentan</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2223</span><span class="NLM_x">–</span> <span class="NLM_lpage">2228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2FS0960-894X%2897%2900400-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlertrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2223-2228&author=W.+Neidhartauthor=V.+Breuauthor=K.+Burriauthor=M.+Clozelauthor=G.+Hirthauthor=U.+Klinkhammerauthor=T.+Gillerauthor=H.+Ramuz&title=Discovery+of+Ro+48%E2%80%935695%3A+A+Potent+Mixed+Endothelin+Receptor+Antagonist+Optimized+from+Bosentan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of RO 48-5695: a potent mixed endothelin receptor antagonist optimized from bosentan</span></div><div class="casAuthors">Neidhart, Werner; Breu, Volker; Burri, Kaspar; Clozel, Martine; Hirth, Georges; Klinkhammer, Uwe; Giller, Thomas; Ramuz, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2223-2228</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Implementation of a pyridylcarbamoyl group and an isopropylpyridylsulfonamide substituent as key components in the scaffold of Bosentan resulted in the identification of the potent orally active endothelin receptor antagonist Ro 48-5695 (I).  It shows affinities for ETA and ETB receptors in the low nanomolar range and high functional antagonistic potency in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEtfXj0NeXqLVg90H21EOLACvtfcHk0lhLLobrYJFXIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlertrc%253D&md5=ca343c3b1de98df36cd31ac92149a9b5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2897%2900400-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252897%252900400-9%26sid%3Dliteratum%253Aachs%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Ro%252048%25E2%2580%25935695%253A%2520A%2520Potent%2520Mixed%2520Endothelin%2520Receptor%2520Antagonist%2520Optimized%2520from%2520Bosentan%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2223%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Harrington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatri, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeHoff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. A.</span><span> </span><span class="NLM_article-title">Research and Development of a Second-Generation Process for Bosentan, an Endothelin Receptor Antagonist</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/doi/10.1021/op010234i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=120-124&author=P.+J.+Harringtonauthor=H.+N.+Khatriauthor=B.+S.+DeHoffauthor=M.+R.+Guinnauthor=M.+A.+Boehlerauthor=K.+A.+Glaser&title=Research+and+Development+of+a+Second-Generation+Process+for+Bosentan%2C+an+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fop010234i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop010234i%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BJ.%26aulast%3DKhatri%26aufirst%3DH.%2BN.%26aulast%3DDeHoff%26aufirst%3DB.%2BS.%26aulast%3DGuinn%26aufirst%3DM.%2BR.%26aulast%3DBoehler%26aufirst%3DM.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BA.%26atitle%3DResearch%2520and%2520Development%2520of%2520a%2520Second-Generation%2520Process%2520for%2520Bosentan%252C%2520an%2520Endothelin%2520Receptor%2520Antagonist%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bolli, M.; Boss, C.; Fischli, W.; Clozel, M.; Weller, T.</span><span> </span><span class="NLM_article-title">Novel Sulfamides and Their Use as Endothelin Receptor Antagonists</span>. WO2002053557, <span class="NLM_month">Jul</span><span class="NLM_day">11</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Bolli&author=C.+Boss&author=W.+Fischli&author=M.+Clozel&author=T.+Weller&title=Novel+Sulfamides+and+Their+Use+as+Endothelin+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DNovel%2520Sulfamides%2520and%2520Their%2520Use%2520as%2520Endothelin%2520Receptor%2520Antagonists%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">The Use of Sulfonylamido Pyrimidines Incorporating an Unsaturated Side Chain as Endothelin Receptor Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=955-959&author=M.+H.+Bolliauthor=C.+Bossauthor=M.+Clozelauthor=W.+Fischliauthor=P.+Hessauthor=T.+Weller&title=The+Use+of+Sulfonylamido+Pyrimidines+Incorporating+an+Unsaturated+Side+Chain+as+Endothelin+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DThe%2520Use%2520of%2520Sulfonylamido%2520Pyrimidines%2520Incorporating%2520an%2520Unsaturated%2520Side%2520Chain%2520as%2520Endothelin%2520Receptor%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D955%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Boss, C.; Fischli, W.; Weller, T.; Clozel, M.; Bolli, M.</span><span> </span><span class="NLM_article-title">Novel Sulfamides</span>. WO2006051502, <span class="NLM_month">May</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+Boss&author=W.+Fischli&author=T.+Weller&author=M.+Clozel&author=M.+Bolli&title=Novel+Sulfamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoss%26aufirst%3DC.%26atitle%3DNovel%2520Sulfamides%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Burri, K.; Clozel, M.; Fischli, W.; Hirth, G.; Löffler, B. M.; Ramuz, H.</span><span> </span><span class="NLM_article-title">Verwendung von Sulfonamiden als Heilmittel und neue Sulfonamide</span>. EP0510526, <span class="NLM_month">Oct</span><span class="NLM_day">28</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=K.+Burri&author=M.+Clozel&author=W.+Fischli&author=G.+Hirth&author=B.+M.+L%C3%B6ffler&author=H.+Ramuz&title=Verwendung+von+Sulfonamiden+als+Heilmittel+und+neue+Sulfonamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DK.%26atitle%3DVerwendung%2520von%2520Sulfonamiden%2520als%2520Heilmittel%2520und%2520neue%2520Sulfonamide%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Burri, K.; Clozel, M.; Fischli, W.; Hirth, G.; Löffler, B.-M.; Ramuz, H.; Neidhart, W.</span><span> </span><span class="NLM_article-title">Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte</span>. EP0526708, <span class="NLM_month">Feb</span><span class="NLM_day">10</span>,<span class="NLM_x"> </span><span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=K.+Burri&author=M.+Clozel&author=W.+Fischli&author=G.+Hirth&author=B.-M.+L%C3%B6ffler&author=H.+Ramuz&author=W.+Neidhart&title=Sulfonamide%2C+ihre+Herstellung+und+Verwendung+als+Heilmittel+und+Zwischenprodukte"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DK.%26atitle%3DSulfonamide%252C%2520ihre%2520Herstellung%2520und%2520Verwendung%2520als%2520Heilmittel%2520und%2520Zwischenprodukte%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Yamada, K.; Yasuda, K.; Kikkawa, K.; Kohno, R.</span><span> </span><span class="NLM_article-title">Sulfonamide derivative and process for preparing the same</span>. EP0743307, <span class="NLM_month">Nov</span><span class="NLM_day">20</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=K.+Yamada&author=K.+Yasuda&author=K.+Kikkawa&author=R.+Kohno&title=Sulfonamide+derivative+and+process+for+preparing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DSulfonamide%2520derivative%2520and%2520process%2520for%2520preparing%2520the%2520same%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Yamada, K.; Yasuda, K.; Kikkawa, K.; Kohno, R.</span><span> </span><span class="NLM_article-title">Sulfonamide Derivate und Verfahren zu deren Herstellung</span>. EP0959072, <span class="NLM_month">Oct</span><span class="NLM_day">31</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=K.+Yamada&author=K.+Yasuda&author=K.+Kikkawa&author=R.+Kohno&title=Sulfonamide+Derivate+und+Verfahren+zu+deren+Herstellung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DSulfonamide%2520Derivate%2520und%2520Verfahren%2520zu%2520deren%2520Herstellung%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Bolli, M.; Boss, C.; Clozel, M.; Fischli, W.; Weller, T.</span><span> </span><span class="NLM_article-title">Pyrimidine-Sulfamides and Their Use as Endothelin Receptor Antagonist</span>. WO2004050640, <span class="NLM_month">Jun</span><span class="NLM_day">17</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Bolli&author=C.+Boss&author=M.+Clozel&author=W.+Fischli&author=T.+Weller&title=Pyrimidine-Sulfamides+and+Their+Use+as+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%26atitle%3DPyrimidine-Sulfamides%2520and%2520Their%2520Use%2520as%2520Endothelin%2520Receptor%2520Antagonist%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Brown, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyall, J. M.</span><span> </span><span class="NLM_article-title">Pyrimidine Reactions</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">794</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1964&pages=794-802&author=D.+J.+Brownauthor=J.+M.+Lyall&title=Pyrimidine+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BJ.%26aulast%3DLyall%26aufirst%3DJ.%2BM.%26atitle%3DPyrimidine%2520Reactions%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D1964%26volume%3D17%26spage%3D794%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Crosby, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthold, R. V.</span><span> </span><span class="NLM_article-title"><i>n</i>-Butyl 5-Chloro-2-pyrimidoxyacetate—A Plant Growth Regulator Analog</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1919</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01081a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1960&pages=1916-1919&author=D.+G.+Crosbyauthor=R.+V.+Berthold&title=n-Butyl+5-Chloro-2-pyrimidoxyacetate%E2%80%94A+Plant+Growth+Regulator+Analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjo01081a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01081a023%26sid%3Dliteratum%253Aachs%26aulast%3DCrosby%26aufirst%3DD.%2BG.%26aulast%3DBerthold%26aufirst%3DR.%2BV.%26atitle%3Dn-Butyl%25205-Chloro-2-pyrimidoxyacetate%25E2%2580%2594A%2520Plant%2520Growth%2520Regulator%2520Analog%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D25%26spage%3D1916%26epage%3D1919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Maggiali, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mossini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barocelli, E.</span><span> </span><span class="NLM_article-title">H1-antihistaminic and antimuscarinic effects of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds</span> <span class="citation_source-journal">Farmaco, Ed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=2901367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaL1cXks1Kgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1988&pages=277-292&author=C.+Maggialiauthor=G.+Moriniauthor=F.+Mossiniauthor=G.+Moriniauthor=E.+Barocelli&title=H1-antihistaminic+and+antimuscarinic+effects+of+2-+and+4-%5Bbenzyl-%282-dimethylaminoethyl%29amino%5Dpyrimidine+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">H1-antihistaminic and antimuscarinic effects of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds</span></div><div class="casAuthors">Maggiali, C.; Morini, Giovanni; Mossini, F.; Morini, Giuseppina; Barocelli, E.; Impicciatore, M.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco, Edizione Scientifica</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-91</span>CODEN:
                <span class="NLM_cas:coden">FRPSAX</span>;
        ISSN:<span class="NLM_cas:issn">0430-0920</span>.
    </div><div class="casAbstract">Fourteen 2- (I) and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimdidines (II) (in both cases R, R1 and R3 = OMe or H; R2 = SMe, Cl, or H) were prepd.  In tests on the isolated guinea pig ileum, I were more potent than II as antihistaminics, but the only compd. which was a pure H1-antihistaminic was II (R = R1 = OMe; R2 = R3 = H), which had a potency similar to that of tonzylamine.  In the same test system, the only compd. to display a specific antimuscarinic activity (though of low potency) was II (R = R3 = H; R1 = OMe; R2 = Sme).  Structure-activity relations are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvP4souxbTUbVg90H21EOLACvtfcHk0ljBK9TagRpzTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXks1Kgtr8%253D&md5=c35b36da1aab0ff900f66a19e48b5070</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaggiali%26aufirst%3DC.%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DMossini%26aufirst%3DF.%26aulast%3DMorini%26aufirst%3DG.%26aulast%3DBarocelli%26aufirst%3DE.%26atitle%3DH1-antihistaminic%2520and%2520antimuscarinic%2520effects%2520of%25202-%2520and%25204-%255Bbenzyl-%25282-dimethylaminoethyl%2529amino%255Dpyrimidine%2520compounds%26jtitle%3DFarmaco%252C%2520Ed.%2520Sci.%26date%3D1988%26volume%3D43%26spage%3D277%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wacker, D. A.; Rossi, K. A.; Wang, Y.</span><span> </span><span class="NLM_article-title">Preparation of pyridones as GPR119 G protein-coupled receptor agonists</span>. WO2009012275, <span class="NLM_month">Jan</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+A.+Wacker&author=K.+A.+Rossi&author=Y.+Wang&title=Preparation+of+pyridones+as+GPR119+G+protein-coupled+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26atitle%3DPreparation%2520of%2520pyridones%2520as%2520GPR119%2520G%2520protein-coupled%2520receptor%2520agonists%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yamanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupton, J. T.</span><span> </span><span class="NLM_article-title">Preparation of novel β-trifluoromethyl vinamidinium salt and its synthetic application to trifluoromethylated heterocycles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1829</span><span class="NLM_x">–</span> <span class="NLM_lpage">1832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2F0040-4039%2896%2900129-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1CmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1829-1832&author=H.+Yamanakaauthor=T.+Takekawaauthor=K.+Moritaauthor=T.+Ishiharaauthor=J.+T.+Gupton&title=Preparation+of+novel+%CE%B2-trifluoromethyl+vinamidinium+salt+and+its+synthetic+application+to+trifluoromethylated+heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of novel β-trifluoromethyl vinamidinium salt and its synthetic application to trifluoromethylated heterocycles</span></div><div class="casAuthors">Yamanaka, Hiroki; Takekawa, Tadashi; Morita, Kenji; Ishihara, Takashi; Gupton, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1829-32</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">β-Trifluoromethylated vinamidinium salt I was prepd. in high yield by the reaction between 3,3,3-trifluoropropanoic acid and phosphorus oxychloride in N,N-dimethylformamide at 70 °C for 1 h.  I reacted readily with bifunctional nitrogen nucleophiles, such as amidine and hydrazine derivs., in acetonitrile or DMSO to furnish the corresponding trifluoromethylated azaheterocycles, e.g. II and III, in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqARGFq6vIgX7Vg90H21EOLACvtfcHk0ljBK9TagRpzTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1CmsLc%253D&md5=d4d1ee23d789d19175506cb4497b253c</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2896%2900129-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252896%252900129-3%26sid%3Dliteratum%253Aachs%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DTakekawa%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DK.%26aulast%3DIshihara%26aufirst%3DT.%26aulast%3DGupton%26aufirst%3DJ.%2BT.%26atitle%3DPreparation%2520of%2520novel%2520%25CE%25B2-trifluoromethyl%2520vinamidinium%2520salt%2520and%2520its%2520synthetic%2520application%2520to%2520trifluoromethylated%2520heterocycles%26jtitle%3DTetrahedron%2520Lett.%26date%3D1996%26volume%3D37%26spage%3D1829%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Potent and Selective ET-A Antagonists. 2. Discovery and Evaluation of Potent Water Soluble <i>N</i>-(6-(2-Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3369</span><span class="NLM_x">–</span> <span class="NLM_lpage">3377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000538f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3369-3377&author=H.+Morimotoauthor=N.+Ohashiauthor=H.+Shimadzuauthor=E.+Kushiyamaauthor=H.+Kawanishiauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Potent+and+Selective+ET-A+Antagonists.+2.+Discovery+and+Evaluation+of+Potent+Water+Soluble+N-%286-%282-Aryloxy%29ethoxy%29-4-pyrimidinyl%29sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm000538f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000538f%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DKushiyama%26aufirst%3DE.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DPotent%2520and%2520Selective%2520ET-A%2520Antagonists.%25202.%2520Discovery%2520and%2520Evaluation%2520of%2520Potent%2520Water%2520Soluble%2520N-%25286-%25282-Aryloxy%2529ethoxy%2529-4-pyrimidinyl%2529sulfonamide%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3369%26epage%3D3377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassal, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1993&pages=759-761&author=M.+Clozelauthor=V.+Breuauthor=K.+Burriauthor=J.-M.+Cassalauthor=W.+Fischliauthor=G.+A.+Grayauthor=G.+Hirthauthor=B.-M.+L%C3%B6fflerauthor=M.+M%C3%BCllerauthor=W.+Neidhartauthor=H.+Ramuz&title=Pathophysiological+role+of+endothelin+revealed+by+the+first+orally+active+endothelin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DCassal%26aufirst%3DJ.-M.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGray%26aufirst%3DG.%2BA.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.-M.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DPathophysiological%2520role%2520of%2520endothelin%2520revealed%2520by%2520the%2520first%2520orally%2520active%2520endothelin%2520receptor%2520antagonist%26jtitle%3DNature%26date%3D1993%26volume%3D365%26spage%3D759%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Neidhart, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramuz, H.</span><span> </span><span class="NLM_article-title">The Discovery of Nonpeptide Endothelin Receptor Antagonists. Progression towards Bosentan</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ygtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=519-524&author=W.+Neidhartauthor=V.+Breuauthor=D.+Burauthor=K.+Burriauthor=M.+Clozelauthor=G.+Hirthauthor=M.+M%C3%BCllerauthor=H.+P.+Wesselauthor=H.+Ramuz&title=The+Discovery+of+Nonpeptide+Endothelin+Receptor+Antagonists.+Progression+towards+Bosentan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of nonpeptide endothelin receptor antagonists. Progression towards bosentan</span></div><div class="casAuthors">Neidhart, Werner; Breu, Volker; Bur, Daniel; Burri, Kaspar; Clozel, Martine; Hirth, Georges; Mueller, Marcel; Wessel, Hans P.; Ramuz, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Chimia</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">519-524</span>CODEN:
                <span class="NLM_cas:coden">CHIMAD</span>;
        ISSN:<span class="NLM_cas:issn">0009-4293</span>.
    
            (<span class="NLM_cas:orgname">Neue Schweizerische Chemische Gesellschaft</span>)
        </div><div class="casAbstract">A review with 23 refs., describing the development of a novel class of nonpeptide endothelin receptor antagonists based on a lead file screening with special investigations on bosentan in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR6LsyBs_RyLVg90H21EOLACvtfcHk0ljcsp266TAtBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ygtLo%253D&md5=4c38eb56ca6997fe10b92799f87cd120</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DBurri%26aufirst%3DK.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DWessel%26aufirst%3DH.%2BP.%26aulast%3DRamuz%26aufirst%3DH.%26atitle%3DThe%2520Discovery%2520of%2520Nonpeptide%2520Endothelin%2520Receptor%2520Antagonists.%2520Progression%2520towards%2520Bosentan%26jtitle%3DChimia%26date%3D1996%26volume%3D50%26spage%3D519%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Breu, V.; Burri, K.; Cassal, J.-M.; Clozel, M.; Hirth, G.; Löffler, B.-M.; Müller, M.; Neidhart, W.; Ramuz, H.</span><span> </span><span class="NLM_article-title">Novel Sulfonamides</span>. WO9619459, <span class="NLM_month">Jun</span><span class="NLM_day">27</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=V.+Breu&author=K.+Burri&author=J.-M.+Cassal&author=M.+Clozel&author=G.+Hirth&author=B.-M.+L%C3%B6ffler&author=M.+M%C3%BCller&author=W.+Neidhart&author=H.+Ramuz&title=Novel+Sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreu%26aufirst%3DV.%26atitle%3DNovel%2520Sulfonamides%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Potent and Selective ET-A Antagonists. 1. Synthesis and Structure–Activity Relationship of <i>N</i>-(6-(2-Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3355</span><span class="NLM_x">–</span> <span class="NLM_lpage">3368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0102304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3355-3368&author=H.+Morimotoauthor=H.+Shimadzuauthor=E.+Kushiyamaauthor=H.+Kawanishiauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Potent+and+Selective+ET-A+Antagonists.+1.+Synthesis+and+Structure%E2%80%93Activity+Relationship+of+N-%286-%282-Aryloxy%29ethoxy%29-4-pyrimidinyl%29sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm0102304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0102304%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DKushiyama%26aufirst%3DE.%26aulast%3DKawanishi%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DPotent%2520and%2520Selective%2520ET-A%2520Antagonists.%25201.%2520Synthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520N-%25286-%25282-Aryloxy%2529ethoxy%2529-4-pyrimidinyl%2529sulfonamide%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3355%26epage%3D3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Morimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi-Kohno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">Modifications and Structure–Activity Relationships at the 2-Position of 4-Sulfonamidopyrimidine Derivatives as Potent Endothelin Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=81-84&author=H.+Morimotoauthor=H.+Shimadzuauthor=T.+Hosakaauthor=Y.+Kawaseauthor=K.+Yasudaauthor=K.+Kikkawaauthor=R.+Yamauchi-Kohnoauthor=K.+Yamada&title=Modifications+and+Structure%E2%80%93Activity+Relationships+at+the+2-Position+of+4-Sulfonamidopyrimidine+Derivatives+as+Potent+Endothelin+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DH.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DHosaka%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DKikkawa%26aufirst%3DK.%26aulast%3DYamauchi-Kohno%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DModifications%2520and%2520Structure%25E2%2580%2593Activity%2520Relationships%2520at%2520the%25202-Position%2520of%25204-Sulfonamidopyrimidine%2520Derivatives%2520as%2520Potent%2520Endothelin%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Brockway, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azar, S. H.</span><span> </span><span class="NLM_article-title">A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat via Radio-Telemetry</span> <span class="citation_source-journal">Clin. Exp. Hypertens.—Theory Pract</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">A13</span><span class="NLM_x">, </span> <span class="NLM_fpage">885</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.3109%2F10641969109042094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A13&publication_year=1991&pages=885-895&author=B.+P.+Brockwayauthor=P.+A.+Millsauthor=S.+H.+Azar&title=A+New+Method+for+Continuous+Chronic+Measurement+and+Recording+of+Blood+Pressure%2C+Heart+Rate+and+Activity+in+the+Rat+via+Radio-Telemetry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.3109%2F10641969109042094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10641969109042094%26sid%3Dliteratum%253Aachs%26aulast%3DBrockway%26aufirst%3DB.%2BP.%26aulast%3DMills%26aufirst%3DP.%2BA.%26aulast%3DAzar%26aufirst%3DS.%2BH.%26atitle%3DA%2520New%2520Method%2520for%2520Continuous%2520Chronic%2520Measurement%2520and%2520Recording%2520of%2520Blood%2520Pressure%252C%2520Heart%2520Rate%2520and%2520Activity%2520in%2520the%2520Rat%2520via%2520Radio-Telemetry%26jtitle%3DClin.%2520Exp.%2520Hypertens.%25E2%2580%2594Theory%2520Pract%26date%3D1991%26volume%3DA13%26spage%3D885%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Guiol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledoussal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgé, J.-M.</span><span> </span><span class="NLM_article-title">A Radiotelemetry System for Chronic Measurement of Blood Pressure and Heart Rate in the Unrestrained Rat Validation of the Method</span> <span class="citation_source-journal">J. Pharmcol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1016%2F1056-8719%2892%2990054-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=1482791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1992&pages=99-105&author=C.+Guiolauthor=C.+Ledoussalauthor=J.-M.+Surg%C3%A9&title=A+Radiotelemetry+System+for+Chronic+Measurement+of+Blood+Pressure+and+Heart+Rate+in+the+Unrestrained+Rat+Validation+of+the+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A radiotelemetry system for chronic measurement of blood pressure and heart rate in the unrestrained rat validation of the method</span></div><div class="casAuthors">Guiol C; Ledoussal C; Surge J M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-105</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">Chronic measurements of systemic arterial blood pressure and heart rate via a chronically implanted telemetric transmitter in unrestrained rats, was validated in a three-phase study.  In the first part, week-to-week variability of systolic, diastolic, and mean arterial pressures, and heart rate was found to be minimal over the course of nine weeks.  In the second part, the reproducibility of cardiovascular response to three successive administration of sotalol, an antihypertensive agent, was studied.  In the last part, cardiovascular parameters determined by telemetry were compared to those obtained by direct arterial catheterization and showed a good linear correlation between those two methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8i2XCcqJVRr5oR8RchjrrfW6udTcc2eZJcamnZ3mw9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7ivFyjug%253D%253D&md5=f501e12d4c69e9c5d9bbf7a85d1d5224</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2892%2990054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252892%252990054-5%26sid%3Dliteratum%253Aachs%26aulast%3DGuiol%26aufirst%3DC.%26aulast%3DLedoussal%26aufirst%3DC.%26aulast%3DSurg%25C3%25A9%26aufirst%3DJ.-M.%26atitle%3DA%2520Radiotelemetry%2520System%2520for%2520Chronic%2520Measurement%2520of%2520Blood%2520Pressure%2520and%2520Heart%2520Rate%2520in%2520the%2520Unrestrained%2520Rat%2520Validation%2520of%2520the%2520Method%26jtitle%3DJ.%2520Pharmcol.%2520Toxicol.%2520Methods%26date%3D1992%26volume%3D28%26spage%3D99%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span> </span><span class="NLM_article-title">Telemetry monitoring of pulmonary arterial pressure in freely moving rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1027-1032&author=P.+Hessauthor=M.+Clozelauthor=J.-P.+Clozel&title=Telemetry+monitoring+of+pulmonary+arterial+pressure+in+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DClozel%26aufirst%3DJ.-P.%26atitle%3DTelemetry%2520monitoring%2520of%2520pulmonary%2520arterial%2520pressure%2520in%2520freely%2520moving%2520rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1996%26volume%3D81%26spage%3D1027%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Iglarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capeleto, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span> </span><span class="NLM_article-title">Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3009103&amp;key=10.1124%2Fjpet.108.142976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18780830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=736-745&author=M.+Iglarzauthor=C.+Binkertauthor=K.+Morrisonauthor=W.+Fischliauthor=J.+Gatfieldauthor=A.+Treiberauthor=T.+Wellerauthor=M.+H.+Bolliauthor=C.+Bossauthor=S.+Buchmannauthor=B.+Capeletoauthor=P.+Hessauthor=C.+Qiuauthor=M.+Clozel&title=Pharmacology+of+Macitentan%2C+an+Orally+Active+Tissue-Targeting+Dual+Endothelin+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist</span></div><div class="casAuthors">Iglarz, Marc; Binkert, Christoph; Morrison, Keith; Fischli, Walter; Gatfield, John; Treiber, Alexander; Weller, Thomas; Bolli, Martin H.; Boss, Christoph; Buchmann, Stephan; Capeleto, Bruno; Hess, Patrick; Qiu, Changbin; Clozel, Martine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">736-745</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Macitentan, also called Actelion-1 or ACT-064992 [N-[5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl]-N'-propylaminosulfonamide],is a new dual ETA/ETB endothelin (ET) receptor antagonist designed for tissue targeting.  Selection of macitentan was based on inhibitory potency on both ET receptors and optimization of physicochem. properties to achieve high affinity for lipophilic milieu.  In vivo, macitentan is metabolized into a major and pharmacol. active metabolite, ACT-132577.  Macitentan and its metabolite antagonized the specific binding of ET-1 on membranes of cells overexpressing ETA and ETB receptors and blunted ET-1-induced calcium mobilization in various natural cell lines, with inhibitory consts. within the nanomolar range.  In functional assays, macitentan and ACT-132577 inhibited ET-1-induced contractions in isolated endothelium-denuded rat aorta (ETA receptors) and sarafotoxin S6c-induced contractions in isolated rat trachea (ETB receptors).  In rats with pulmonary hypertension, macitentan prevented both the increase of pulmonary pressure and the right ventricle hypertrophy, and it markedly improved survival.  In diabetic rats, chronic administration of macitentan decreased blood pressure and proteinuria and prevented end-organ damage (renal vascular hypertrophy and structural injury).  In conclusion, macitentan, by its tissue-targeting properties and dual antagonism of ET receptors, protects against end-organ damage in diabetes and improves survival in pulmonary hypertensive rats.  This profile makes macitentan a new agent to treat cardiovascular disorders assocd. with chronic tissue ET system activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIo4YPpTRKFrVg90H21EOLACvtfcHk0lj1V_qOD50p5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvO&md5=00d0f8e55081e3851b8f9b5740b8d419</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142976%26sid%3Dliteratum%253Aachs%26aulast%3DIglarz%26aufirst%3DM.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DMorrison%26aufirst%3DK.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DCapeleto%26aufirst%3DB.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DClozel%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520Macitentan%252C%2520an%2520Orally%2520Active%2520Tissue-Targeting%2520Dual%2520Endothelin%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D736%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Sidharta, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Giersbergen, P. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingemanse, J.</span><span> </span><span class="NLM_article-title">Macitentan: entry-into-humans study with a new endothelin receptor antagonist</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">984</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=977-984&author=P.+N.+Sidhartaauthor=P.+L.+M.+van+Giersbergenauthor=A.+Halabiauthor=J.+Dingemanse&title=Macitentan%3A+entry-into-humans+study+with+a+new+endothelin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSidharta%26aufirst%3DP.%2BN.%26aulast%3Dvan%2BGiersbergen%26aufirst%3DP.%2BL.%2BM.%26aulast%3DHalabi%26aufirst%3DA.%26aulast%3DDingemanse%26aufirst%3DJ.%26atitle%3DMacitentan%253A%2520entry-into-humans%2520study%2520with%2520a%2520new%2520endothelin%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D977%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Gabbay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, K.</span><span> </span><span class="NLM_article-title">Review of bosentan in the management of pulmonary arterial hypertension</span> <span class="citation_source-journal">Vasc. Health Risk Manage.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">887</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm3009103&amp;key=18200808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm3009103&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=887-900&author=E.+Gabbayauthor=J.+Fraserauthor=K.+McNeil&title=Review+of+bosentan+in+the+management+of+pulmonary+arterial+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Review of bosentan in the management of pulmonary arterial hypertension</span></div><div class="casAuthors">Gabbay, Eli; Fraser, John; McNeil, Keith</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Health and Risk Management</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">887-900</span>CODEN:
                <span class="NLM_cas:coden">VHRMAT</span>;
        ISSN:<span class="NLM_cas:issn">1176-6344</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  The dual endothelin receptor antagonist, bosentan, is an orally active therapy, which is effective in the treatment of pulmonary arterial hypertension (PAH).  This review critically appraises the evidence for the efficacy of bosentan in idiopathic and familial PAH, in PAH assocd. with connective tissue disease and in PAH which may develop in assocn. with other conditions.  Data from the pivotal placebo controlled studies and their open labeled extensions as well as long term survival and quality of life data is presented.  Data is also presented on the potential benefit of bosentan in patients with inoperable chronic thromboembolic pulmonary hypertension.  The safety and tolerability of bosentan as well as drug interactions are discussed.  Dosage recommendations in adults and pediatrics are presented.  An algorithm is provided to guide the reader in monitoring potential increases in alanine and aspartate transaminase levels that may occur with bosentan use and the dose adjustments that are recommended as a result of any increase in the levels of these enzymes are shown.  Finally, the role of bosentan as part of combination therapy in PAH is examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyWSGo0bulf7Vg90H21EOLACvtfcHk0lj1V_qOD50p5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKqsLo%253D&md5=d5bba2c592c2653f383961d729db921b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabbay%26aufirst%3DE.%26aulast%3DFraser%26aufirst%3DJ.%26aulast%3DMcNeil%26aufirst%3DK.%26atitle%3DReview%2520of%2520bosentan%2520in%2520the%2520management%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DVasc.%2520Health%2520Risk%2520Manage.%26date%3D2007%26volume%3D3%26spage%3D887%26epage%3D900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Dhillon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, G. M.</span><span> </span><span class="NLM_article-title">Bosentan—A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-350&author=S.+Dhillonauthor=G.+M.+Keating&title=Bosentan%E2%80%94A+Review+of+its+Use+in+the+Management+of+Mildly+Symptomatic+Pulmonary+Arterial+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26aulast%3DKeating%26aufirst%3DG.%2BM.%26atitle%3DBosentan%25E2%2580%2594A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Mildly%2520Symptomatic%2520Pulmonary%2520Arterial%2520Hypertension%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2009%26volume%3D9%26spage%3D331%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Dhillon, S.</span><span> </span><span class="NLM_article-title">Bosentan—A Review of its Use in the Management of Digital Ulcers Associated with Systemic Sclerosis</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">2005</span><span class="NLM_x">–</span> <span class="NLM_lpage">2024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=2005-2024&author=S.+Dhillon&title=Bosentan%E2%80%94A+Review+of+its+Use+in+the+Management+of+Digital+Ulcers+Associated+with+Systemic+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDhillon%26aufirst%3DS.%26atitle%3DBosentan%25E2%2580%2594A%2520Review%2520of%2520its%2520Use%2520in%2520the%2520Management%2520of%2520Digital%2520Ulcers%2520Associated%2520with%2520Systemic%2520Sclerosis%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D2005%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span>Study of ACT-064992 on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension; <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT00660179" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00660179</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study+of+ACT-064992+on+Morbidity+and+Mortality+in+Patients+With+Symptomatic+Pulmonary+Arterial+Hypertension%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00660179%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DStudy%2520of%2520ACT-064992%2520on%2520Morbidity%2520and%2520Mortality%2520in%2520Patients%2520With%2520Symptomatic%2520Pulmonary%2520Arterial%2520Hypertension%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span>Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-1); <span class="NLM_publisher-name">ClinicalTrials.gov</span>,, <a href="http://clinicaltrials.gov/ct2/show/NCT01474109" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01474109</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+for+the+Treatment+of+Digital+Ulcers+in+Systemic+Sclerosis+Patients+%28DUAL-1%29%3B+ClinicalTrials.gov%2C%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01474109%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520for%2520the%2520Treatment%2520of%2520Digital%2520Ulcers%2520in%2520Systemic%2520Sclerosis%2520Patients%2520%2528DUAL-1%2529%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span>Macitentan for the Treatment of Digital Ulcers in System Sclerosis Patients (DUAL-2); <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT01474122" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01474122</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+for+the+Treatment+of+Digital+Ulcers+in+System+Sclerosis+Patients+%28DUAL-2%29%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01474122%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520for%2520the%2520Treatment%2520of%2520Digital%2520Ulcers%2520in%2520System%2520Sclerosis%2520Patients%2520%2528DUAL-2%2529%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span>Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma; <span class="NLM_publisher-name">ClinicalTrials.gov</span>, <a href="http://clinicaltrials.gov/ct2/show/NCT01499251" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01499251</a><div class="note"><p class="first last">(Accessed May 2012)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Macitentan+in+Combo+With+Dose-dense+Temozolomide+in+Patients+With+Recurrent+Glioblastoma%3B+ClinicalTrials.gov%2C+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01499251%28Accessed+May+2012%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMacitentan%2520in%2520Combo%2520With%2520Dose-dense%2520Temozolomide%2520in%2520Patients%2520With%2520Recurrent%2520Glioblastoma%26pub%3DClinicalTrials.gov" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Zhong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbs, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span> </span><span class="NLM_article-title">Active-Site-Directed Modification of Subtilisin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2263</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00006a052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=2259-2263&author=Z.+Zhongauthor=J.+A.+Bibbsauthor=W.+Yuanauthor=C.-H.+Wong&title=Active-Site-Directed+Modification+of+Subtilisin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fja00006a052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00006a052%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DBibbs%26aufirst%3DJ.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DC.-H.%26atitle%3DActive-Site-Directed%2520Modification%2520of%2520Subtilisin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm3009103">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53758"></div></div></div></div></div><hr /></hr><p class="last">Experimental details on synthesis and characterization of the sulfamide and 4,6-dichloropyrimidine building blocks and the target compounds <b>8</b> and <b>17</b>–<b>71</b>. Two X-ray single crystal structures of compound <b>17</b> crystallized from different solvents.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3009103/suppl_file/jm3009103_si_001.pdf">jm3009103_si_001.pdf (528.48 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3009103&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm3009103%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3009103" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                678KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992f932b103d48","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
